,words,labels,sentence_id,full sentence
113,Selenium,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
114,content,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
115,in,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
116,the,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
117,tested,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
118,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
119,ranged,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
120,from,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
121,0.9,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
122,to,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
123,24.5,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
124,μg/100,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
125,g.,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
126,The,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
127,average,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
128,content,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
129,of,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
130,selenium,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
131,in,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
132,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
133,based,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
134,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
135,popular,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
136,gluten,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
137,-,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
138,free,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
139,cereals,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
140,was,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
141,2.8,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
142,μg/100,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
143,g,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
144,and,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
145,in,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
146,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
147,based,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
148,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
149,oat,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
150,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
151,amaranth,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
152,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
153,teff,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
154,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
155,and,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
156,quinoa,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
157,was,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
158,10.8,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
159,μg/100,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
160,g.,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
161,It,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
162,indicates,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
163,that,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
164,products,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
165,based,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
166,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
167,less,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
168,popular,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
169,grains,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
170,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
171,especially,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
172,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
173,oat,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
174,",",O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
175,should,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
176,be,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
177,more,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
178,frequently,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
179,chosen,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
180,as,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
181,a,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
182,source,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
183,of,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
184,selenium,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
185,by,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
186,people,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
187,on,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
188,gluten,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
189,-,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
190,free,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
191,diet,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
192,than,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
193,traditionally,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
194,consumed,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
195,gluten,B,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
196,-,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
197,free,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
198,grains,I,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
199,.,O,3.0,"Selenium content in the tested products ranged from 0.9 to 24.5 μg/100 g. The average content of selenium in products based on popular gluten - free cereals was 2.8 μg/100 g and in products based on oat , amaranth , teff , and quinoa was 10.8 μg/100 g. It indicates that products based on less popular grains , especially on oat , should be more frequently chosen as a source of selenium by people on gluten - free diet than traditionally consumed gluten - free grains ."
253,Modern,O,6.0,Modern breeding programs were conceived in the 1960s .
254,breeding,O,6.0,Modern breeding programs were conceived in the 1960s .
255,programs,O,6.0,Modern breeding programs were conceived in the 1960s .
256,were,O,6.0,Modern breeding programs were conceived in the 1960s .
257,conceived,O,6.0,Modern breeding programs were conceived in the 1960s .
258,in,O,6.0,Modern breeding programs were conceived in the 1960s .
259,the,O,6.0,Modern breeding programs were conceived in the 1960s .
260,1960s,O,6.0,Modern breeding programs were conceived in the 1960s .
261,.,O,6.0,Modern breeding programs were conceived in the 1960s .
335,Increasing,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
336,milk,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
337,yield,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
338,is,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
339,still,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
340,the,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
341,most,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
342,profitable,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
343,breeding,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
344,objective,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
345,for,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
346,several,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
347,breeds,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
348,.,O,9.0,Increasing milk yield is still the most profitable breeding objective for several breeds .
349,Almost,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
350,all,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
351,milk,B,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
352,is,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
353,used,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
354,for,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
355,cheese,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
356,production,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
357,and,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
358,",",O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
359,consequently,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
360,",",O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
361,milk,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
362,content,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
363,traits,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
364,are,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
365,very,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
366,important,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
367,.,O,10.0,"Almost all milk is used for cheese production and , consequently , milk content traits are very important ."
456,However,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
457,",",O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
458,the,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
459,possibility,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
460,of,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
461,including,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
462,other,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
463,traits,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
464,of,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
465,selective,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
466,interest,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
467,is,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
468,limited,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
469,by,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
470,high,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
471,recording,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
472,costs,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
473,.,O,14.0,"However , the possibility of including other traits of selective interest is limited by high recording costs ."
2303,After,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2304,16,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2305,weeks,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2306,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2307,ginger,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2308,supplementation,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2309,alleviated,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2310,the,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2311,HFD,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2312,-,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2313,induced,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2314,increases,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2315,in,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2316,body,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2317,weight,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2318,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2319,fat,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2320,accumulation,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2321,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2322,and,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2323,levels,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2324,of,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2325,serum,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2326,glucose,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2327,",",O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2328,triglyceride,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2329,and,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2330,cholesterol,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2331,.,O,74.0,"After 16 weeks , ginger supplementation alleviated the HFD - induced increases in body weight , fat accumulation , and levels of serum glucose , triglyceride and cholesterol ."
2355,Furthermore,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2356,",",O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2357,ginger,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2358,administration,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2359,corrected,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2360,the,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2361,HFD,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2362,-,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2363,induced,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2364,changes,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2365,in,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2366,concentrations,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2367,of,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2368,intermediates,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2369,in,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2370,glycolysis,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2371,and,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2372,the,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2373,TCA,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2374,cycle,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
2375,.,O,76.0,"Furthermore , ginger administration corrected the HFD - induced changes in concentrations of intermediates in glycolysis and the TCA cycle ."
3685,Pretreatment,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3686,of,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3687,severe,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3688,responders,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3689,with,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3690,bST,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3691,enhanced,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3692,milk,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3693,production,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3694,before,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3695,infection,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3696,",",O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3697,protected,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3698,the,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3699,mammary,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3700,glands,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3701,from,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3702,excessive,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3703,loss,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3704,of,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3705,milk,B,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3706,during,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3707,the,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3708,subsequently,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3709,induced,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3710,coliform,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3711,mastitis,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3712,",",O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3713,and,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3714,accelerated,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3715,normalization,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3716,of,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3717,milk,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3718,composition,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
3719,.,O,118.0,"Pretreatment of severe responders with bST enhanced milk production before infection , protected the mammary glands from excessive loss of milk during the subsequently induced coliform mastitis , and accelerated normalization of milk composition ."
4179,Brazilian,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4180,red,B,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4181,wine,I,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4182,contains,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4183,trans,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4184,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4185,astringin,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4186,",",O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4187,trans,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4188,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4189,piceid,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4190,",",O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4191,trans,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4192,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4193,resveratrol,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4194,",",O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4195,cis,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4196,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4197,resveratrol,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4198,(,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4199,in,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4200,high,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4201,quantity,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4202,:,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4203,5,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4204,times,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4205,more,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4206,than,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4207,the,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4208,trans,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4209,form,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4210,),O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4211,",",O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4212,epsilon,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4213,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4214,viniferin,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4215,",",O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4216,and,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4217,a,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4218,compound,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4219,isolated,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4220,for,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4221,the,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4222,first,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4223,time,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4224,in,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4225,wine,B,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4226,",",O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4227,trans,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4228,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4229,delta,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4230,-,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4231,viniferin,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4232,.,O,133.0,"Brazilian red wine contains trans - astringin , trans - piceid , trans - resveratrol , cis - resveratrol ( in high quantity : 5 times more than the trans form ) , epsilon - viniferin , and a compound isolated for the first time in wine , trans - delta - viniferin ."
4253,delta,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4254,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4255,Viniferin,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4256,contributes,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4257,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4258,as,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4259,well,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4260,as,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4261,cis,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4262,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4263,resveratrol,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4264,and,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4265,trans,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4266,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4267,piceid,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4268,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4269,to,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4270,a,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4271,significant,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4272,proportion,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4273,of,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4274,stilbenes,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4275,in,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4276,wine,B,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4277,dietary,I,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4278,intake,I,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4279,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4280,particularly,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4281,with,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4282,Merlot,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4283,varieties,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4284,containing,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4285,an,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4286,average,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4287,level,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4288,of,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4289,10,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4290,mg,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4291,/,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4292,L,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4293,for,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4294,delta,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4295,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4296,viniferin,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4297,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4298,15,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4299,mg,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4300,/,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4301,L,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4302,for,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4303,cis,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4304,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4305,resveratrol,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4306,",",O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4307,and,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4308,13,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4309,mg,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4310,/,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4311,L,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4312,for,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4313,trans,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4314,-,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4315,piceid,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4316,.,O,135.0,"delta - Viniferin contributes , as well as cis - resveratrol and trans - piceid , to a significant proportion of stilbenes in wine dietary intake , particularly with Merlot varieties containing an average level of 10 mg / L for delta - viniferin , 15 mg / L for cis - resveratrol , and 13 mg / L for trans - piceid ."
4600,Among,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4601,the,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4602,latter,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4603,",",O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4604,66·4,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4605,%,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4606,sold,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4607,only,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4608,industrial,B,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4609,foods,I,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4610,(,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4611,e.g.,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4612,pretzels,B,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4613,",",O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4614,biscuits,B,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4615,",",O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4616,wafers,B,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4617,",",O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4618,chocolate,B,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4619,and,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4620,ice,B,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4621,cream,I,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4622,),O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4623,",",O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4624,21·5,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4625,%,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4626,only,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4627,home,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4628,-,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4629,made,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4630,(,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4631,e.g.,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4632,savoury,I,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4633,and,I,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4634,sweet,I,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4635,pastries,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4636,),O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4637,and,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4638,12·1,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4639,%,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4640,both,O,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4641,.,B,146.0,"Among the latter , 66·4 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 21·5 % only home - made ( e.g. savoury and sweet pastries ) and 12·1 % both ."
4720,Soft,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4721,drinks,B,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4722,and,I,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4723,alcoholic,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4724,beverages,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4725,were,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4726,available,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4727,in,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4728,80·7,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4729,and,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4730,42·0,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4731,%,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4732,of,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4733,the,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4734,vending,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4735,sites,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4736,selling,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4737,beverages,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4738,",",O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4739,respectively,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4740,.,O,149.0,"Soft drinks and alcoholic beverages were available in 80·7 and 42·0 % of the vending sites selling beverages , respectively ."
4814,In,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4815,vivo,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4816,",",O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4817,alpha,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4818,linolenic,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4819,acid,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4820,(,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4821,ALA,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4822,",",O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4823,18:3n-3,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4824,),O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4825,can,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4826,be,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4827,converted,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4828,to,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4829,EPA,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4830,or,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4831,DHA,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
4832,.,O,153.0,"In vivo , alpha linolenic acid ( ALA , 18:3n-3 ) can be converted to EPA or DHA ."
5858,The,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5859,red,B,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5860,wine,I,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5861,",",O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5862,which,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5863,had,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5864,a,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5865,negligible,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5866,tyramine,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5867,content,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5868,",",O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5869,provoked,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5870,a,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5871,typical,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5872,migraine,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5873,attack,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5874,in,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5875,9,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5876,of,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5877,11,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5878,such,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5879,patients,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5880,",",O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5881,whereas,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5882,none,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5883,of,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5884,the,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5885,8,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5886,challenged,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5887,with,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5888,vodka,B,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5889,had,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5890,an,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5891,attack,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
5892,.,O,189.0,"The red wine , which had a negligible tyramine content , provoked a typical migraine attack in 9 of 11 such patients , whereas none of the 8 challenged with vodka had an attack ."
6426,In,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6427,children,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6428,",",O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6429,100,B,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6430,%,B,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6431,fruit,I,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6432,juice,I,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6433,is,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6434,associated,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6435,with,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6436,increased,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6437,intakes,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6438,of,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6439,nutrients,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6440,such,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6441,as,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6442,vitamin,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6443,C,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6444,",",O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6445,folate,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6446,",",O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6447,and,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6448,potassium,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6449,.,O,209.0,"In children , 100 % fruit juice is associated with increased intakes of nutrients such as vitamin C , folate , and potassium ."
6642,Osteoporosis,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6643,can,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6644,be,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6645,defined,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6646,as,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6647,a,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6648,disease,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6649,characterized,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6650,by,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6651,low,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6652,bone,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6653,mass,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6654,and,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6655,microarchitectural,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6656,deterioration,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6657,of,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6658,bone,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6659,tissue,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6660,",",O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6661,leading,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6662,to,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6663,enhanced,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6664,bone,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6665,fragility,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6666,and,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6667,a,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6668,consequent,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6669,increase,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6670,in,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6671,fracture,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6672,risk,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6673,.,O,216.0,"Osteoporosis can be defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue , leading to enhanced bone fragility and a consequent increase in fracture risk ."
6731,The,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6732,role,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6733,of,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6734,calcium,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6735,intake,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6736,in,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6737,determining,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6738,bone,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6739,mineral,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6740,mass,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6741,is,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6742,well,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6743,recognized,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6744,to,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6745,be,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6746,the,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6747,most,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6748,critical,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6749,nutritional,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6750,factor,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6751,to,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6752,achieve,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6753,optimal,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6754,peak,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6755,bone,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6756,mass,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6757,.,O,219.0,The role of calcium intake in determining bone mineral mass is well recognized to be the most critical nutritional factor to achieve optimal peak bone mass .
6799,Although,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6800,studies,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6801,supporting,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6802,the,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6803,beneficial,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6804,effects,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6805,of,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6806,milk,B,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6807,or,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6808,calcium,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6809,on,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6810,bone,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6811,health,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6812,are,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6813,predominant,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6814,in,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6815,the,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6816,literature,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6817,",",O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6818,perplexity,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6819,or,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6820,discordance,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6821,on,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6822,this,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6823,subject,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6824,was,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6825,expressed,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6826,by,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6827,some,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6828,authors,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6829,.,O,221.0,"Although studies supporting the beneficial effects of milk or calcium on bone health are predominant in the literature , perplexity or discordance on this subject was expressed by some authors ."
6875,Milk,B,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6876,and,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6877,dairy,B,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6878,products,I,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6879,are,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6880,an,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6881,optimal,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6882,source,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6883,of,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6884,calcium,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6885,as,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6886,well,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6887,as,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6888,of,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6889,other,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6890,limiting,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6891,nutrients,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6892,(,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6893,e.g.,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6894,",",O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6895,potassium,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6896,and,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6897,magnesium,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6898,),O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6899,",",O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6900,with,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6901,important,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6902,effects,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6903,on,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6904,bone,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6905,health,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6906,.,O,225.0,"Milk and dairy products are an optimal source of calcium as well as of other limiting nutrients ( e.g. , potassium and magnesium ) , with important effects on bone health ."
6977,As,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6978,a,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6979,general,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6980,conclusion,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6981,",",O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6982,calcium,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6983,is,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6984,essential,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6985,for,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6986,bone,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6987,health,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6988,",",O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6989,although,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6990,it,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6991,will,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6992,not,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6993,prevent,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6994,bone,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6995,loss,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6996,due,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6997,to,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6998,other,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
6999,factors,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7000,;,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7001,in,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7002,this,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7003,context,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7004,",",O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7005,milk,B,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7006,and,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7007,dairy,B,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7008,foods,I,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7009,are,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7010,bioavailable,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7011,",",O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7012,relatively,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7013,inexpensive,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7014,sources,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7015,of,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7016,calcium,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7017,for,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7018,the,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7019,human,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7020,diet,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7021,.,O,229.0,"As a general conclusion , calcium is essential for bone health , although it will not prevent bone loss due to other factors ; in this context , milk and dairy foods are bioavailable , relatively inexpensive sources of calcium for the human diet ."
7061,The,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7062,purpose,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7063,of,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7064,this,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7065,study,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7066,was,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7067,to,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7068,determine,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7069,the,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7070,ideal,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7071,combination,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7072,of,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7073,coffee,B,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7074,",",O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7075,cream,B,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7076,",",O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7077,and,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7078,sugar,B,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7079,in,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7080,order,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7081,to,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7082,minimize,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7083,MG,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7084,consumption,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7085,.,O,232.0,"The purpose of this study was to determine the ideal combination of coffee , cream , and sugar in order to minimize MG consumption ."
7373,Patient,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7374,history,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7375,of,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7376,food,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7377,intolerance,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7378,was,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7379,documented,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7380,by,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7381,a,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7382,standardized,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7383,questionnaire,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7384,.,O,244.0,Patient history of food intolerance was documented by a standardized questionnaire .
7385,Fruit,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7386,-,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7387,specific,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7388,IgE,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7389,antibodies,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7390,were,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7391,detected,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7392,in,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7393,69.1,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7394,%,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7395,of,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7396,serum,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7397,samples,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7398,.,O,245.0,Fruit - specific IgE antibodies were detected in 69.1 % of serum samples .
7495,Thus,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7496,",",O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7497,serologic,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7498,tests,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7499,seem,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7500,to,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7501,be,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7502,of,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7503,low,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7504,significance,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7505,for,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7506,prediction,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7507,o,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7508,food,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7509,allergy,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7510,in,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7511,latex,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7512,-,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7513,allergic,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7514,patients,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
7515,.,O,249.0,"Thus , serologic tests seem to be of low significance for prediction o food allergy in latex - allergic patients ."
8093,Food,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8094,fortification,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8095,is,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8096,designed,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8097,to,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8098,improve,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8099,the,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8100,nutritional,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8101,profile,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8102,of,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8103,diets,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8104,.,O,270.0,Food fortification is designed to improve the nutritional profile of diets .
8522,A,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8523,significant,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8524,direct,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8525,trend,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8526,in,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8527,risk,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8528,was,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8529,found,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8530,for,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8531,bread,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8532,(,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8533,OR,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8534,=,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8535,1.94,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8536,for,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8537,the,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8538,highest,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8539,versus,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8540,the,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8541,lowest,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8542,intake,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8543,quintile,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8544,),O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8545,",",O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8546,and,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8547,a,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8548,modest,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8549,excess,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8550,of,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8551,risk,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8552,was,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8553,observed,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8554,for,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8555,pasta,B,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8556,and,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8557,rice,B,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8558,(,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8559,OR,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8560,=,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8561,1.29,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8562,),O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8563,",",O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8564,and,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8565,milk,B,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8566,and,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8567,yoghurt,B,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8568,(,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8569,OR,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8570,=,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8571,1.27,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8572,),O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8573,.,O,282.0,"A significant direct trend in risk was found for bread ( OR = 1.94 for the highest versus the lowest intake quintile ) , and a modest excess of risk was observed for pasta and rice ( OR = 1.29 ) , and milk and yoghurt ( OR = 1.27 ) ."
8632,The,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8633,results,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8634,of,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8635,this,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8636,study,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8637,provide,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8638,further,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8639,indications,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8640,on,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8641,dietary,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8642,correlates,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8643,of,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8644,RCC,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8645,",",O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8646,and,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8647,in,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8648,particular,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8649,indicate,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8650,that,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8651,a,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8652,diet,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8653,rich,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8654,in,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8655,refined,B,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8656,cereals,I,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8657,and,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8658,poor,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8659,in,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8660,vegetables,B,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8661,may,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8662,have,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8663,an,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8664,unfavorable,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8665,role,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8666,on,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8667,RCC,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8668,.,O,285.0,"The results of this study provide further indications on dietary correlates of RCC , and in particular indicate that a diet rich in refined cereals and poor in vegetables may have an unfavorable role on RCC ."
8781,Kurakkan,B,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8782,flour,I,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8783,pittu,I,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8784,and,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8785,wheat,B,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8786,flour,I,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8787,roti,I,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8788,were,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8789,classified,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8790,as,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8791,medium,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8792,-,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8793,GI,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8794,foods,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8795,with,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8796,GI,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8797,values,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8798,of,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8799,85+/-6,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8800,and,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8801,72+/-6,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
8802,.,O,288.0,Kurakkan flour pittu and wheat flour roti were classified as medium - GI foods with GI values of 85+/-6 and 72+/-6 .
9038,Lactalbumin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9039,and,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9040,lactoferrin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9041,decreased,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9042,plasma,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9043,leptin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9044,and,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9045,insulin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9046,",",O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9047,and,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9048,lactalbumin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9049,increased,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9050,peptide,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9051,YY,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9052,.,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9118,Dietary,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9119,lactalbumin,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9120,and,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9121,lactoferrin,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9122,improved,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9123,energy,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9124,balance,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9125,and,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9126,metabolism,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9127,",",O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9128,and,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9129,decreased,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9130,adiposity,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9131,",",O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9132,with,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9133,the,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9134,effects,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9135,of,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9136,lactoferrin,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9137,being,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9138,partly,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9139,independent,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9140,of,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9141,caloric,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9142,intake,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9143,.,O,301.0,"Dietary lactalbumin and lactoferrin improved energy balance and metabolism , and decreased adiposity , with the effects of lactoferrin being partly independent of caloric intake ."
9544,However,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9545,",",O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9546,FTs,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9547,role,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9548,in,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9549,soybean,B,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9550,is,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9551,not,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9552,fully,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9553,resolved,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9554,due,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9555,to,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9556,the,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9557,presence,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9558,of,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9559,multiple,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9560,(,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9561,ten,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9562,),O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9563,homologs,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9564,in,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9565,the,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9566,genome,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9567,.,O,316.0,"However , FTs role in soybean is not fully resolved due to the presence of multiple ( ten ) homologs in the genome ."
9615,One,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9616,FT,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9617,homolog,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9618,",",O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9619,GmFT7,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9620,showed,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9621,strong,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9622,expression,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9623,during,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9624,soybean,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9625,floral,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9626,transition,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9627,.,O,319.0,"One FT homolog , GmFT7 showed strong expression during soybean floral transition ."
9827,Cell,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9828,cultures,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9829,were,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9830,treated,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9831,with,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9832,glutamate,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9833,(,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9834,100,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9835,μM,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9836,),O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9837,for,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9838,24,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9839,h,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9840,",",O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9841,and,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9842,the,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9843,effect,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9844,of,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9845,extracts,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9846,was,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9847,determined,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9848,on,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9849,cells,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9850,subjected,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9851,to,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9852,this,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9853,excitotoxicity,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9854,.,O,328.0,"Cell cultures were treated with glutamate ( 100 μM ) for 24 h , and the effect of extracts was determined on cells subjected to this excitotoxicity ."
9871,Whereas,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9872,lingonberry,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9873,fruit,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9874,extract,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9875,did,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9876,not,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9877,provide,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9878,protection,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9879,from,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9880,glutamate,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9881,toxicity,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9882,",",O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9883,blueberry,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9884,fruit,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9885,extracts,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9886,were,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9887,extremely,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9888,protective,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9889,.,O,330.0,"Whereas lingonberry fruit extract did not provide protection from glutamate toxicity , blueberry fruit extracts were extremely protective ."
9890,Leaf,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9891,extracts,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9892,of,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9893,both,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9894,lingonberry,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9895,and,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9896,blueberry,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9897,showed,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9898,a,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9899,significant,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9900,neuroprotective,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9901,effect,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9902,.,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
10095,Interim,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10096,dietary,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10097,guidelines,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10098,to,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10099,reduce,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10100,the,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10101,risk,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10102,of,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10103,cancer,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10104,were,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10105,proposed,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10106,in,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10107,accordance,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10108,with,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10109,these,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10110,conclusions,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10111,.,O,339.0,Interim dietary guidelines to reduce the risk of cancer were proposed in accordance with these conclusions .
10332,The,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10333,acute,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10334,dietary,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10335,exposure,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10336,to,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10337,potato,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10338,GAs,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10339,was,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10340,estimated,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10341,using,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10342,a,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10343,probabilistic,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10344,approach,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10345,and,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10346,applying,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10347,processing,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10348,factors,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10349,for,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10350,food,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10351,.,O,348.0,The acute dietary exposure to potato GAs was estimated using a probabilistic approach and applying processing factors for food .
10370,The,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10371,MOEs,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10372,for,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10373,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10374,younger,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10375,age,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10376,groups,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10377,indicate,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10378,a,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10379,health,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10380,concern,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10381,for,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10382,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10383,food,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10384,consumption,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10385,surveys,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10386,with,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10387,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10388,highest,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10389,mean,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10390,exposure,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10391,",",O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10392,as,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10393,well,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10394,as,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10395,for,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10396,the,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10397,P95,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10398,exposure,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10399,in,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10400,all,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10401,surveys,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10402,.,O,350.0,"The MOEs for the younger age groups indicate a health concern for the food consumption surveys with the highest mean exposure , as well as for the P95 exposure in all surveys ."
10454,For,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10455,horses,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10456,",",O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10457,farm,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10458,and,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10459,companion,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10460,animals,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10461,",",O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10462,no,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10463,risk,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10464,characterisation,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10465,for,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10466,potato,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10467,GAs,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10468,could,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10469,be,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10470,performed,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10471,due,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10472,to,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10473,insufficient,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10474,data,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10475,on,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10476,occurrence,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10477,in,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10478,feed,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10479,and,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10480,on,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10481,potential,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10482,adverse,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10483,effects,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10484,of,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10485,GAs,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10486,in,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10487,these,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10488,species,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10489,.,O,353.0,"For horses , farm and companion animals , no risk characterisation for potato GAs could be performed due to insufficient data on occurrence in feed and on potential adverse effects of GAs in these species ."
10535,The,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10536,plant,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10537,-,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10538,based,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10539,emulsions,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10540,are,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10541,directed,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10542,to,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10543,prevent,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10544,diet,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10545,-,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10546,related,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10547,chronic,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10548,diseases,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10549,including,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10550,diabetes,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10551,",",O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10552,cardiovascular,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10553,",",O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10554,obesity,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10555,and,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10556,other,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10557,disorders,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10558,due,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10559,to,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10560,the,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10561,presence,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10562,of,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10563,healthy,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10564,long,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10565,-,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10566,chain,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10567,unsaturated,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10568,fatty,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10569,acids,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10570,as,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10571,compared,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10572,to,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10573,bovine,B,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10574,milk,I,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10575,.,O,356.0,"The plant - based emulsions are directed to prevent diet - related chronic diseases including diabetes , cardiovascular , obesity and other disorders due to the presence of healthy long - chain unsaturated fatty acids as compared to bovine milk ."
10682,It,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10683,also,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10684,covers,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10685,fats,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10686,digestibility,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10687,",",O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10688,protein,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10689,stability,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10690,",",O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10691,protein,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10692,solubility,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10693,and,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10694,digestibility,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
10695,.,O,361.0,"It also covers fats digestibility , protein stability , protein solubility and digestibility ."
11040,The,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11041,main,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11042,cause,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11043,of,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11044,obesity,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11045,is,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11046,energy,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11047,imbalance,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11048,",",O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11049,of,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11050,which,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11051,contributing,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11052,factors,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11053,include,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11054,a,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11055,sedentary,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11056,lifestyle,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11057,",",O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11058,epigenetic,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11059,factors,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11060,and,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11061,excessive,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11062,caloric,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11063,intake,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11064,through,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11065,food,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11066,and,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11067,beverages,B,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11068,.,O,371.0,"The main cause of obesity is energy imbalance , of which contributing factors include a sedentary lifestyle , epigenetic factors and excessive caloric intake through food and beverages ."
11541,Immunological,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11542,and,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11543,respiratory,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11544,findings,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11545,were,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11546,studied,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11547,in,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11548,a,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11549,group,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11550,of,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11551,45,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11552,female,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11553,spice,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11554,-,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11555,factory,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11556,workers,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11557,(,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11558,mean,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11559,age,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11560,:,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11561,39,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11562,years,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11563,;,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11564,mean,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11565,exposure,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11566,:,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11567,17,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11568,years,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11569,),O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11570,.,O,386.0,Immunological and respiratory findings were studied in a group of 45 female spice - factory workers ( mean age : 39 years ; mean exposure : 17 years ) .
11730,Ventilatory,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11731,capacity,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11732,was,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11733,measured,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11734,by,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11735,recording,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11736,maximum,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11737,expiratory,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11738,flow,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11739,-,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11740,volume,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11741,(,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11742,MEFV,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11743,),O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11744,curves,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
11745,.,O,394.0,Ventilatory capacity was measured by recording maximum expiratory flow - volume ( MEFV ) curves .
12524,When,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12525,consumers,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12526,were,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12527,informed,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12528,of,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12529,sodium,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12530,reduction,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12531,and,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12532,its,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12533,health,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12534,benefits,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12535,before,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12536,tasting,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12537,cottage,B,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12538,cheese,I,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12539,with,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12540,lower,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12541,sodium,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12542,(,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12543,4,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12544,-,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12545,12,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12546,%,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12547,),O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12548,",",O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12549,overall,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12550,liking,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12551,scores,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12552,for,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12553,the,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12554,lower,B,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12555,sodium,I,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12556,cottage,I,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12557,cheeses,I,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12558,were,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12559,not,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12560,different,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12561,from,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12562,higher,B,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12563,sodium,I,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12564,cottage,I,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12565,cheeses,I,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12566,.,O,419.0,"When consumers were informed of sodium reduction and its health benefits before tasting cottage cheese with lower sodium ( 4 - 12 % ) , overall liking scores for the lower sodium cottage cheeses were not different from higher sodium cottage cheeses ."
12932,A,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12933,review,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12934,of,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12935,the,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12936,development,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12937,of,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12938,food,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12939,allergy,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12940,in,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12941,a,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12942,birth,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12943,cohort,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12944,of,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12945,620,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12946,Australian,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12947,infants,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12948,at,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12949,high,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12950,risk,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12951,for,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12952,development,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12953,of,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12954,atopic,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12955,disease,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12956,has,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12957,recently,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12958,been,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12959,completed,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12960,.,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12961,Extrapolating,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12962,to,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12963,a,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12964,random,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12965,community,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12966,population,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12967,showed,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12968,that,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12969,at,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12970,the,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12971,age,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12972,of,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12973,two,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12974,",",O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12975,egg,B,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12976,appears,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12977,the,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12978,most,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12979,frequent,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12980,food,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12981,allergen,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12982,(,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12983,3.2,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12984,%,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12985,),O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12986,",",O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12987,while,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12988,cow,B,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12989,milk,I,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12990,(,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12991,2.0,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12992,%,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12993,),O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12994,",",O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12995,and,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12996,peanut,B,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12997,are,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12998,of,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
12999,similar,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13000,frequency,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13001,(,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13002,1.9,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13003,%,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13004,),O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13005,.,O,431.0,"Extrapolating to a random community population showed that at the age of two , egg appears the most frequent food allergen ( 3.2 % ) , while cow milk ( 2.0 % ) , and peanut are of similar frequency ( 1.9 % ) ."
13089,Rice,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13090,hypersensitivity,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13091,was,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13092,rare,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13093,in,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13094,both,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13095,Australia,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13096,and,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13097,Asian,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13098,countries,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13099,.,O,434.0,Rice hypersensitivity was rare in both Australia and Asian countries .
13258,Plasma,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13259,IL-6,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13260,concentrations,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13261,increased,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13262,significantly,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13263,(,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13264,P,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13265, ,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13266,<,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13267, ,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13268,0·001,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13269,),O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13270,during,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13271,4,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13272, ,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13273,h,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13274,after,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13275,the,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13276,meals,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13277,.,O,440.0,Plasma IL-6 concentrations increased significantly ( P   <   0·001 ) during 4   h after the meals .
13440,We,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13441,determined,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13442,the,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13443,intake,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13444,of,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13445,gluten,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13446,from,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13447,wheat,B,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13448,",",O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13449,barley,B,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13450,",",O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13451,rye,B,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13452,and,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13453,oats,B,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13454,in,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13455,a,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13456,cross,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13457,-,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13458,sectional,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13459,National,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13460,Danish,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13461,Survey,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13462,of,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13463,Dietary,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13464,Habits,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13465,among,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13466,Infants,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13467,and,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13468,Young,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13469,Children,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13470,(,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13471,2006,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13472,-,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13473,2007,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13474,),O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13475,.,O,447.0,"We determined the intake of gluten from wheat , barley , rye and oats in a cross - sectional National Danish Survey of Dietary Habits among Infants and Young Children ( 2006 - 2007 ) ."
13929,Foods,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13930,contain,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13931,a,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13932,wide,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13933,range,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13934,of,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13935,food,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13936,ingredients,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13937,that,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13938,serve,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13939,numerous,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13940,technical,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13941,functions,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13942,.,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
14103,These,O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14104,ingredients,O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14105,include,O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14106,carmine,O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14107,",",O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14108,cochineal,O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14109,extract,O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14110,",",O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14111,annatto,O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14112,",",O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14113,tragacanth,O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14114,gum,O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14115,and,O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14116,papain,O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14117,.,O,471.0,"These ingredients include carmine , cochineal extract , annatto , tragacanth gum and papain ."
14231,Of,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14232,this,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14233,total,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14234,",",O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14235,195,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14236,patients,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14237,had,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14238,apple,B,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14239,and/or,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14240,hazelnut,I,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14241,allergy,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14242,",",O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14243,and,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14244,103,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14245,had,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14246,Apiaceae,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14247,sensitivity,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14248,;,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14249,only,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14250,one,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14251,patient,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14252,had,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14253,Apiaceae,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14254,allergy,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14255,alone,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14256,.,O,475.0,"Of this total , 195 patients had apple and/or hazelnut allergy , and 103 had Apiaceae sensitivity ; only one patient had Apiaceae allergy alone ."
14380,This,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14381,study,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14382,suggests,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14383,that,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14384,most,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14385,Apiaceae,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14386,determinants,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14387,cross,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14388,-,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14389,react,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14390,with,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14391,apple,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14392,or,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14393,hazelnut,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14394,determinants,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14395,",",O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14396,whereas,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14397,only,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14398,some,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14399,apple,B,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14400,or,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14401,hazelnut,B,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14402,determinants,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14403,cross,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14404,-,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14405,react,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14406,with,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14407,Apiaceae,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14408,-,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14409,allergenic,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14410,determinants,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14411,;,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14412,moreover,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14413,",",O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14414,it,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14415,shows,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14416,that,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14417,birch,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14418,-,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14419,specific,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14420,IgE,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14421,levels,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14422,heavily,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14423,influence,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14424,the,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14425,onset,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14426,of,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14427,OAS,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14428,as,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14429,a,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14430,whole,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14431,",",O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14432,and,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14433,probably,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14434,play,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14435,a,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14436,critical,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14437,role,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14438,in,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14439,the,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14440,development,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14441,of,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14442,allergies,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14443,to,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14444,distinct,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14445,vegetable,B,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14446,foods,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14447,as,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14448,well,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14449,.,O,479.0,"This study suggests that most Apiaceae determinants cross - react with apple or hazelnut determinants , whereas only some apple or hazelnut determinants cross - react with Apiaceae - allergenic determinants ; moreover , it shows that birch - specific IgE levels heavily influence the onset of OAS as a whole , and probably play a critical role in the development of allergies to distinct vegetable foods as well ."
14647,Adjustment,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14648,in,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14649,the,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14650,statistical,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14651,analysis,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14652,for,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14653,energy,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14654,intake,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14655,and,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14656,for,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14657,other,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14658,dietary,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14659,variables,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14660,(,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14661,fiber,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14662,from,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14663,fruits,B,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14664,and,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14665,fiber,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14666,from,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14667,vegetables,B,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14668,),O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14669,",",O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14670,which,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14671,were,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14672,found,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14673,to,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14674,be,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14675,risk,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14676,factors,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14677,in,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14678,the,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14679,study,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14680,",",O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14681,did,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14682,not,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14683,substantially,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14684,change,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14685,the,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14686,results,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14687,found,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14688,for,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14689,beer,B,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14690,and,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14691,other,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14692,alcoholic,B,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14693,beverages,I,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14694,.,O,487.0,"Adjustment in the statistical analysis for energy intake and for other dietary variables ( fiber from fruits and fiber from vegetables ) , which were found to be risk factors in the study , did not substantially change the results found for beer and other alcoholic beverages ."
14801,Modern,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14802,diets,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14803,enriched,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14804,in,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14805,sugars,B,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14806,and,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14807,saturated,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14808,fats,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14809,increase,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14810,lipid,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14811,accumulation,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14812,in,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14813,hepatocytes,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14814,(,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14815,nonalcoholic,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14816,fatty,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14817,liver,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14818,disease,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14819,),O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
14820,.,O,492.0,Modern diets enriched in sugars and saturated fats increase lipid accumulation in hepatocytes ( nonalcoholic fatty liver disease ) .
15358,However,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15359,",",O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15360,health,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15361,-,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15362,promoting,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15363,effects,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15364,are,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15365,associated,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15366,with,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15367,consumption,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15368,of,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15369,anhydrous,B,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15370,milk,I,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15371,fat,I,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15372,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15373,AMF,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15374,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15375,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15376,ruminant,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15377,trans,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15378,fatty,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15379,acids,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15380,",",O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15381,such,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15382,as,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15383,conjugated,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15384,linoleic,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15385,acid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15386,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15387,CLA,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15388,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15389,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15390,vaccenic,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15391,acid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15392,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15393,VA,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15394,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15395,contained,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15396,in,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15397,the,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15398,lipid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15399,fraction,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15400,of,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15401,milk,B,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15402,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15403,dairy,B,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15404,products,I,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15405,.,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15591,Diet,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15592,in,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15593,the,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15594,year,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15595,before,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15596,sigmoidoscopy,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15597,was,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15598,measured,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15599,with,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15600,a,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15601,food,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15602,frequency,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15603,questionnaire,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15604,.,O,522.0,Diet in the year before sigmoidoscopy was measured with a food frequency questionnaire .
15887,Analysis,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15888,of,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15889,blood,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15890,via,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15891,untargeted,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15892,metabolomics,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15893,analysis,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15894,identified,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15895,eight,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15896,",",O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15897,four,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15898,",",O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15899,and,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15900,four,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15901,metabolites,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15902,significantly,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15903,altered,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15904,by,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15905,protein,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15906,level,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15907,",",O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15908,protein,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15909,source,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15910,",",O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15911,and,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15912,a,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15913,protein,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15914,level,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15915,-,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15916,source,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15917,interaction,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15918,",",O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15919,respectively,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
15920,.,O,530.0,"Analysis of blood via untargeted metabolomics analysis identified eight , four , and four metabolites significantly altered by protein level , protein source , and a protein level - source interaction , respectively ."
16644,The,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16645,addition,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16646,of,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16647,dairy,B,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16648,products,I,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16649,to,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16650,meals,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16651,high,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16652,in,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16653,carbohydrates,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16654,and,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16655,fat,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16656,may,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16657,lessen,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16658,these,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16659,risks,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16660,through,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16661,reductions,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16662,in,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16663,postprandial,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16664,glucose,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16665,and,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16666,triglyceride,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16667,responses,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16668,.,O,553.0,The addition of dairy products to meals high in carbohydrates and fat may lessen these risks through reductions in postprandial glucose and triglyceride responses .
16726,Coffee,B,556.0,Coffee is a popular beverage throughout the world .
16727,is,O,556.0,Coffee is a popular beverage throughout the world .
16728,a,O,556.0,Coffee is a popular beverage throughout the world .
16729,popular,O,556.0,Coffee is a popular beverage throughout the world .
16730,beverage,O,556.0,Coffee is a popular beverage throughout the world .
16731,throughout,O,556.0,Coffee is a popular beverage throughout the world .
16732,the,O,556.0,Coffee is a popular beverage throughout the world .
16733,world,O,556.0,Coffee is a popular beverage throughout the world .
16734,.,O,556.0,Coffee is a popular beverage throughout the world .
16990,Apple,B,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16991,",",O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16992,carrot,B,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16993,",",O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16994,potato,B,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16995,",",O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16996,hazelnut,B,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16997,and,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16998,birch,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
16999,reactivity,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17000,was,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17001,transferable,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17002,in,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17003,Prausnitz,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17004,-,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17005,Küstner,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17006,test,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17007,like,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17008,IgE,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17009,antibodies,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17010,.,O,568.0,"Apple , carrot , potato , hazelnut and birch reactivity was transferable in Prausnitz - Küstner test like IgE antibodies ."
17461,For,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17462,serum,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17463,lipid,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17464,analysis,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17465,",",O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17466,blood,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17467,samples,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17468,were,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17469,obtained,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17470,on,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17471,days,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17472,0,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17473,",",O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17474,7,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17475,and,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17476,14,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17477,in,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17478,study,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17479,1,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17480,and,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17481,on,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17482,days,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17483,0,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17484,",",O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17485,7,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17486,",",O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17487,14,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17488,and,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17489,21,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17490,in,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17491,study,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17492,2,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17493,.,O,582.0,"For serum lipid analysis , blood samples were obtained on days 0 , 7 and 14 in study 1 and on days 0 , 7 , 14 and 21 in study 2 ."
17494,Statistical,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17495,analyses,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17496,of,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17497,the,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17498,data,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17499,in,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17500,Study,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17501,1,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17502,indicated,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17503,a,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17504,tendency,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17505,for,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17506,serum,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17507,total,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17508,cholesterol,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17509,and,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17510,high,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17511,density,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17512,lipoprotein,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17513,-,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17514,cholesterol,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17515,to,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17516,increase,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17517,with,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17518,administration,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17519,of,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17520,CTL,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17521,",",O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17522,NSM,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17523,and,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17524,DTA,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17525,.,O,583.0,"Statistical analyses of the data in Study 1 indicated a tendency for serum total cholesterol and high density lipoprotein - cholesterol to increase with administration of CTL , NSM and DTA ."
17600,However,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17601,",",O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17602,it,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17603,appears,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17604,that,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17605,this,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17606,hypercholesterolaemic,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17607,effect,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17608,is,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17609,apparent,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17610,only,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17611,when,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17612,the,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17613,background,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17614,diet,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17615,is,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17616,low,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17617,in,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17618,saturated,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17619,fat,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17620,and,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17621,cholesterol,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
17622,.,O,587.0,"However , it appears that this hypercholesterolaemic effect is apparent only when the background diet is low in saturated fat and cholesterol ."
18017,The,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18018,principal,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18019,classes,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18020,of,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18021,red,B,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18022,wine,I,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18023,polyphenols,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18024,include,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18025,flavonols,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18026,(,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18027,quercetin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18028,and,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18029,myricetin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18030,),O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18031,",",O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18032,flavanols,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18033,(,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18034,catechin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18035,and,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18036,epicatechin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18037,),O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18038,",",O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18039,anthocyanin,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18040,and,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18041,stilbenes,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18042,(,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18043,resveratrol,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18044,),O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18045,.,O,601.0,"The principal classes of red wine polyphenols include flavonols ( quercetin and myricetin ) , flavanols ( catechin and epicatechin ) , anthocyanin and stilbenes ( resveratrol ) ."
18396,As,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18397,an,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18398,alternative,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18399,",",O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18400,we,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18401,hypothesized,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18402,that,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18403,a,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18404,timed,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18405,piece,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18406,of,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18407,chocolate,B,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18408,scheduled,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18409,to,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18410,the,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18411,onset,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18412,of,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18413,the,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18414,activity,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18415,phase,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18416,may,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18417,be,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18418,sufficient,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18419,stimulus,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18420,to,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18421,synchronize,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18422,circadian,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18423,rhythms,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18424,under,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18425,conditions,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18426,of,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18427,shift,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18428,-,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18429,work,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18430,or,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18431,jet,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18432,-,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18433,lag,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18434,.,O,616.0,"As an alternative , we hypothesized that a timed piece of chocolate scheduled to the onset of the activity phase may be sufficient stimulus to synchronize circadian rhythms under conditions of shift - work or jet - lag ."
18650,Gluten,B,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18651,-,I,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18652,free,I,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18653,beers,I,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18654,produced,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18655,using,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18656,alternative,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18657,materials,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18658,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18659,such,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18660,as,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18661,rice,B,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18662,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18663,sorghum,B,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18664,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18665,maize,B,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18666,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18667,millet,B,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18668,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18669,oats,B,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18670,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18671,and,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18672,pseudocereals,B,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18673,(,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18674,e.g.,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18675,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18676,buckwheat,B,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18677,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18678,quinoa,B,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18679,and,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18680,Amaranth,B,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18681,),O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18682,",",O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18683,are,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18684,studied,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18685,in,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18686,this,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18687,review,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18688,that,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18689,examines,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18690,the,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18691,effects,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18692,of,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18693,specific,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18694,substitutions,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18695,on,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18696,the,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18697,different,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18698,characteristics,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18699,of,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18700,the,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18701,final,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18702,beer,B,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18703,to,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18704,ensure,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18705,the,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18706,appropriateness,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18707,of,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18708,their,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18709,use,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
18710,.,O,624.0,"Gluten - free beers produced using alternative materials , such as rice , sorghum , maize , millet , oats , and pseudocereals ( e.g. , buckwheat , quinoa and Amaranth ) , are studied in this review that examines the effects of specific substitutions on the different characteristics of the final beer to ensure the appropriateness of their use ."
19134,Stomach,O,637.0,Stomach cancer is the most prevalent malignant neoplasm in Korea .
19135,cancer,O,637.0,Stomach cancer is the most prevalent malignant neoplasm in Korea .
19136,is,O,637.0,Stomach cancer is the most prevalent malignant neoplasm in Korea .
19137,the,O,637.0,Stomach cancer is the most prevalent malignant neoplasm in Korea .
19138,most,O,637.0,Stomach cancer is the most prevalent malignant neoplasm in Korea .
19139,prevalent,O,637.0,Stomach cancer is the most prevalent malignant neoplasm in Korea .
19140,malignant,O,637.0,Stomach cancer is the most prevalent malignant neoplasm in Korea .
19141,neoplasm,O,637.0,Stomach cancer is the most prevalent malignant neoplasm in Korea .
19142,in,O,637.0,Stomach cancer is the most prevalent malignant neoplasm in Korea .
19143,Korea,O,637.0,Stomach cancer is the most prevalent malignant neoplasm in Korea .
19144,.,O,637.0,Stomach cancer is the most prevalent malignant neoplasm in Korea .
19202,An,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19203,increased,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19204,risk,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19205,of,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19206,stomach,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19207,cancer,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19208,was,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19209,noted,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19210,among,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19211,people,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19212,who,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19213,frequently,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19214,consume,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19215,broiled,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19216,meats,B,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19217,and,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19218,fishes,B,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19219,",",O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19220,salted,B,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19221,side,I,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19222,dishes,I,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19223,(,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19224,salted,B,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19225,/,B,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19226,fermented,B,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19227,fish,I,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19228,products,I,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19229,),O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19230,and,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19231,salty,B,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19232,stewed,I,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19233,foods,I,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19234,",",O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19235,such,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19236,as,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19237,soybean,B,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19238,paste,I,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19239,thick,I,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19240,stew,I,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19241,.,O,640.0,"An increased risk of stomach cancer was noted among people who frequently consume broiled meats and fishes , salted side dishes ( salted / fermented fish products ) and salty stewed foods , such as soybean paste thick stew ."
19279,For,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19280,meat,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19281,and,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19282,fish,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19283,",",O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19284,pan,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19285,frying,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19286,was,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19287,associated,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19288,with,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19289,decreased,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19290,risk,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19291,",",O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19292,whereas,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19293,stewing,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19294,or,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19295,broiling,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19296,was,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19297,associated,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19298,with,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19299,increased,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19300,risk,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19301,.,O,643.0,"For meat and fish , pan frying was associated with decreased risk , whereas stewing or broiling was associated with increased risk ."
19630,There,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19631,is,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19632,no,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19633,clear,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19634,indication,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19635,that,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19636,the,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19637,risks,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19638,observed,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19639,in,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19640,this,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19641,Chinese,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19642,population,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19643,are,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19644,substantially,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19645,different,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19646,from,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19647,those,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19648,observed,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19649,in,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19650,Caucasian,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19651,populations,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19652,.,O,656.0,There is no clear indication that the risks observed in this Chinese population are substantially different from those observed in Caucasian populations .
19653,Prevention,O,657.0,Prevention and management of hypertension are the major public health challenges worldwide .
19654,and,O,657.0,Prevention and management of hypertension are the major public health challenges worldwide .
19655,management,O,657.0,Prevention and management of hypertension are the major public health challenges worldwide .
19656,of,O,657.0,Prevention and management of hypertension are the major public health challenges worldwide .
19657,hypertension,O,657.0,Prevention and management of hypertension are the major public health challenges worldwide .
19658,are,O,657.0,Prevention and management of hypertension are the major public health challenges worldwide .
19659,the,O,657.0,Prevention and management of hypertension are the major public health challenges worldwide .
19660,major,O,657.0,Prevention and management of hypertension are the major public health challenges worldwide .
19661,public,O,657.0,Prevention and management of hypertension are the major public health challenges worldwide .
19662,health,O,657.0,Prevention and management of hypertension are the major public health challenges worldwide .
19663,challenges,O,657.0,Prevention and management of hypertension are the major public health challenges worldwide .
19664,worldwide,O,657.0,Prevention and management of hypertension are the major public health challenges worldwide .
19665,.,O,657.0,Prevention and management of hypertension are the major public health challenges worldwide .
19666,Uncontrolled,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19667,high,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19668,blood,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19669,pressure,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19670,may,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19671,lead,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19672,to,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19673,a,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19674,shortened,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19675,life,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19676,expectancy,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19677,and,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19678,a,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19679,higher,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19680,morbidity,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19681,due,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19682,to,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19683,a,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19684,high,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19685,risk,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19686,of,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19687,cardiovascular,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19688,complications,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19689,such,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19690,as,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19691,coronary,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19692,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19693,disease,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19694,(,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19695,which,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19696,leads,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19697,to,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19698,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19699,attack,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19700,),O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19701,and,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19702,stroke,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19703,",",O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19704,congestive,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19705,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19706,failure,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19707,",",O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19708,heart,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19709,rhythm,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19710,irregularities,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19711,",",O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19712,and,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19713,kidney,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19714,failure,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19715,etc,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19716,.,O,658.0,"Uncontrolled high blood pressure may lead to a shortened life expectancy and a higher morbidity due to a high risk of cardiovascular complications such as coronary heart disease ( which leads to heart attack ) and stroke , congestive heart failure , heart rhythm irregularities , and kidney failure etc ."
19717,In,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19718,recent,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19719,years,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19720,",",O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19721,it,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19722,has,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19723,been,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19724,recognized,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19725,that,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19726,many,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19727,dietary,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19728,constituents,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19729,may,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19730,contribute,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19731,to,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19732,human,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19733,cardiovascular,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19734,health,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
19735,.,O,659.0,"In recent years , it has been recognized that many dietary constituents may contribute to human cardiovascular health ."
20098,Alzheimer,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20099,disease,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20100,(,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20101,AD,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20102,),O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20103,is,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20104,one,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20105,of,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20106,the,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20107,most,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20108,common,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20109,forms,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20110,of,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20111,dementia,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20112,in,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20113,the,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20114,elderly,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20115,.,O,671.0,Alzheimer disease ( AD ) is one of the most common forms of dementia in the elderly .
20550,In,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20551,ancient,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20552,Mayan,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20553,texts,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20554,cocoa,B,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20555,is,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20556,considered,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20557,a,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20558,gift,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20559,of,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20560,the,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20561,gods,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20562,:,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20563,Pre,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20564,-,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20565,Columbian,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20566,populations,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20567,used,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20568,chocolate,B,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20569,as,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20570,medicine,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20571,",",O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20572,too,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20573,.,O,683.0,"In ancient Mayan texts cocoa is considered a gift of the gods : Pre - Columbian populations used chocolate as medicine , too ."
20817,After,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20818,allowance,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20819,for,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20820,non,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20821,-,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20822,dietary,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20823,confounding,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20824,factors,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20825,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20826,total,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20827,energy,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20828,intake,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20829,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20830,significant,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20831,trends,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20832,of,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20833,increasing,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20834,risk,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20835,of,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20836,colorectal,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20837,cancer,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20838,with,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20839,increasing,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20840,intake,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20841,emerged,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20842,for,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20843,bread,B,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20844,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20845,cereal,B,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20846,dishes,I,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20847,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20848,odds,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20849,ratio,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20850,[,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20851,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20852,],O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20853,in,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20854,highest,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20855,vs.,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20856,lowest,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20857,quintile,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20858,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20859,1.7,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20860,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20861,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20862,potatoes,B,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20863,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20864,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20865,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20866,1.2,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20867,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20868,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20869,cakes,B,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20870,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20871,desserts,B,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20872,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20873,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20874,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20875,1.1,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20876,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20877,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20878,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20879,refined,B,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20880,sugar,I,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20881,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20882,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20883,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20884,1.4,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20885,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20886,.,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
21486,Infrared,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21487,thermal,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21488,images,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21489,indicated,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21490,significantly,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21491,greater,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21492,surface,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21493,temperatures,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21494,and,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21495,heat,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21496,loss,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21497,in,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21498,treated,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21499,birds,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21500,following,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21501,external,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21502,oil,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21503,applications,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21504,;,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21505,however,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21506,",",O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21507,measurements,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21508,collected,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21509,by,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21510,coelomically,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21511,implanted,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21512,temperature,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21513,transmitters,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21514,showed,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21515,that,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21516,internal,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21517,body,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21518,temperatures,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21519,were,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21520,stable,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21521,over,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21522,the,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21523,course,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21524,of,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21525,the,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21526,study,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21527,period,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21528,.,O,714.0,"Infrared thermal images indicated significantly greater surface temperatures and heat loss in treated birds following external oil applications ; however , measurements collected by coelomically implanted temperature transmitters showed that internal body temperatures were stable over the course of the study period ."
21591,Many,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21592,studies,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21593,have,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21594,shown,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21595,therapeutic,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21596,effects,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21597,of,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21598,cinnamon,B,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21599,including,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21600,its,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21601,antimicrobial,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21602,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21603,antiviral,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21604,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21605,antifungal,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21606,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21607,antioxidant,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21608,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21609,antitumor,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21610,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21611,antihypertensive,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21612,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21613,antilipemic,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21614,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21615,antidiabetic,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21616,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21617,gastroprotective,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21618,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21619,and,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21620,immunomodulatory,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21621,effects,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21622,.,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21860,The,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21861,most,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21862,common,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21863,biogenic,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21864,amines,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21865,found,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21866,in,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21867,foods,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21868,are,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21869,histamine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21870,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21871,tyramine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21872,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21873,cadaverine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21874,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21875,2,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21876,-,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21877,phenylethylamine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21878,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21879,spermine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21880,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21881,spermidine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21882,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21883,putrescine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21884,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21885,tryptamine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21886,",",O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21887,and,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21888,agmatine,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
21889,.,O,728.0,"The most common biogenic amines found in foods are histamine , tyramine , cadaverine , 2 - phenylethylamine , spermine , spermidine , putrescine , tryptamine , and agmatine ."
22240,Practical,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22241,Application,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22242,:,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22243,Although,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22244,the,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22245,health,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22246,benefits,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22247,of,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22248,fruits,B,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22249,are,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22250,strongly,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22251,indicated,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22252,from,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22253,studies,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22254,of,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22255,diet,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22256,and,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22257,disease,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22258,",",O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22259,it,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22260,is,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22261,not,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22262,known,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22263,what,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22264,role,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22265,individual,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22266,fruit,B,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22267,types,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22268,can,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22269,play,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22270,",",O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22271,particularly,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22272,for,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22273,tropical,B,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22274,fruits,I,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22275,.,O,744.0,"Practical Application : Although the health benefits of fruits are strongly indicated from studies of diet and disease , it is not known what role individual fruit types can play , particularly for tropical fruits ."
22388,Because,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22389,PPAR,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22390,agonists,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22391,have,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22392,the,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22393,potential,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22394,to,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22395,prevent,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22396,or,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22397,ameliorate,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22398,diseases,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22399,such,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22400,as,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22401,hyperlipidemia,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22402,",",O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22403,diabetes,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22404,",",O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22405,atherosclerosis,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22406,",",O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22407,and,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22408,obesity,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22409,",",O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22410,we,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22411,have,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22412,explored,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22413,new,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22414,natural,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22415,agonists,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22416,for,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22417,PPAR,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22418,.,O,748.0,"Because PPAR agonists have the potential to prevent or ameliorate diseases such as hyperlipidemia , diabetes , atherosclerosis , and obesity , we have explored new natural agonists for PPAR ."
22467,It,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22468,also,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22469,enhanced,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22470,human,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22471,PPARdelta,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22472,activity,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22473,in,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22474,a,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22475,dose,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22476,-,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22477,dependent,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22478,manner,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22479,with,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22480,an,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22481,11.5,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22482,-,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22483,fold,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22484,increase,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22485,at,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22486,0.5,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22487,%,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22488,.,O,751.0,It also enhanced human PPARdelta activity in a dose - dependent manner with an 11.5 - fold increase at 0.5 % .
22489,However,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22490,",",O,752.0,"However , it only slightly affected human PPARgamma activity ."
22491,it,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22492,only,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22493,slightly,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22494,affected,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22495,human,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22496,PPARgamma,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22497,activity,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22498,.,O,752.0,"However , it only slightly affected human PPARgamma activity ."
22641,This,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22642,study,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22643,unambiguously,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22644,clarified,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22645,at,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22646,the,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22647,cellular,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22648,level,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22649,that,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22650,cow,B,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22651,'s,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22652,milk,I,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22653,increased,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22654,the,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22655,activities,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22656,of,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22657,human,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22658,PPARalpha,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22659,",",O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22660,PPARdelta,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22661,",",O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22662,and,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22663,RXRalpha,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
22664,.,O,758.0,"This study unambiguously clarified at the cellular level that cow 's milk increased the activities of human PPARalpha , PPARdelta , and RXRalpha ."
23124,LDL,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23125,isolated,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23126,from,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23127,animals,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23128,fed,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23129,corn,B,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23130,oil,I,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23131,",",O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23132,lard,B,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23133,or,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23134,milk,B,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23135,fat,I,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23136,had,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23137,significantly,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23138,greater,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23139,albumin,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23140,transfer,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23141,across,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23142,cultured,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23143,endothelial,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23144,monolayers,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23145,compared,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23146,with,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23147,those,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23148,of,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23149,the,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23150,low,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23151,fat,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23152,diet,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23153,group,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23154,.,O,774.0,"LDL isolated from animals fed corn oil , lard or milk fat had significantly greater albumin transfer across cultured endothelial monolayers compared with those of the low fat diet group ."
23690,Large,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23691,-,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23692,scale,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23693,intervention,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23694,studies,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23695,and,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23696,randomized,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23697,clinical,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23698,trials,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23699,are,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23700,warranted,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23701,to,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23702,determine,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23703,if,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23704,yogurt,B,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23705,consumption,I,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23706,has,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23707,beneficial,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23708,effects,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23709,on,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23710,insulin,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23711,sensitivity,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23712,and,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23713,reduces,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23714,the,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23715,risk,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23716,of,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23717,type,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23718,2,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23719,diabetes,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
23720,.,O,795.0,Large - scale intervention studies and randomized clinical trials are warranted to determine if yogurt consumption has beneficial effects on insulin sensitivity and reduces the risk of type 2 diabetes .
24035,In,O,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24036,this,O,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24037,study,O,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24038,",",O,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24039,tofu,B,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24040,was,O,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24041,made,O,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24042,from,O,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24043,yellow,B,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24044,split,I,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24045,peas,I,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24046,(,O,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24047,Pisum,O,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24048,sativum,O,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24049,),O,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24050,.,O,805.0,"In this study , tofu was made from yellow split peas ( Pisum sativum ) ."
24328,Milk,B,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24329,consumption,I,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24330,is,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24331,an,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24332,accepted,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24333,strategy,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24334,in,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24335,building,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24336,peak,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24337,bone,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24338,mass,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24339,and,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24340,therefore,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24341,may,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24342,reduce,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24343,the,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24344,risk,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24345,of,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24346,osteoporosis,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24347,.,O,820.0,Milk consumption is an accepted strategy in building peak bone mass and therefore may reduce the risk of osteoporosis .
24348,In,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24349,childhood,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24350,calcium,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24351,",",O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24352,phosphorous,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24353,",",O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24354,and,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24355,growth,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24356,factors,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24357,are,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24358,the,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24359,important,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24360,components,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24361,to,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24362,support,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24363,bone,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24364,growth,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24365,but,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24366,in,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24367,adults,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24368,the,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24369,positive,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24370,influence,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24371,on,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24372,bone,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24373,density,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24374,/,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24375,maintenance,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24376,may,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24377,also,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24378,be,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24379,due,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24380,to,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24381,other,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24382,bioactive,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24383,proteins,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24384,/,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24385,peptides,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24386,or,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24387,lipids,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24388,in,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24389,milk,B,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24390,acting,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24391,directly,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24392,in,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24393,the,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24394,gastrointestinal,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24395,tract,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24396,(,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24397,GIT,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24398,),O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24399,.,O,821.0,"In childhood calcium , phosphorous , and growth factors are the important components to support bone growth but in adults the positive influence on bone density / maintenance may also be due to other bioactive proteins / peptides or lipids in milk acting directly in the gastrointestinal tract ( GIT ) ."
24503,In,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24504,this,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24505,review,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24506,",",O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24507,the,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24508,role,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24509,of,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24510,milk,B,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24511,and,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24512,milk,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24513,components,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24514,in,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24515,improving,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24516,calcium,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24517,absorption,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24518,and,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24519,thereby,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24520,supporting,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24521,bone,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24522,health,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24523,is,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24524,discussed,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24525,.,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24526,In,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24527,addition,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24528,",",O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24529,some,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24530,reference,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24531,is,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24532,made,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24533,to,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24534,the,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24535,significance,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24536,of,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24537,combining,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24538,the,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24539,inherent,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24540,beneficial,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24541,components,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24542,from,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24543,milk,B,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24544,with,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24545,fortificants,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24546,/,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24547,nutrients,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24548,that,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24549,will,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24550,support,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24551,bone,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24552,health,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24553,through,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24554,adulthood,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24555,.,O,827.0,"In addition , some reference is made to the significance of combining the inherent beneficial components from milk with fortificants / nutrients that will support bone health through adulthood ."
24656,We,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24657,recruited,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24658,703,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24659,histologically,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24660,confirmed,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24661,cases,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24662,of,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24663,ESCC,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24664,and,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24665,1664,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24666,controls,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24667,individually,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24668,matched,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24669,to,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24670,cases,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24671,for,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24672,age,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24673,",",O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24674,sex,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24675,",",O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24676,and,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24677,district,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24678,of,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24679,residence,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
24680,.,O,832.0,"We recruited 703 histologically confirmed cases of ESCC and 1664 controls individually matched to cases for age , sex , and district of residence ."
25568,These,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25569,findings,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25570,suggest,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25571,that,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25572,our,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25573,patients,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25574,',O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25575,symptoms,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25576,were,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25577,caused,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25578,by,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25579,an,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25580,IgE,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25581,-,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25582,mediated,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25583,hypersensitivity,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25584,to,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25585,cereal,B,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25586,flours,I,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25587,from,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25588,animal,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25589,formula,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25590,feeds,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25591,.,O,862.0,These findings suggest that our patients ' symptoms were caused by an IgE - mediated hypersensitivity to cereal flours from animal formula feeds .
25757,Dry,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25758,matter,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25759,was,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25760,recovered,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25761,at,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25762,a,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25763,rate,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25764,averaging,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25765,100,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25766,%,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25767,suggesting,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25768,that,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25769,the,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25770,method,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25771,used,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25772,to,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25773,measure,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25774,the,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25775,flow,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25776,rate,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25777,and,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25778,sample,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25779,duodenal,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25780,digesta,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25781,was,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25782,adequate,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
25783,.,O,869.0,Dry matter was recovered at a rate averaging 100 % suggesting that the method used to measure the flow rate and sample duodenal digesta was adequate .
26428,Our,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26429,second,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26430,aim,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26431,was,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26432,to,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26433,describe,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26434,training,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26435,-,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26436,of,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26437,-,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26438,trainers,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26439,workshops,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26440,in,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26441,both,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26442,countries,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26443,as,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26444,an,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26445,initial,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26446,response,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26447,to,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26448,the,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26449,findings,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26450,from,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26451,the,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26452,first,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26453,objective,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
26454,.,O,894.0,Our second aim was to describe training - of - trainers workshops in both countries as an initial response to the findings from the first objective .
27125,Virgin,B,920.0,Virgin olive oil led to the lowest oxidation and ultrastructural alterations .
27126,olive,I,920.0,Virgin olive oil led to the lowest oxidation and ultrastructural alterations .
27127,oil,I,920.0,Virgin olive oil led to the lowest oxidation and ultrastructural alterations .
27128,led,O,920.0,Virgin olive oil led to the lowest oxidation and ultrastructural alterations .
27129,to,O,920.0,Virgin olive oil led to the lowest oxidation and ultrastructural alterations .
27130,the,O,920.0,Virgin olive oil led to the lowest oxidation and ultrastructural alterations .
27131,lowest,O,920.0,Virgin olive oil led to the lowest oxidation and ultrastructural alterations .
27132,oxidation,O,920.0,Virgin olive oil led to the lowest oxidation and ultrastructural alterations .
27133,and,O,920.0,Virgin olive oil led to the lowest oxidation and ultrastructural alterations .
27134,ultrastructural,O,920.0,Virgin olive oil led to the lowest oxidation and ultrastructural alterations .
27135,alterations,O,920.0,Virgin olive oil led to the lowest oxidation and ultrastructural alterations .
27136,.,O,920.0,Virgin olive oil led to the lowest oxidation and ultrastructural alterations .
28032,Although,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28033,the,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28034,total,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28035,and,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28036,bioavailable,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28037,Cd,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28038,were,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28039,high,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28040,in,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28041,soil,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28042,",",O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28043,its,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28044,speciation,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28045,in,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28046,vegetables,B,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28047,was,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28048,mainly,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28049,presented,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28050,as,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28051,HAc,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28052,-,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28053,extractable,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28054,fraction,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28055,",",O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28056,which,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28057,has,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28058,a,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28059,relatively,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28060,low,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28061,bioactivity,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28062,.,O,952.0,"Although the total and bioavailable Cd were high in soil , its speciation in vegetables was mainly presented as HAc - extractable fraction , which has a relatively low bioactivity ."
28079,To,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28080,estimate,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28081,the,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28082,effects,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28083,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28084,consuming,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28085,hot,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28086,beverages,B,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28087,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28088,including,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28089,mate,B,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28090,(,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28091,an,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28092,infusion,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28093,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28094,the,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28095,herb,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28096,Ilex,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28097,paraguayensis,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28098,),O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28099,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28100,tea,B,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28101,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28102,coffee,B,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28103,and,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28104,coffee,B,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28105,with,I,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28106,milk,I,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28107,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28108,and,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28109,other,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28110,food,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28111,items,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28112,on,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28113,esophageal,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28114,cancer,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28115,risk,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28116,",",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28117,we,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28118,analyzed,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28119,data,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28120,from,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28121,830,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28122,cases,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28123,and,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28124,"1,779",O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28125,controls,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28126,participating,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28127,in,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28128,a,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28129,series,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28130,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28131,5,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28132,hospital,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28133,-,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28134,based,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28135,case,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28136,-,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28137,control,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28138,studies,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28139,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28140,squamous,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28141,-,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28142,cell,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28143,carcinoma,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28144,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28145,the,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28146,esophagus,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28147,conducted,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28148,in,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28149,high,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28150,-,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28151,risk,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28152,areas,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28153,of,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28154,South,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28155,America,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28156,.,O,954.0,"To estimate the effects of consuming hot beverages , including mate ( an infusion of the herb Ilex paraguayensis ) , tea , coffee and coffee with milk , and other food items on esophageal cancer risk , we analyzed data from 830 cases and 1,779 controls participating in a series of 5 hospital - based case - control studies of squamous - cell carcinoma of the esophagus conducted in high - risk areas of South America ."
28226,The,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28227,joint,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28228,effects,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28229,of,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28230,mate,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28231,amount,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28232,and,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28233,mate,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28234,temperature,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28235,were,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28236,more,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28237,than,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28238,multiplicative,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28239,",",O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28240,following,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28241,a,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28242,statistically,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28243,significant,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28244,synergistic,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28245,interaction,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28246,(,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28247,p,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28248,=,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28249,0.02,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28250,),O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28251,which,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28252,was,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28253,particularly,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28254,evident,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28255,among,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28256,heavy,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28257,drinkers,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28258,(,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28259,>,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28260,1.50,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28261,l,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28262,/,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28263,day,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28264,),O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28265,of,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28266,very,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28267,hot,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28268,mate,B,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28269,(,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28270,odds,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28271,ratio,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28272,=,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28273,4.14,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28274,",",O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28275,95,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28276,%,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28277,confidence,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28278,interval,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28279,:,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28280,2.24,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28281,-,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28282,7.67,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28283,),O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28284,compared,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28285,to,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28286,light,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28287,drinkers,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28288,(,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28289,<,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28290,0.50,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28291,l,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28292,/,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28293,day,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28294,),O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28295,of,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28296,cold,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28297,/,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28298,warm,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28299,/,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28300,hot,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28301,mate,B,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
28302,.,O,957.0,"The joint effects of mate amount and mate temperature were more than multiplicative , following a statistically significant synergistic interaction ( p = 0.02 ) which was particularly evident among heavy drinkers ( > 1.50 l / day ) of very hot mate ( odds ratio = 4.14 , 95 % confidence interval : 2.24 - 7.67 ) compared to light drinkers ( < 0.50 l / day ) of cold / warm / hot mate ."
29234,This,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29235,review,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29236,concludes,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29237,that,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29238,green,B,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29239,tea,I,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29240,consumption,I,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29241,overall,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29242,may,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29243,be,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29244,considered,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29245,beneficial,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29246,for,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29247,human,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29248,health,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29249,.,O,990.0,This review concludes that green tea consumption overall may be considered beneficial for human health .
29250,Spices,B,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29251,and,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29252,herbs,B,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29253,have,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29254,been,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29255,used,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29256,since,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29257,ancient,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29258,times,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29259,as,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29260,flavor,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29261,and,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29262,aroma,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29263,enhancers,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29264,",",O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29265,colorants,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29266,",",O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29267,preservatives,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29268,",",O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29269,and,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29270,traditional,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29271,medicines,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29272,.,O,991.0,"Spices and herbs have been used since ancient times as flavor and aroma enhancers , colorants , preservatives , and traditional medicines ."
29603,FF,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29604,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29605,RFS,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29606,conditions,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29607,were,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29608,liked,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29609,more,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29610,than,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29611,RF,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29612,for,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29613,the,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29614,breakfast,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29615,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29616,lunch,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29617,meals,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29618,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29619,French,B,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29620,toast,I,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29621,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29622,chicken,B,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29623,entrée,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29624,",",O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29625,and,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29626,vegetables,B,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29627,.,O,1003.0,"FF and RFS conditions were liked more than RF for the breakfast and lunch meals , French toast , chicken entrée , and vegetables ."
29732,The,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29733,objective,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29734,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29735,this,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29736,work,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29737,was,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29738,to,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29739,identify,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29740,the,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29741,effect,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29742,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29743,tomato,B,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29744,juice,I,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29745,on,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29746,the,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29747,expression,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29748,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29749,genes,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29750,and,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29751,levels,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29752,of,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29753,metabolites,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29754,related,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29755,to,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29756,steatosis,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29757,in,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29758,rats,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
29759,.,O,1008.0,The objective of this work was to identify the effect of tomato juice on the expression of genes and levels of metabolites related to steatosis in rats .
31754,Diet,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31755,over,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31756,the,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31757,year,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31758,before,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31759,diagnosis,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31760,or,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31761,interview,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31762,date,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31763,was,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31764,assessed,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31765,using,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31766,a,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31767,validated,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31768,food,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31769,frequency,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31770,questionnaire,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31771,adapted,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31772,to,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31773,include,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31774,regional,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31775,foods,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31776,.,O,1077.0,Diet over the year before diagnosis or interview date was assessed using a validated food frequency questionnaire adapted to include regional foods .
31835,Regardless,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31836,of,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31837,ethnic,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31838,group,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31839,or,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31840,energy,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31841,adjustment,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31842,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31843,high,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31844,and,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31845,frequent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31846,vegetable,B,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31847,consumption,I,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31848,(,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31849,particularly,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31850,dark,B,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31851,green,I,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31852,vegetables,I,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31853,),O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31854,was,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31855,protective,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31856,",",O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31857,consistent,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31858,with,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31859,20,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31860,-,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31861,50,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31862,%,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31863,reductions,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31864,in,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31865,risk,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31866,.,O,1080.0,"Regardless of ethnic group or energy adjustment , high and frequent vegetable consumption ( particularly dark green vegetables ) was protective , consistent with 20 - 50 % reductions in risk ."
31953,These,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31954,findings,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31955,add,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31956,to,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31957,growing,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31958,evidence,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31959,that,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31960,plant,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31961,foods,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31962,may,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31963,protect,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31964,against,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31965,colon,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31966,cancer,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31967,;,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31968,however,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31969,",",O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31970,the,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31971,effects,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31972,of,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31973,the,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31974,other,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31975,food,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31976,groups,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31977,varied,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31978,by,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31979,ethnic,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31980,group,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31981,and,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31982,energy,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31983,adjustment,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
31984,.,O,1083.0,"These findings add to growing evidence that plant foods may protect against colon cancer ; however , the effects of the other food groups varied by ethnic group and energy adjustment ."
32371,Buckwheat,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32372,proteins,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32373,have,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32374,unique,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32375,amino,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32376,acid,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32377,composition,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32378,with,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32379,special,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32380,biological,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32381,activities,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32382,of,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32383,cholesterol,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32384,-,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32385,lowering,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32386,effects,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32387,",",O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32388,antihypertensition,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32389,effects,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32390,",",O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32391,and,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32392,improving,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32393,the,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32394,constipation,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32395,and,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32396,obisity,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32397,conditions,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32398,by,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32399,acting,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32400,similar,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32401,as,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32402,to,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32403,dietary,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32404,fiber,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32405,and,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32406,interrupting,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32407,the,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32408,in,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32409,vivo,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32410,metabolisms,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32411,.,O,1101.0,"Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol - lowering effects , antihypertensition effects , and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms ."
32583,A,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32584,total,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32585,of,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32586,558,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32587,patients,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32588,with,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32589,ovarian,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32590,cancer,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32591,diagnosed,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32592,in,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32593,1993,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32594,-,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32595,1999,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32596,and,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32597,607,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32598,controls,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32599,were,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32600,interviewed,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32601,regarding,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32602,their,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32603,diet,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
32604,.,O,1109.0,A total of 558 patients with ovarian cancer diagnosed in 1993 - 1999 and 607 controls were interviewed regarding their diet .
33150,Design,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33151,/,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33152,Setting,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33153,In,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33154,the,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33155,absence,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33156,of,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33157,global,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33158,food,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33159,-,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33160,based,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33161,dietary,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33162,guidelines,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33163,",",O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33164,we,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33165,selected,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33166,the,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33167,Dietary,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33168,Approaches,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33169,to,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33170,Stop,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33171,Hypertension,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33172,(,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33173,DASH,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33174,),O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33175,diet,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33176,as,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33177,an,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33178,example,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33179,because,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33180,there,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33181,is,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33182,evidence,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33183,it,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33184,prevents,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33185,diet,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33186,-,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33187,related,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33188,chronic,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33189,disease,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33190,and,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33191,supports,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33192,adequate,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33193,micronutrient,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33194,intakes,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33195,.,O,1125.0,"Design / Setting In the absence of global food - based dietary guidelines , we selected the Dietary Approaches to Stop Hypertension ( DASH ) diet as an example because there is evidence it prevents diet - related chronic disease and supports adequate micronutrient intakes ."
33216,Food,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33217,availability,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33218,was,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33219,estimated,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33220,using,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33221,FAO,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33222,Food,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33223,Balance,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33224,Sheet,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33225,data,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33226,on,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33227,country,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33228,-,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33229,level,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33230,food,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33231,supply,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33232,.,O,1127.0,Food availability was estimated using FAO Food Balance Sheet data on country - level food supply .
33368,Change,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33369,in,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33370,nutritional,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33371,composition,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33372,of,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33373,different,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33374,species,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33375,of,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33376,bamboo,B,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33377,shoots,I,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33378,with,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33379,processing,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33380,has,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33381,also,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33382,been,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33383,reviewed,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33384,.,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33479,Using,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33480,the,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33481,traditional,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33482,knowledge,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33483,",",O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33484,pharmaceutical,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33485,preparations,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33486,of,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33487,bamboo,B,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33488,shoots,I,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33489,like,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33490,bamboo,B,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33491,salt,I,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33492,",",O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33493,bamboo,B,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33494,vinegar,I,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33495,",",O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33496,bamboo,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33497,extracts,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33498,for,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33499,diabetes,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33500,and,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33501,cholesterol,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33502,control,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33503,",",O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33504,etc,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33505,.,O,1140.0,"Using the traditional knowledge , pharmaceutical preparations of bamboo shoots like bamboo salt , bamboo vinegar , bamboo extracts for diabetes and cholesterol control , etc ."
33976,The,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33977,incidence,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33978,and,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33979,mortality,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33980,rates,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33981,of,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33982,testicular,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33983,and,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33984,prostatic,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33985,cancers,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33986,in,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33987,42,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33988,countries,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33989,were,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33990,correlated,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33991,with,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33992,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33993,dietary,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33994,practices,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33995,in,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33996,these,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33997,countries,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33998,using,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
33999,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34000,cancer,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34001,rates,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34002,(,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34003,1988,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34004,-,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34005,92,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34006,),O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34007,provided,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34008,by,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34009,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34010,International,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34011,Agency,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34012,for,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34013,Research,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34014,on,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34015,Cancer,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34016,(,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34017,IARC,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34018,),O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34019,and,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34020,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34021,food,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34022,supply,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34023,data,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34024,(,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34025,1961,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34026,-,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34027,90,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34028,),O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34029,provided,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34030,by,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34031,the,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34032,Food,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34033,and,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34034,Agriculture,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34035,Organization,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34036,(,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34037,FAO,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34038,),O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34039,.,O,1160.0,The incidence and mortality rates of testicular and prostatic cancers in 42 countries were correlated with the dietary practices in these countries using the cancer rates ( 1988 - 92 ) provided by the International Agency for Research on Cancer ( IARC ) and the food supply data ( 1961 - 90 ) provided by the Food and Agriculture Organization ( FAO ) .
34139,Concerning,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34140,prostatic,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34141,cancer,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34142,",",O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34143,milk,B,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34144,(,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34145,1961,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34146,-,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34147,90,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34148,),O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34149,was,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34150,most,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34151,closely,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34152,correlated,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34153,(,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34154,r,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34155,=,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34156,0.711,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34157,),O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34158,with,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34159,its,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34160,incidence,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34161,",",O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34162,followed,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34163,by,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34164,meat,B,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34165,and,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34166,coffee,B,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34167,.,O,1164.0,"Concerning prostatic cancer , milk ( 1961 - 90 ) was most closely correlated ( r = 0.711 ) with its incidence , followed by meat and coffee ."
34168,Stepwise,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34169,-,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34170,multiple,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34171,-,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34172,regression,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34173,analysis,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34174,identified,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34175,milk,B,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34176,+,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34177,cheese,B,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34178,as,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34179,a,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34180,factor,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34181,contributing,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34182,to,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34183,the,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34184,incidence,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34185,of,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34186,prostatic,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34187,cancer,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34188,(,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34189,R,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34190,=,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34191,0.525,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34192,),O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34193,.,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34194,The,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34195,food,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34196,that,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34197,was,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34198,most,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34199,closely,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34200,correlated,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34201,with,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34202,the,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34203,mortality,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34204,rate,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34205,of,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34206,prostatic,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34207,cancer,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34208,was,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34209,milk,B,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34210,(,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34211,r,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34212,=,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34213,0.766,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34214,),O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34215,",",O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34216,followed,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34217,by,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34218,coffee,B,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34219,",",O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34220,cheese,B,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34221,and,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34222,animal,B,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34223,fats,I,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34224,.,O,1166.0,"The food that was most closely correlated with the mortality rate of prostatic cancer was milk ( r = 0.766 ) , followed by coffee , cheese and animal fats ."
34251,The,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34252,results,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34253,of,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34254,our,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34255,study,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34256,suggest,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34257,a,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34258,role,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34259,of,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34260,milk,B,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34261,and,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34262,dairy,B,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34263,products,I,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34264,in,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34265,the,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34266,development,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34267,and,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34268,growth,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34269,of,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34270,testicular,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34271,and,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34272,prostatic,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34273,cancers,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34274,.,O,1168.0,The results of our study suggest a role of milk and dairy products in the development and growth of testicular and prostatic cancers .
34306,Sources,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34307,and,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34308,quantities,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34309,of,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34310,milk,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34311,loss,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34312,in,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34313,primary,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34314,production,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34315,are,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34316,presented,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34317,in,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34318,this,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34319,paper,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34320,through,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34321,an,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34322,analysis,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34323,of,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34324,results,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34325,from,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34326,a,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34327,2018,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34328,survey,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34329,.,O,1170.0,Sources and quantities of milk loss in primary production are presented in this paper through an analysis of results from a 2018 survey .
34599,Moreover,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34600,",",O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34601,barley,B,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34602,considered,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34603,as,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34604,a,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34605,good,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34606,source,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34607,of,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34608,starch,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34609,",",O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34610,minerals,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34611,",",O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34612,vitamins,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34613,",",O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34614,and,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34615,protein,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34616,pose,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34617,it,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34618,as,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34619,an,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34620,ideal,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34621,food,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34622,supplement,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34623,.,O,1180.0,"Moreover , barley considered as a good source of starch , minerals , vitamins , and protein pose it as an ideal food supplement ."
34844,Predictive,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34845,regression,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34846,models,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34847,were,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34848,used,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34849,to,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34850,plot,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34851,mixture,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34852,response,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34853,surfaces,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34854,of,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34855,the,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34856,critical,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34857,sensory,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34858,attributes,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34859,(,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34860,taste,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34861,",",O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34862,mouthfeel,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34863,",",O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34864,and,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34865,overall,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34866,liking,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34867,),O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34868,that,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34869,influenced,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34870,purchase,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34871,intent,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
34872,.,O,1189.0,"Predictive regression models were used to plot mixture response surfaces of the critical sensory attributes ( taste , mouthfeel , and overall liking ) that influenced purchase intent ."
35114,Mixtures,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35115,of,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35116,raw,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35117,and,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35118,roasted,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35119,English,B,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35120,walnuts,I,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35121,of,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35122,several,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35123,varieties,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35124,were,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35125,defatted,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35126,",",O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35127,powdered,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35128,",",O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35129,and,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35130,used,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35131,as,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35132,separate,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35133,antigens,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35134,in,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35135,sheep,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35136,and,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35137,New,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35138,Zealand,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35139,white,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35140,rabbits,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35141,.,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35266,Substantial,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35267,cross,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35268,-,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35269,reactivity,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35270,was,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35271,observed,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35272,with,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35273,pecan,B,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35274,while,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35275,minimal,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35276,cross,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35277,-,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35278,reactivity,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35279,was,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35280,noted,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35281,for,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35282,hazelnut,B,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35283,",",O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35284,mustard,B,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35285,",",O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35286,mace,B,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35287,",",O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35288,and,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35289,poppy,B,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35290,seed,I,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35291,among,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35292,almost,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35293,100,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35294,foods,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35295,and,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35296,food,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35297,ingredients,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35298,tested,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35299,.,O,1202.0,"Substantial cross - reactivity was observed with pecan while minimal cross - reactivity was noted for hazelnut , mustard , mace , and poppy seed among almost 100 foods and food ingredients tested ."
35330,Researchers,O,1204.0,Researchers do not understand what causes ovarian cancer .
35331,do,O,1204.0,Researchers do not understand what causes ovarian cancer .
35332,not,O,1204.0,Researchers do not understand what causes ovarian cancer .
35333,understand,O,1204.0,Researchers do not understand what causes ovarian cancer .
35334,what,O,1204.0,Researchers do not understand what causes ovarian cancer .
35335,causes,O,1204.0,Researchers do not understand what causes ovarian cancer .
35336,ovarian,O,1204.0,Researchers do not understand what causes ovarian cancer .
35337,cancer,O,1204.0,Researchers do not understand what causes ovarian cancer .
35338,.,O,1204.0,Researchers do not understand what causes ovarian cancer .
35356, ,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35357,1,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35358,hypothesis,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35359,is,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35360,that,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35361,high,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35362,levels,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35363,of,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35364,lactose,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35365,consumption,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35366,and,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35367,retained,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35368,ability,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35369,to,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35370,digest,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35371,lactose,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35372,(,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35373,lactase,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35374,persistence,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35375,),O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35376,lead,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35377,to,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35378,high,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35379,levels,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35380,of,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35381,galactose,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35382,exposure,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35383,which,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35384,increases,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35385,the,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35386,ovarian,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35387,cancer,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35388,risk,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35389,.,O,1206.0,  1 hypothesis is that high levels of lactose consumption and retained ability to digest lactose ( lactase persistence ) lead to high levels of galactose exposure which increases the ovarian cancer risk .
35559, ,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35560,Using,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35561,the,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35562,case,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35563,control,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35564,data,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35565,",",O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35566,others,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35567,found,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35568,an,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35569,increased,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35570,risk,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35571,for,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35572,total,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35573,lactose,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35574,intake,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35575,in,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35576,women,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35577,who,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35578,never,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35579,used,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35580,oral,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35581,contraceptives,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35582,(,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35583,OCs,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35584,),O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35585,.,O,1215.0,"  Using the case control data , others found an increased risk for total lactose intake in women who never used oral contraceptives ( OCs ) ."
35863,Five,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35864,days,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35865,after,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35866,the,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35867,initiation,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35868,of,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35869,ruminal,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35870,infusions,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35871,",",O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35872,experimental,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35873,mastitis,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35874,was,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35875,induced,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35876,by,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35877,the,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35878,intramammary,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35879,infusion,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35880,of,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35881,100,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35882,microg,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35883,of,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35884,bacterial,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35885,lipopolysaccharide,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35886,(,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35887,LPS,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35888,),O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
35889,.,O,1228.0,"Five days after the initiation of ruminal infusions , experimental mastitis was induced by the intramammary infusion of 100 microg of bacterial lipopolysaccharide ( LPS ) ."
36133,Short,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36134,-,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36135,chain,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36136,fatty,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36137,acid,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36138,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36139,SCFA,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36140,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36141,",",O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36142,hydrogen,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36143,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36144,H2,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36145,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36146,",",O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36147,and,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36148,methane,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36149,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36150,CH4,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36151,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36152,productions,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36153,and,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36154,neutral,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36155,-,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36156,detergent,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36157,fiber,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36158,(,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36159,NDF,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36160,),O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36161,digestibility,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36162,differed,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36163,significantly,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36164,with,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36165,fiber,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36166,source,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36167,.,O,1237.0,"Short - chain fatty acid ( SCFA ) , hydrogen ( H2 ) , and methane ( CH4 ) productions and neutral - detergent fiber ( NDF ) digestibility differed significantly with fiber source ."
36810,Less,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36811,is,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36812,known,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36813,about,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36814,the,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36815,impact,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36816,of,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36817,nutritional,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36818,interventions,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36819,in,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36820,people,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36821,with,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36822,a,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36823,diagnosis,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36824,of,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36825,cancer,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36826,",",O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36827,but,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36828,nutrition,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36829,including,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36830,adiposity,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36831,and,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36832,physical,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36833,activity,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36834,predict,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36835,breast,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36836,cancer,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36837,outcome,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
36838,.,O,1259.0,"Less is known about the impact of nutritional interventions in people with a diagnosis of cancer , but nutrition including adiposity and physical activity predict breast cancer outcome ."
37359,Reference,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37360,Doses,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37361,were,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37362,not,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37363,established,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37364,for,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37365,other,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37366,tree,B,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37367,nuts,I,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37368,beyond,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37369,hazelnut,B,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37370,and,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37371,cashew,B,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37372,because,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37373,of,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37374,the,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37375,absence,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37376,of,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37377,data,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37378,on,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37379,NOAELs,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37380,and,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37381,LOAELs,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37382,from,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37383,individual,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37384,subjects,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37385,.,O,1278.0,Reference Doses were not established for other tree nuts beyond hazelnut and cashew because of the absence of data on NOAELs and LOAELs from individual subjects .
37386,The,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37387,calcium,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37388,economy,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37389,is,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37390,a,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37391,dynamic,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37392,state,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37393,influenced,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37394,by,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37395,fluxes,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37396,in,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37397,dietary,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37398,calcium,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37399,intake,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37400,",",O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37401,intestinal,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37402,calcium,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37403,absorption,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37404,",",O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37405,and,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37406,renal,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37407,calcium,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37408,conservation,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37409,.,O,1279.0,"The calcium economy is a dynamic state influenced by fluxes in dietary calcium intake , intestinal calcium absorption , and renal calcium conservation ."
37864,In,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37865,bacon,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37866,-,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37867,fed,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37868,rats,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37869,",",O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37870,the,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37871,amount,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37872,of,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37873,NOC,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37874,input,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37875,(,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37876,diet,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37877,),O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37878,and,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37879,output,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37880,(,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37881,feces,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37882,),O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37883,was,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37884,similar,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37885,.,O,1299.0,"In bacon - fed rats , the amount of NOC input ( diet ) and output ( feces ) was similar ."
37912,No,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37913,ACF,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37914,were,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37915,detected,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37916,in,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37917,the,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37918,colon,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37919,of,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37920,bacon,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37921,-,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37922,fed,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37923,uninitiated,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37924,rats,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37925,.,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
38011,The,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38012,association,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38013,of,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38014,habitual,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38015,coffee,B,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38016,consumption,I,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38017,with,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38018,a,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38019,lower,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38020,risk,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38021,of,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38022,diseases,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38023,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38024,like,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38025,type,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38026,2,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38027,diabetes,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38028,mellitus,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38029,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38030,chronic,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38031,liver,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38032,disease,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38033,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38034,certain,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38035,cancer,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38036,types,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38037,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38038,or,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38039,with,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38040,reduced,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38041,all,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38042,-,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38043,cause,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38044,mortality,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38045,",",O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38046,has,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38047,been,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38048,confirmed,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38049,in,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38050,prospective,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38051,cohort,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38052,studies,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38053,in,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38054,many,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38055,regions,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38056,of,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38057,the,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38058,world,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
38059,.,O,1305.0,"The association of habitual coffee consumption with a lower risk of diseases , like type 2 diabetes mellitus , chronic liver disease , certain cancer types , or with reduced all - cause mortality , has been confirmed in prospective cohort studies in many regions of the world ."
39021,Crossed,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39022,line,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39023,immunoelectrophoresis,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39024,(,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39025,CLIE,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39026,),O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39027,was,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39028,used,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39029,to,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39030,show,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39031,that,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39032,a,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39033,minor,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39034,allergen,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39035,present,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39036,in,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39037,birch,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39038,pollen,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39039,and,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39040,another,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39041,present,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39042,in,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39043,timothy,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39044,pollen,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39045,shared,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39046,common,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39047,epitopes,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39048,with,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39049,antigens,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39050,in,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39051,apple,B,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39052,",",O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39053,carrot,B,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39054,and,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39055,celery,B,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39056,tuber,I,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39057,.,O,1342.0,"Crossed line immunoelectrophoresis ( CLIE ) was used to show that a minor allergen present in birch pollen and another present in timothy pollen shared common epitopes with antigens in apple , carrot and celery tuber ."
39065,Structural,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39066,similarities,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39067,were,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39068,also,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39069,noticed,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39070,in,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39071,some,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39072,mugwort,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39073,pollen,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39074,antigens,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39075,and,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39076,antigens,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39077,in,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39078,apple,B,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39079,",",O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39080,carrot,B,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39081,and,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39082,celery,B,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39083,",",O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39084,but,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39085,none,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39086,of,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39087,these,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39088,mugwort,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39089,antigens,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39090,acted,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39091,as,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39092,an,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39093,allergen,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39094,.,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39219,Only,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39220,with,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39221,comprehensive,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39222,food,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39223,and,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39224,alcohol,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39225,strategies,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39226,based,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39227,on,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39228,fiscal,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39229,and,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39230,regulatory,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39231,measures,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39232,(,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39233,including,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39234,a,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39235,minimum,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39236,unit,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39237,price,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39238,for,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39239,alcohol,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39240,",",O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39241,the,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39242,alcohol,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39243,duty,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39244,escalator,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39245,",",O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39246,and,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39247,an,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39248,extension,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39249,of,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39250,the,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39251,sugar,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39252,levy,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39253,on,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39254,food,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39255,content,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39256,),O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39257,can,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39258,the,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39259,disease,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39260,burden,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39261,be,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39262,curtailed,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39263,.,O,1349.0,"Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures ( including a minimum unit price for alcohol , the alcohol duty escalator , and an extension of the sugar levy on food content ) can the disease burden be curtailed ."
39294,We,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39295,also,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39296,discuss,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39297,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39298,major,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39299,contribution,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39300,of,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39301,obesity,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39302,and,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39303,alcohol,B,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39304,to,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39305,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39306,ten,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39307,most,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39308,common,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39309,cancers,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39310,as,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39311,well,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39312,as,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39313,measures,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39314,outlined,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39315,by,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39316,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39317,departing,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39318,Chief,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39319,Medical,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39320,Officer,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39321,to,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39322,combat,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39323,rising,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39324,levels,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39325,of,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39326,obesity,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39327,-,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39328,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39329,highest,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39330,of,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39331,any,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39332,country,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39333,in,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39334,the,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39335,west,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39336,.,O,1351.0,We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity - the highest of any country in the west .
39495,Understanding,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39496,of,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39497,the,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39498,harm,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39499,to,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39500,health,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39501,from,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39502,lifestyle,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39503,causes,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39504,among,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39505,the,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39506,general,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39507,population,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39508,is,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39509,low,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39510,",",O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39511,with,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39512,a,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39513,poor,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39514,knowledge,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39515,of,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39516,alcohol,B,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39517,consumption,I,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39518,and,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39519,dietary,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39520,guidelines,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39521,.,O,1357.0,"Understanding of the harm to health from lifestyle causes among the general population is low , with a poor knowledge of alcohol consumption and dietary guidelines ."
39604,Dairy,B,1360.0,Dairy products are important sources of dietary fat in India .
39605,products,I,1360.0,Dairy products are important sources of dietary fat in India .
39606,are,O,1360.0,Dairy products are important sources of dietary fat in India .
39607,important,O,1360.0,Dairy products are important sources of dietary fat in India .
39608,sources,O,1360.0,Dairy products are important sources of dietary fat in India .
39609,of,O,1360.0,Dairy products are important sources of dietary fat in India .
39610,dietary,O,1360.0,Dairy products are important sources of dietary fat in India .
39611,fat,O,1360.0,Dairy products are important sources of dietary fat in India .
39612,in,O,1360.0,Dairy products are important sources of dietary fat in India .
39613,India,O,1360.0,Dairy products are important sources of dietary fat in India .
39614,.,O,1360.0,Dairy products are important sources of dietary fat in India .
39660,In,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39661,the,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39662,present,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39663,study,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39664,",",O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39665,ghee,B,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39666,",",O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39667,at,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39668,levels,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39669,ranging,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39670,from,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39671,0.25,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39672,to,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39673,10,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39674,%,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39675,",",O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39676,was,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39677,included,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39678,in,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39679,a,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39680,nutritionally,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39681,balanced,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39682,AIN-76,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39683,diet,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39684,fed,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39685,to,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39686,Wistar,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39687,rats,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39688,for,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39689,a,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39690,period,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39691,of,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39692,8,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39693,weeks,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39694,.,O,1364.0,"In the present study , ghee , at levels ranging from 0.25 to 10 % , was included in a nutritionally balanced AIN-76 diet fed to Wistar rats for a period of 8 weeks ."
39778,Similar,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39779,results,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39780,were,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39781,observed,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39782,when,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39783,ghee,B,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39784,was,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39785,subjected,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39786,to,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39787,a,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39788,higher,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39789,temperature,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39790,(,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39791,120,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39792,degrees,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39793,C,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39794,),O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39795,to,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39796,generate,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39797,cholesterol,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39798,oxidation,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39799,products,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39800,and,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39801,fed,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39802,to,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39803,the,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39804,animals,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
39805,.,O,1368.0,Similar results were observed when ghee was subjected to a higher temperature ( 120 degrees C ) to generate cholesterol oxidation products and fed to the animals .
40279,The,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40280,National,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40281,Institutes,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40282,of,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40283,Health,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40284,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40285,AARP,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40286,(,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40287,NIH,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40288,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40289,AARP,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40290,),O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40291,Diet,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40292,and,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40293,Health,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40294,Study,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40295,recruited,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40296,"566,398",O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40297,individuals,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40298,aged,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40299,50,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40300,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40301,71,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40302,at,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40303,baseline,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40304,in,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40305,1995,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40306,-,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40307,1996,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40308,.,O,1381.0,"The National Institutes of Health - AARP ( NIH - AARP ) Diet and Health Study recruited 566,398 individuals aged 50 - 71 at baseline in 1995 - 1996 ."
40620,Overweight,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40621,children,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40622,",",O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40623,particularly,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40624,girls,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40625,",",O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40626,reported,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40627,eating,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40628,less,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40629,bread,B,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40630,",",O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40631,cake,B,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40632,",",O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40633,and,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40634,cream,B,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40635,",",O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40636,adding,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40637,less,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40638,sugar,B,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40639,to,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40640,beverages,B,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40641,",",O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40642,and,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40643,eating,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40644,sweets,B,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40645,and,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40646,ice,B,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40647,cream,I,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40648,less,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40649,frequently,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40650,than,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40651,thin,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40652,and,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40653,normal,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40654,-,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40655,weight,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40656,children,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40657,.,O,1393.0,"Overweight children , particularly girls , reported eating less bread , cake , and cream , adding less sugar to beverages , and eating sweets and ice cream less frequently than thin and normal - weight children ."
40676,Overweight,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40677,teen,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40678,-,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40679,agers,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40680,appear,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40681,to,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40682,be,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40683,more,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40684,conscious,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40685,of,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40686,their,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40687,food,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40688,intake,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40689,than,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40690,under-,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40691,and,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40692,normal,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40693,-,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40694,weight,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40695,children,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
40696,.,O,1395.0,Overweight teen - agers appear to be more conscious of their food intake than under- and normal - weight children .
41634,Flavonoids,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41635,have,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41636,anti,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41637,-,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41638,inflammatory,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41639,and,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41640,antioxidative,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41641,effects,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41642,and,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41643,thus,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41644,may,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41645,protect,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41646,against,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41647,diabetes,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
41648,.,O,1427.0,Flavonoids have anti - inflammatory and antioxidative effects and thus may protect against diabetes .
42222,Our,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42223,results,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42224,support,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42225,that,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42226,the,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42227,dietary,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42228,pattern,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42229,may,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42230,have,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42231,a,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42232,role,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42233,in,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42234,the,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42235,prevention,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42236,and,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42237,management,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42238,of,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42239,dyslipidemia,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42240,and,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42241,abnormal,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42242,fasting,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42243,plasma,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42244,glucose,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42245,.,O,1448.0,Our results support that the dietary pattern may have a role in the prevention and management of dyslipidemia and abnormal fasting plasma glucose .
42470,Therefore,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42471,",",O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42472,the,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42473,results,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42474,are,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42475,clearly,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42476,indicative,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42477,of,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42478,the,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42479,beneficial,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42480,effects,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42481,of,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42482,garlic,B,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42483,in,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42484,reducing,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42485,lateral,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42486,side,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42487,effects,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42488,of,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42489,hyperlipidemia,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42490,.,O,1454.0,"Therefore , the results are clearly indicative of the beneficial effects of garlic in reducing lateral side effects of hyperlipidemia ."
42602,With,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42603,respect,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42604,to,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42605,habitual,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42606,diet,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42607,",",O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42608,an,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42609,increase,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42610,in,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42611,risk,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42612,was,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42613,associated,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42614,with,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42615,consumption,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42616,of,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42617,preserved,B,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42618,fish,I,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42619,",",O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42620,cold,B,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42621,cuts,I,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42622,and,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42623,oleaginous,B,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42624,fruits,I,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42625,.,O,1460.0,"With respect to habitual diet , an increase in risk was associated with consumption of preserved fish , cold cuts and oleaginous fruits ."
42911,Epidemiological,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42912,studies,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42913,have,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42914,shown,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42915,that,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42916,consumption,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42917,of,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42918,fruits,B,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42919,and,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42920,vegetables,B,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42921,is,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42922,associated,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42923,with,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42924,reduced,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42925,risk,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42926,of,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42927,chronic,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42928,diseases,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
42929,.,O,1472.0,Epidemiological studies have shown that consumption of fruits and vegetables is associated with reduced risk of chronic diseases .
43138,On,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43139,the,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43140,basis,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43141,of,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43142,these,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43143,results,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43144,",",O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43145,the,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43146,bioactivity,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43147,index,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43148,(,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43149,BI,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43150,),O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43151,for,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43152,dietary,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43153,cancer,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43154,prevention,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43155,is,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43156,proposed,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43157,to,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43158,provide,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43159,a,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43160,simple,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43161,reference,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43162,for,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43163,consumers,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43164,to,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43165,choose,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43166,vegetables,B,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43167,in,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43168,accordance,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43169,with,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43170,their,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43171,beneficial,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43172,activities,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43173,.,O,1481.0,"On the basis of these results , the bioactivity index ( BI ) for dietary cancer prevention is proposed to provide a simple reference for consumers to choose vegetables in accordance with their beneficial activities ."
43174,The,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43175,BI,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43176,could,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43177,be,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43178,a,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43179,new,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43180,alternative,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43181,biomarker,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43182,for,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43183,future,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43184,epidemiological,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43185,studies,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43186,in,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43187,dietary,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43188,cancer,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43189,prevention,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43190,and,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43191,health,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43192,promotion,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43193,.,O,1482.0,The BI could be a new alternative biomarker for future epidemiological studies in dietary cancer prevention and health promotion .
43214,Polyphenol,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43215,benefits,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43216,have,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43217,been,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43218,proposed,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43219,supported,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43220,by,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43221,in,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43222,vitro,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43223,studies,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43224,",",O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43225,animal,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43226,work,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43227,",",O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43228,and,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43229,clinical,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43230,trials,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43231,",",O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43232,which,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43233,have,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43234,been,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43235,conducted,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43236,mostly,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43237,in,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43238,healthy,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43239,volunteers,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43240,.,O,1484.0,"Polyphenol benefits have been proposed supported by in vitro studies , animal work , and clinical trials , which have been conducted mostly in healthy volunteers ."
43739,Understanding,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43740,the,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43741,role,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43742,of,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43743,low,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43744,-,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43745,level,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43746,arsenic,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43747,as,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43748,it,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43749,relates,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43750,to,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43751,subclinical,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43752,CVD,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43753,may,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43754,contribute,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43755,to,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43756,CVD,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43757,prevention,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43758,and,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43759,control,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43760,.,O,1503.0,Understanding the role of low - level arsenic as it relates to subclinical CVD may contribute to CVD prevention and control .
43881,Of,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43882,the,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43883,tree,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43884,nuts,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43885,",",O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43886,walnuts,B,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43887,",",O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43888,pecans,B,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43889,and,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43890,chestnuts,B,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43891,have,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43892,the,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43893,highest,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43894,contents,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43895,of,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43896,antioxidants,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
43897,.,O,1510.0,"Of the tree nuts , walnuts , pecans and chestnuts have the highest contents of antioxidants ."
44119,Among,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44120,major,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44121,food,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44122,groups,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44123,",",O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44124,milk,B,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44125,and,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44126,dairy,B,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44127,products,I,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44128,as,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44129,well,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44130,as,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44131,added,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44132,lipids,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44133,were,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44134,marginally,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44135,positively,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44136,associated,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44137,with,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44138,risk,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44139,for,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44140,prostate,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44141,cancer,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44142,.,O,1519.0,"Among major food groups , milk and dairy products as well as added lipids were marginally positively associated with risk for prostate cancer ."
44249,52,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44250,(,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44251,87,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44252,%,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44253,),O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44254,of,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44255,these,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44256,patients,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44257,had,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44258,been,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44259,using,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44260,oral,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44261,contraceptive,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44262,steroids,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44263,",",O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44264,tobacco,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44265,",",O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44266,and/or,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44267,ergotamine,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44268,for,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44269,an,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44270,average,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44271,of,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44272,3,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44273,years,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44274,",",O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44275,22,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44276,years,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44277,",",O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44278,and,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44279,7.4,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44280,years,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44281,respectively,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44282,.,O,1525.0,"52 ( 87 % ) of these patients had been using oral contraceptive steroids , tobacco , and/or ergotamine for an average of 3 years , 22 years , and 7.4 years respectively ."
44622,No,O,1538.0,No bands were detected from paprika extract .
44623,bands,O,1538.0,No bands were detected from paprika extract .
44624,were,O,1538.0,No bands were detected from paprika extract .
44625,detected,O,1538.0,No bands were detected from paprika extract .
44626,from,O,1538.0,No bands were detected from paprika extract .
44627,paprika,O,1538.0,No bands were detected from paprika extract .
44628,extract,O,1538.0,No bands were detected from paprika extract .
44629,.,O,1538.0,No bands were detected from paprika extract .
44673,In,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44674,summary,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44675,",",O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44676,we,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44677,demonstrate,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44678,that,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44679,inhalation,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44680,of,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44681,dust,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44682,from,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44683,paprika,B,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44684,",",O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44685,coriander,B,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44686,",",O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44687,and,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44688,mace,B,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44689,can,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44690,result,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44691,in,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44692,an,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44693,IgE,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44694,-,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44695,mediated,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44696,reaction,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44697,to,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44698,these,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44699,spices,B,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44700,.,O,1540.0,"In summary , we demonstrate that inhalation of dust from paprika , coriander , and mace can result in an IgE - mediated reaction to these spices ."
44733,In,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44734,contrast,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44735,",",O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44736,consumption,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44737,of,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44738,white,B,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44739,meat,I,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44740,(,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44741,chicken,B,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44742,),O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44743,is,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44744,not,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44745,associated,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44746,with,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44747,risk,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44748,and,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44749,might,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44750,even,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44751,reduce,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44752,the,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44753,occurrence,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44754,of,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44755,colorectal,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44756,cancer,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44757,.,O,1543.0,"In contrast , consumption of white meat ( chicken ) is not associated with risk and might even reduce the occurrence of colorectal cancer ."
44801,),O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44802,",",O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44803,then,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44804,randomized,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44805,to,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44806,10,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44807,different,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44808,AIN-76,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44809,-,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44810,based,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44811,diets,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44812,.,O,1546.0,") , then randomized to 10 different AIN-76 - based diets ."
44922,The,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44923,ACF,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44924,multiplicity,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44925,was,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44926,nearly,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44927,the,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44928,same,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44929,in,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44930,all,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44931,groups,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44932,",",O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44933,except,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44934,bacon,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44935,-,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44936,fed,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44937,rats,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44938,",",O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44939,with,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44940,no,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44941,effect,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44942,of,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44943,fat,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44944,and,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44945,protein,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44946,level,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44947,or,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44948,source,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44949,(,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44950,p,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44951,=,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44952,0.7,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44953,between,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44954,8,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44955,groups,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44956,by,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44957,analysis,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44958,of,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44959,variance,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44960,),O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
44961,.,O,1551.0,"The ACF multiplicity was nearly the same in all groups , except bacon - fed rats , with no effect of fat and protein level or source ( p = 0.7 between 8 groups by analysis of variance ) ."
45112,A,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45113,bacon,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45114,-,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45115,based,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45116,diet,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45117,appears,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45118,to,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45119,protect,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45120,against,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45121,carcinogenesis,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45122,",",O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45123,perhaps,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45124,because,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45125,bacon,B,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45126,contains,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45127,5,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45128,%,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45129,NaCl,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45130,and,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45131,increased,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45132,the,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45133,rats,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45134,',O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45135,water,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45136,intake,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45137,.,O,1557.0,"A bacon - based diet appears to protect against carcinogenesis , perhaps because bacon contains 5 % NaCl and increased the rats ' water intake ."
45316,It,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45317,has,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45318,been,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45319,suggested,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45320,that,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45321,diet,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45322,may,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45323,influence,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45324,the,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45325,risk,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45326,of,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45327,melanoma,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45328,",",O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45329,but,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45330,few,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45331,studies,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45332,are,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45333,available,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45334,on,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45335,this,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45336,topic,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45337,.,O,1567.0,"It has been suggested that diet may influence the risk of melanoma , but few studies are available on this topic ."
45495,etc,O,1573.0,etc .
45496,.,O,1573.0,etc .
45772,Spinach,B,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45773,contained,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45774,the,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45775,largest,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45776,amount,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45777,of,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45778,SQDG,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45779,",",O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45780,followed,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45781,by,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45782,parsley,B,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45783,",",O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45784,green,B,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45785,onion,I,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45786,",",O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45787,chive,B,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45788,",",O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45789,sweet,B,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45790,pepper,I,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45791,",",O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45792,green,B,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45793,tea,I,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45794,",",O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45795,carrot,B,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45796,and,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45797,garlic,B,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45798,.,O,1583.0,"Spinach contained the largest amount of SQDG , followed by parsley , green onion , chive , sweet pepper , green tea , carrot and garlic ."
45829,Therefore,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45830,",",O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45831,the,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45832,inhibition,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45833,of,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45834,pol,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45835,alpha,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45836,activity,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45837,by,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45838,SQDG,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45839,may,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45840,lead,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45841,to,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45842,cell,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45843,growth,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45844,suppression,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
45845,.,O,1586.0,"Therefore , the inhibition of pol alpha activity by SQDG may lead to cell growth suppression ."
46974,Epidemiological,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46975,studies,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46976,suggest,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46977,that,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46978,the,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46979,consumption,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46980,of,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46981,tea,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46982,flavonoids,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46983,may,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46984,be,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46985,associated,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46986,with,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46987,reduced,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46988,risk,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46989,of,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46990,coronary,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46991,heart,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46992,disease,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46993,",",O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46994,stroke,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46995,and,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46996,cancer,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46997,-,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46998,related,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46999,deaths,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
47000,.,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
47027,To,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47028,date,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47029,few,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47030,studies,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47031,have,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47032,demonstrated,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47033,that,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47034,these,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47035,bioavailable,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47036,flavonoids,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47037,retain,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47038,antioxidant,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47039,properties,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47040,in,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47041,vivo,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47042,.,O,1628.0,To date few studies have demonstrated that these bioavailable flavonoids retain antioxidant properties in vivo .
47130,Subjects,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47131,consuming,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47132,no,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47133,tea,B,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47134,exhibited,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47135,no,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47136,significant,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47137,change,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47138,in,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47139,FRAP,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47140,across,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47141,the,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47142,6,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47143,hours,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47144,of,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47145,the,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47146,study,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47147,day,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47148,.,O,1631.0,Subjects consuming no tea exhibited no significant change in FRAP across the 6 hours of the study day .
47149,Similarly,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47150,consumption,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47151,of,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47152,milky,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47153,tea,B,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47154,produced,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47155,no,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47156,change,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47157,in,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47158,FRAP,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47159,between,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47160,9.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47161,a.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47162,and,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47163,12.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47164,p.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47165,and,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47166,the,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47167,50,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47168,%,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47169,increase,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47170,in,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47171,FRAP,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47172,noted,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47173,between,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47174,12.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47175,p.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47176,and,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47177,15.00,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47178,p.m.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47179,was,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47180,not,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47181,statistically,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47182,significant,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47183,.,O,1632.0,Similarly consumption of milky tea produced no change in FRAP between 9.00 a.m. and 12.00 p.m. and the 50 % increase in FRAP noted between 12.00 p.m. and 15.00 p.m. was not statistically significant .
47241,This,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47242,is,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47243,an,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47244,effect,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47245,which,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47246,appears,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47247,to,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47248,be,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47249,totally,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47250,negated,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47251,by,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47252,the,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47253,drinking,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47254,of,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47255,tea,B,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47256,with,I,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47257,milk,I,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47258,.,O,1635.0,This is an effect which appears to be totally negated by the drinking of tea with milk .
47544,Baseline,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47545,FFQ,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47546,data,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47547,were,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47548,used,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47549,to,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47550,generate,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47551,thirty,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47552,-,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47553,four,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47554,food,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47555,groups,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47556,.,O,1644.0,Baseline FFQ data were used to generate thirty - four food groups .
47557,Principal,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47558,component,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47559,analysis,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47560,identified,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47561,dietary,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47562,patterns,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47563,that,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47564,were,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47565,categorised,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47566,into,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47567,quartiles,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47568,",",O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47569,with,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47570,higher,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47571,quartiles,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47572,representing,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47573,higher,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47574,adherence,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47575,to,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47576,the,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47577,dietary,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47578,pattern,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47579,.,O,1645.0,"Principal component analysis identified dietary patterns that were categorised into quartiles , with higher quartiles representing higher adherence to the dietary pattern ."
47781,The,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47782,',O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47783,prudent,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47784,',O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47785,diet,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47786,did,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47787,not,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47788,show,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47789,a,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47790,significant,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47791,trend,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47792,with,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47793,cardiovascular,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47794,outcomes,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47795,or,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47796,mortality,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47797,.,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47878,The,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47879,glucose,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47880,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47881,insulin,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47882,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47883,C,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47884,-,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47885,peptide,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47886,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47887,alpha,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47888,amino,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47889,nitrogen,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47890,(,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47891,AAN,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47892,),O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47893,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47894,glucagon,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47895,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47896,plasma,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47897,urea,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47898,nitrogen,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47899,(,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47900,PUN,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47901,),O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47902,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47903,nonesterified,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47904,fatty,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47905,acid,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47906,(,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47907,NEFA,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47908,),O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47909,",",O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47910,and,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47911,triglyceride,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47912,area,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47913,responses,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47914,were,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47915,determined,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47916,using,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47917,the,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47918,water,B,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47919,meal,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47920,as,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47921,a,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47922,baseline,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47923,.,O,1655.0,"The glucose , insulin , C - peptide , alpha amino nitrogen ( AAN ) , glucagon , plasma urea nitrogen ( PUN ) , nonesterified fatty acid ( NEFA ) , and triglyceride area responses were determined using the water meal as a baseline ."
47984,The,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47985,simultaneous,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47986,ingestion,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47987,of,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47988,glucose,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47989,with,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47990,cottage,B,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47991,cheese,I,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47992,or,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47993,egg,B,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47994,white,I,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47995,protein,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47996,decreased,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47997,the,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47998,glucose,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
47999,area,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48000,response,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48001,to,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48002,glucose,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48003,by,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48004,11,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48005,%,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48006,and,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48007,20,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48008,%,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48009,",",O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48010,respectively,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48011,.,O,1658.0,"The simultaneous ingestion of glucose with cottage cheese or egg white protein decreased the glucose area response to glucose by 11 % and 20 % , respectively ."
48123,The,O,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48124,glucagon,O,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48125,area,O,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48126,response,O,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48127,was,O,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48128,similar,O,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48129,following,O,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48130,ingestion,O,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48131,of,O,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48132,cottage,B,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48133,cheese,I,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48134,or,O,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48135,egg,B,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48136,white,I,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48137,protein,O,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48138,.,O,1664.0,The glucagon area response was similar following ingestion of cottage cheese or egg white protein .
48928,The,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48929,results,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48930,indicated,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48931,that,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48932,plasma,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48933,glucose,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48934,concentrations,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48935,after,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48936,meals,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48937,containing,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48938,equal,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48939,amounts,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48940,of,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48941,carbohydrate,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48942,as,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48943,rice,B,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48944,",",O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48945,spaghetti,B,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48946,",",O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48947,or,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48948,lentil,B,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48949,were,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48950,similar,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48951,and,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48952,somewhat,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48953,lower,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48954,than,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48955,meals,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48956,containing,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48957,potato,B,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
48958,.,O,1690.0,"The results indicated that plasma glucose concentrations after meals containing equal amounts of carbohydrate as rice , spaghetti , or lentil were similar and somewhat lower than meals containing potato ."
49128,Their,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49129,common,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49130,central,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49131,feature,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49132,is,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49133,the,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49134,usage,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49135,of,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49136,olive,B,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49137,oil,I,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49138,as,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49139,the,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49140,main,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49141,source,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49142,of,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49143,fat,B,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49144,.,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49330,In,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49331,total,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49332,",",O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49333,324,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49334,quarters,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49335,from,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49336,82,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49337,Holstein,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49338,Friesian,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49339,heifers,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49340,from,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49341,3,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49342,commercial,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49343,dairy,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49344,herds,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49345,equipped,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49346,with,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49347,an,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49348,automatic,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49349,milking,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49350,system,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49351,were,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49352,included,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49353,and,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49354,followed,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49355,from,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49356,calving,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49357,up,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49358,to,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49359,4,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49360,mo,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49361,in,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49362,lactation,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49363,.,O,1702.0,"In total , 324 quarters from 82 Holstein Friesian heifers from 3 commercial dairy herds equipped with an automatic milking system were included and followed from calving up to 4 mo in lactation ."
49422,The,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49423,milk,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49424,prolactin,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49425,level,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49426,in,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49427,early,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49428,lactation,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49429,was,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49430,measured,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49431,",",O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49432,and,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49433,the,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49434,relation,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49435,with,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49436,NAS,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49437,IMI,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49438,was,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49439,determined,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
49440,.,O,1706.0,"The milk prolactin level in early lactation was measured , and the relation with NAS IMI was determined ."
50075,Peanut,B,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50076,and,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50077,peanut,B,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50078,component,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50079,diets,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50080,retarded,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50081,an,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50082,increase,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50083,in,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50084,TC,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50085,and,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50086,CE,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50087,.,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50122,High,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50123,salt,B,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50124,intake,I,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50125,increases,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50126,blood,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50127,pressure,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50128,",",O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50129,and,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50130,dietary,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50131,salt,B,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50132,intake,I,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50133,has,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50134,been,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50135,clearly,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50136,demonstrated,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50137,to,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50138,be,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50139,associated,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50140,with,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50141,hypertension,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50142,incidence,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50143,.,O,1728.0,"High salt intake increases blood pressure , and dietary salt intake has been clearly demonstrated to be associated with hypertension incidence ."
50202,However,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50203,",",O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50204,recent,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50205,studies,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50206,using,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50207,salt,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50208,-,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50209,sensitive,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50210,hypertensive,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50211,models,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50212,have,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50213,revealed,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50214,that,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50215,miso,B,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50216,lessens,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50217,the,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50218,effects,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50219,of,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50220,salt,B,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50221,on,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50222,blood,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50223,pressure,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50224,.,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50296,However,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50297,",",O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50298,in,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50299,basic,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50300,studies,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50301,",",O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50302,it,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50303,was,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50304,found,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50305,that,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50306,the,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50307,ingredients,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50308,of,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50309,miso,B,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50310,attenuate,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50311,sympathetic,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50312,nerve,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50313,activity,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50314,",",O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50315,resulting,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50316,in,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50317,lowered,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50318,blood,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50319,pressure,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50320,and,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50321,heart,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50322,rate,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
50323,.,O,1736.0,"However , in basic studies , it was found that the ingredients of miso attenuate sympathetic nerve activity , resulting in lowered blood pressure and heart rate ."
51819,Faecal,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51820,steroid,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51821,excretion,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51822,by,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51823,the,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51824,legume,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51825,groups,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51826,was,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51827,not,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51828,significantly,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51829,different,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51830,from,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51831,that,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51832,of,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51833,control,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51834,group,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51835,2,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
51836,.,O,1777.0,Faecal steroid excretion by the legume groups was not significantly different from that of control group 2 .
52050,Before,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52051,fortification,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52052,the,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52053,mean,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52054,serum,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52055,and,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52056,red,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52057,blood,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52058,cell,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52059,folate,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52060,concentrations,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52061,were,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52062,9.7,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52063,+,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52064,/-,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52065,4.3,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52066,and,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52067,290,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52068,+,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52069,/-,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52070,102,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52071,nmol,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52072,/,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52073,L,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52074,",",O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52075,respectively,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52076,",",O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52077,compared,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52078,with,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52079,37.2,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52080,+,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52081,/-,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52082,9.5,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52083,and,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52084,707,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52085,+,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52086,/-,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52087,179,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52088,nmol,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52089,/,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52090,L,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52091,postfortification,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52092,",",O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52093,respectively,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52094,.,O,1785.0,"Before fortification the mean serum and red blood cell folate concentrations were 9.7 + /- 4.3 and 290 + /- 102 nmol / L , respectively , compared with 37.2 + /- 9.5 and 707 + /- 179 nmol / L postfortification , respectively ."
52375,There,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52376,is,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52377,no,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52378,consistent,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52379,adjustment,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52380,for,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52381,important,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52382,potential,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52383,confounders,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52384,of,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52385,any,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52386,tea,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52387,relationship,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52388,",",O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52389,such,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52390,as,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52391,coffee,B,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52392,and,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52393,alcohol,B,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52394,consumption,I,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52395,and,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52396,physical,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52397,activity,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52398,levels,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52399,.,O,1797.0,"There is no consistent adjustment for important potential confounders of any tea relationship , such as coffee and alcohol consumption and physical activity levels ."
52525,Dietary,O,1802.0,Dietary intake was assessed using a FFQ .
52526,intake,O,1802.0,Dietary intake was assessed using a FFQ .
52527,was,O,1802.0,Dietary intake was assessed using a FFQ .
52528,assessed,O,1802.0,Dietary intake was assessed using a FFQ .
52529,using,O,1802.0,Dietary intake was assessed using a FFQ .
52530,a,O,1802.0,Dietary intake was assessed using a FFQ .
52531,FFQ,O,1802.0,Dietary intake was assessed using a FFQ .
52532,.,O,1802.0,Dietary intake was assessed using a FFQ .
52701,These,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52702,data,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52703,suggest,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52704,that,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52705,the,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52706,traditional,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52707,Mediterranean,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52708,dietary,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52709,pattern,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52710,is,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52711,inversely,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52712,associated,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52713,with,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52714,BMI,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52715,and,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52716,obesity,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52717,.,O,1807.0,These data suggest that the traditional Mediterranean dietary pattern is inversely associated with BMI and obesity .
52896,and,O,1816.0,and Lactobacillus spp .
52897,Lactobacillus,O,1816.0,and Lactobacillus spp .
52898,spp,O,1816.0,and Lactobacillus spp .
52899,.,O,1816.0,and Lactobacillus spp .
52975,The,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52976,identification,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52977,and,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52978,quantification,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52979,of,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52980,spice,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52981,-,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52982,specific,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52983,phytochemicals,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52984,provided,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52985,insight,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52986,into,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52987,the,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52988,potential,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52989,influence,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52990,of,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52991,these,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52992,chemicals,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52993,on,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52994,the,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52995,gut,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52996,microbial,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52997,communities,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52998,and,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
52999,activities,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
53000,.,O,1820.0,The identification and quantification of spice - specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities .
53059,The,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53060,objective,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53061,of,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53062,the,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53063,present,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53064,study,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53065,was,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53066,to,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53067,investigate,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53068,how,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53069,glycaemic,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53070,and,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53071,insulinaemic,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53072,responses,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53073,to,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53074,a,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53075,mashed,B,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53076,potato,I,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53077,meal,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53078,changed,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53079,when,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53080,a,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53081,high,B,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53082,-,I,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53083,fat,I,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53084,food,I,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53085,(,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53086,rapeseed,B,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53087,oil,I,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53088,),O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53089,",",O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53090,a,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53091,high,B,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53092,-,I,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53093,protein,I,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53094,food,I,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53095,(,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53096,chicken,B,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53097,breast,I,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53098,),O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53099,and/or,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53100,salad,B,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53101,were,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53102,added,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53103,to,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53104,the,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53105,meal,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53106,.,O,1824.0,"The objective of the present study was to investigate how glycaemic and insulinaemic responses to a mashed potato meal changed when a high - fat food ( rapeseed oil ) , a high - protein food ( chicken breast ) and/or salad were added to the meal ."
53107,Healthy,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53108,subjects,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53109,(,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53110,n,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53111,11,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53112,),O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53113,ingested,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53114,the,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53115,test,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53116,meals,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53117,once,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53118,and,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53119,the,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53120,reference,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53121,food,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53122,(,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53123,glucose,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53124,solution,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53125,),O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53126,twice,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53127,in,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53128,a,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53129,random,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53130,order,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53131,at,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53132,1,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53133,-,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53134,week,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53135,intervals,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53136,.,O,1825.0,Healthy subjects ( n 11 ) ingested the test meals once and the reference food ( glucose solution ) twice in a random order at 1 - week intervals .
53389,A,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53390,cross,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53391,-,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53392,sectional,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53393,case,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53394,-,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53395,control,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53396,observational,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53397,study,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53398,was,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53399,conducted,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53400,enrolling,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53401,83,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53402,patients,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53403,with,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53404,well,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53405,-,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53406,differentiated,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53407,G1,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53408,/,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53409,G2,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53410,GEP,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53411,-,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53412,NETs,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53413,after,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53414,resection,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53415,",",O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53416,as,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53417,well,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53418,as,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53419,83,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53420,healthy,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53421,subjects,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53422,",",O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53423,age,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53424,",",O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53425,sex,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53426,and,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53427,body,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53428,mass,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53429,index,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53430,-,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53431,matched,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
53432,.,O,1838.0,"A cross - sectional case - control observational study was conducted enrolling 83 patients with well - differentiated G1 / G2 GEP - NETs after resection , as well as 83 healthy subjects , age , sex and body mass index - matched ."
66212,Both,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66213,red,B,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66214,wine,I,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66215,and,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66216,ethanol,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66217,suppressed,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66218,post,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66219,-,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66220,ischemic,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66221,expression,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66222,of,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66223,adhesion,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66224,molecules,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66225,and,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66226,microglial,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66227,activation,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66228,.,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66594,Several,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66595,studies,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66596,have,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66597,shown,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66598,the,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66599,antigenotoxic,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66600,potential,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66601,of,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66602,different,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66603,fruits,B,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66604,and,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66605,plants,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66606,(,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66607,Part,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66608,1,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66609,),O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66610,.,O,2326.0,Several studies have shown the antigenotoxic potential of different fruits and plants ( Part 1 ) .
66658,In,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66659,addition,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66660,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66661,an,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66662,analysis,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66663,of,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66664,some,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66665,phytochemicals,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66666,extracted,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66667,from,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66668,those,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66669,vegetables,B,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66670,and,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66671,the,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66672,analysis,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66673,of,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66674,a,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66675,resin,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66676,(,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66677,"propolis),whose",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66678,antigenotoxic,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66679,power,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66680,has,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66681,been,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66682,demonstrated,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66683,in,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66684,various,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66685,tests,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66686,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66687,including,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66688,the,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66689,Ames,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66690,assay,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66691,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66692,sister,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66693,chromatid,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66694,exchange,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66695,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66696,chromosomal,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66697,aberrations,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66698,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66699,micronucleus,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66700,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66701,and,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66702,comet,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66703,assay,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66704,",",O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66705,was,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66706,also,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66707,performed,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66708,.,O,2328.0,"In addition , an analysis of some phytochemicals extracted from those vegetables and the analysis of a resin ( propolis),whose antigenotoxic power has been demonstrated in various tests , including the Ames assay , sister chromatid exchange , chromosomal aberrations , micronucleus , and comet assay , was also performed ."
66904,Red,B,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66905,wine,I,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66906,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66907,liquor,B,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66908,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66909,and,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66910,beer,B,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66911,were,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66912,not,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66913,associated,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66914,with,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66915,prostate,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66916,cancer,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66917,nor,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66918,was,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66919,total,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66920,alcohol,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66921,consumed,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66922,at,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66923,ages,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66924,18,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66925,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66926,30,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66927,",",O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66928,and,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66929,45,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
66930,.,O,2336.0,"Red wine , liquor , and beer were not associated with prostate cancer nor was total alcohol consumed at ages 18 , 30 , and 45 ."
67106,Red,B,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67107,rice,I,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67108,cooked,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67109,using,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67110,ghee,B,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67111,showed,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67112,the,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67113,lowest,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67114,amount,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67115,of,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67116,glucose,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67117,release,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67118,during,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67119,in,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67120,vitro,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67121,digestion,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67122,.,O,2344.0,Red rice cooked using ghee showed the lowest amount of glucose release during in vitro digestion .
67511,Alcohol,B,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67512,consumption,I,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67513,was,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67514,not,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67515,clearly,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67516,related,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67517,to,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67518,risk,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67519,",",O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67520,and,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67521,no,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67522,association,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67523,was,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67524,found,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67525,for,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67526,drinking,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67527,regular,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67528,coffee,B,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67529,or,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67530,herbal,B,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67531,tea,I,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67532,or,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67533,using,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67534,milk,B,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67535,/,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67536,cream,I,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67537,in,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67538,coffee,B,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67539,or,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67540,tea,B,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
67541,.,O,2358.0,"Alcohol consumption was not clearly related to risk , and no association was found for drinking regular coffee or herbal tea or using milk / cream in coffee or tea ."
68767,It,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68768,was,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68769,assumed,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68770,that,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68771,one,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68772,serving,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68773,of,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68774,discretionary,B,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68775,food,I,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68776,each,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68777,week,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68778,was,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68779,replaced,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68780,with,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68781,either,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68782,a,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68783,serving,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68784,of,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68785,fruit,B,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68786,or,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68787,popcorn,B,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68788,",",O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68789,and,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68790,a,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68791,serving,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68792,(,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68793,375,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68794,mL,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68795,),O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68796,of,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68797,SSBs,B,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68798,was,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68799,replaced,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68800,with,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68801,coffee,B,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68802,",",O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68803,tea,B,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68804,",",O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68805,or,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68806,milk,B,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
68807,.,O,2399.0,"It was assumed that one serving of discretionary food each week was replaced with either a serving of fruit or popcorn , and a serving ( 375 mL ) of SSBs was replaced with coffee , tea , or milk ."
69688,One,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69689,of,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69690,these,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69691,",",O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69692,Listeria,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69693,monocytogenes,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69694,",",O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69695,has,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69696,attracted,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69697,considerable,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69698,attention,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69699,because,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69700,of,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69701,two,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69702,major,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69703,cheese,B,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69704,-,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69705,related,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69706,outbreaks,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69707,of,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69708,listeriosis,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69709,that,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69710,were,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69711,characterized,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69712,by,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69713,cases,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69714,of,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69715,meningitis,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69716,",",O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69717,abortion,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69718,",",O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69719,and,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69720,perinatal,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69721,septicemia,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69722,.,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
70305,Blood,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70306,-,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70307,glucose,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70308,response,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70309,to,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70310,meals,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70311,containing,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70312,grapes,B,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70313,",",O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70314,honeydew,B,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70315,",",O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70316,orange,B,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70317,",",O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70318,or,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70319,strawberries,B,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70320,was,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70321,slightly,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70322,higher,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70323,than,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70324,meals,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70325,containing,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70326,apple,B,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70327,",",O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70328,banana,B,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70329,",",O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70330,or,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70331,no,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70332,fruit,B,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70333,and,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70334,the,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70335,small,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70336,amount,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70337,of,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70338,starch,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70339,in,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70340,apple,B,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70341,and,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70342,banana,B,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70343,may,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70344,have,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70345,contributed,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70346,to,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70347,their,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70348,lower,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70349,blood,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70350,-,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70351,glucose,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70352,response,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70353,compared,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70354,to,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70355,the,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70356,other,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70357,fruits,B,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70358,tested,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70359,.,O,2450.0,"Blood - glucose response to meals containing grapes , honeydew , orange , or strawberries was slightly higher than meals containing apple , banana , or no fruit and the small amount of starch in apple and banana may have contributed to their lower blood - glucose response compared to the other fruits tested ."
70662,Total,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70663,frequency,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70664,of,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70665,usual,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70666,milk,B,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70667,intake,I,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70668,was,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70669,not,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70670,associated,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70671,with,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70672,increased,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70673,risk,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70674,.,O,2462.0,Total frequency of usual milk intake was not associated with increased risk .
70806,Laboratory,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70807,and,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70808,animal,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70809,studies,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70810,suggest,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70811,that,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70812,dietary,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70813,flavonols,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70814,may,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70815,reduce,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70816,breast,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70817,cancer,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70818,risk,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70819,but,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70820,there,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70821,are,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70822,limited,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70823,epidemiological,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70824,studies,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
70825,.,O,2468.0,Laboratory and animal studies suggest that dietary flavonols may reduce breast cancer risk but there are limited epidemiological studies .
72093,The,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72094,aqueous,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72095,extracts,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72096,of,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72097,rosemary,B,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72098,and,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72099,sage,B,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72100,were,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72101,the,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72102,richest,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72103,in,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72104,phenolic,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72105,compounds,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72106,and,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72107,showed,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72108,the,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72109,highest,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72110,ability,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72111,in,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72112,binding,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72113,iron,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72114,and,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72115,inhibiting,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72116,DPPH,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72117,",",O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72118,superoxide,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72119,radicals,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72120,and,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72121,advanced,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72122,glycation,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72123,end,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72124,-,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72125,product,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72126,production,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72127,",",O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72128,lipid,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72129,peroxidation,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72130,",",O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72131,and,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72132,the,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72133,activity,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72134,of,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72135,α,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72136,-,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72137,glucosidase,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72138,and,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72139,α,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72140,-,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72141,amylase,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72142,.,O,2507.0,"The aqueous extracts of rosemary and sage were the richest in phenolic compounds and showed the highest ability in binding iron and inhibiting DPPH , superoxide radicals and advanced glycation end - product production , lipid peroxidation , and the activity of α - glucosidase and α - amylase ."
72289,Principal,O,2514.0,Principal component analysis was used to identify dietary patterns .
72290,component,O,2514.0,Principal component analysis was used to identify dietary patterns .
72291,analysis,O,2514.0,Principal component analysis was used to identify dietary patterns .
72292,was,O,2514.0,Principal component analysis was used to identify dietary patterns .
72293,used,O,2514.0,Principal component analysis was used to identify dietary patterns .
72294,to,O,2514.0,Principal component analysis was used to identify dietary patterns .
72295,identify,O,2514.0,Principal component analysis was used to identify dietary patterns .
72296,dietary,O,2514.0,Principal component analysis was used to identify dietary patterns .
72297,patterns,O,2514.0,Principal component analysis was used to identify dietary patterns .
72298,.,O,2514.0,Principal component analysis was used to identify dietary patterns .
73143,It,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73144,should,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73145,be,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73146,noted,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73147,that,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73148,the,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73149,doses,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73150,of,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73151,garlic,B,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73152,used,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73153,in,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73154,clinical,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73155,trials,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73156,were,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73157,usually,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73158,far,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73159,lower,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73160,than,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73161,those,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73162,used,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73163,in,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73164,animal,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73165,studies,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73166,",",O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73167,which,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73168,might,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73169,cover,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73170,its,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73171,potential,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73172,effects,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73173,.,O,2540.0,"It should be noted that the doses of garlic used in clinical trials were usually far lower than those used in animal studies , which might cover its potential effects ."
73202,In,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73203,addition,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73204,",",O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73205,the,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73206,biological,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73207,availability,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73208,of,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73209,garlic,B,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73210,products,I,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73211,is,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73212,of,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73213,importance,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73214,",",O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73215,which,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73216,was,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73217,omitted,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73218,in,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73219,many,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73220,studies,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73221,.,O,2542.0,"In addition , the biological availability of garlic products is of importance , which was omitted in many studies ."
73415,The,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73416,medians,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73417,of,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73418,milk,B,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73419,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73420,yogurt,B,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73421,and,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73422,cheese,B,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73423,consumption,I,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73424,were,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73425,293,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73426,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73427,interquartile,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73428,range,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73429,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73430,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73431,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73432,146,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73433,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73434,439,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73435,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73436,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73437,35·3,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73438,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73439,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73440,8·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73441,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73442,71·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73443,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73444,and,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73445,14·6,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73446,(,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73447,IQR,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73448,4·8,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73449,-,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73450,26·9,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73451,),O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73452,g,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73453,/,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73454,d,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73455,",",O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73456,respectively,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73457,.,O,2551.0,"The medians of milk , yogurt and cheese consumption were 293 ( interquartile range ( IQR ) 146 - 439 ) , 35·3 ( IQR 8·8 - 71·8 ) and 14·6 ( IQR 4·8 - 26·9 ) g / d , respectively ."
73458,Low,B,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73459,-,I,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73460,fat,I,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73461,dairy,I,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73462,consumption,I,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73463,was,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73464,inversely,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73465,associated,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73466,with,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73467,visceral,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73468,:,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73469,subcutaneous,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73470,fat,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73471,ratio,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73472,estimated,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73473,with,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73474,dual,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73475,-,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73476,energy,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73477,X,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73478,-,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73479,ray,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73480,absorptiometry,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73481,(,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73482,-2·58,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73483,%,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73484,(,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73485,95,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73486,%,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73487,CI,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73488,-3·91,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73489,",",O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73490,-1·23,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73491,%,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73492,),O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73493,per,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73494,serving,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73495,/,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73496,d,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73497,),O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73498,.,O,2552.0,"Low - fat dairy consumption was inversely associated with visceral : subcutaneous fat ratio estimated with dual - energy X - ray absorptiometry ( -2·58 % ( 95 % CI -3·91 , -1·23 % ) per serving / d ) ."
73772,The,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73773,insulin,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73774,rise,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73775,was,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73776,statistically,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73777,significantly,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73778,greater,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73779,than,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73780,would,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73781,be,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73782,predicted,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73783,from,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73784,the,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73785,glucose,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73786,response,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73787,for,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73788,oatmeal,B,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73789,",",O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73790,lentils,B,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73791,",",O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73792,kidney,B,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73793,beans,I,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73794,",",O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73795,and,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73796,high,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73797,-,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73798,amylose,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73799,corn,B,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73800,muffins,I,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73801,.,O,2562.0,"The insulin rise was statistically significantly greater than would be predicted from the glucose response for oatmeal , lentils , kidney beans , and high - amylose corn muffins ."
73926,Perinatal,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73927,outcomes,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73928,were,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73929,collected,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73930,at,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73931,delivery,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73932,with,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73933,birth,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73934,weight,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73935,data,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73936,calculated,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73937,into,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73938,percentiles,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73939,to,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73940,assess,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73941,small,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73942,and,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73943,large,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73944,for,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73945,gestational,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73946,age,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73947,and,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73948,preterm,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73949,delivery,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73950,at,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73951,<,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73952,37,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73953,wk,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
73954,.,O,2570.0,Perinatal outcomes were collected at delivery with birth weight data calculated into percentiles to assess small and large for gestational age and preterm delivery at < 37 wk .
74221,Poor,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74222,dietary,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74223,behaviors,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74224,in,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74225,the,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74226,periconceptional,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74227,period,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74228,could,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74229,be,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74230,altered,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74231,to,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74232,promote,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74233,behavior,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74234,change,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74235,in,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74236,dietary,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74237,intake,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74238,to,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74239,improve,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74240,perinatal,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74241,outcomes,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74242,and,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74243,the,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74244,long,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74245,-,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74246,term,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74247,health,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74248,of,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74249,the,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74250,child,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74251,.,O,2576.0,Poor dietary behaviors in the periconceptional period could be altered to promote behavior change in dietary intake to improve perinatal outcomes and the long - term health of the child .
74252,Natural,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74253,rubber,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74254,latex,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74255,allergy,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74256,is,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74257,responsible,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74258,for,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74259,a,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74260,wide,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74261,spectrum,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74262,of,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74263,clinical,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74264,symptoms,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74265,",",O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74266,ranging,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74267,from,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74268,rhinoconjunctivitis,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74269,to,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74270,severe,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74271,anaphylaxis,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74272,",",O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74273,in,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74274,both,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74275,adults,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74276,and,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74277,children,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74278,.,O,2577.0,"Natural rubber latex allergy is responsible for a wide spectrum of clinical symptoms , ranging from rhinoconjunctivitis to severe anaphylaxis , in both adults and children ."
74509,A,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74510,history,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74511,of,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74512,previous,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74513,surgery,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74514,was,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74515,found,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74516,in,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74517,5/10,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74518,positive,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74519,-,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74520,latex,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74521,-,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74522,SPT,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74523,children,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74524,",",O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74525,in,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74526,63/316,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74527,negative,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74528,-,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74529,latex,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74530,-,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74531,SPT,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74532,atopic,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74533,children,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74534,(,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74535,P,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74536,<,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74537,0.05,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74538,),O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74539,",",O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74540,and,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74541,in,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74542,23/127,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74543,nonatopic,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74544,children,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74545,.,O,2588.0,"A history of previous surgery was found in 5/10 positive - latex - SPT children , in 63/316 negative - latex - SPT atopic children ( P < 0.05 ) , and in 23/127 nonatopic children ."
74672,PAs,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74673,have,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74674,been,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74675,reported,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74676,to,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74677,be,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74678,hepatotoxic,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74679,",",O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74680,mutagenic,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74681,",",O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74682,and,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74683,carcinogenic,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74684,;,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74685,they,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74686,are,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74687,a,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74688,significant,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74689,group,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74690,of,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74691,natural,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74692,toxins,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74693,affecting,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74694,livestock,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74695,",",O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74696,wildlife,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74697,",",O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74698,and,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74699,humans,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
74700,.,O,2595.0,"PAs have been reported to be hepatotoxic , mutagenic , and carcinogenic ; they are a significant group of natural toxins affecting livestock , wildlife , and humans ."
75107,Changes,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75108,in,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75109,the,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75110,chemical,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75111,modification,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75112,of,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75113,the,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75114,milk,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75115,protein,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75116,were,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75117,monitored,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75118,by,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75119,measuring,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75120,the,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75121,protein,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75122,-,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75123,bound,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75124,carbonyls,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75125,and,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75126,PAGE,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75127,protein,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75128,profiles,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75129,.,O,2610.0,Changes in the chemical modification of the milk protein were monitored by measuring the protein - bound carbonyls and PAGE protein profiles .
75857,Work,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75858,in,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75859,the,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75860,field,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75861,or,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75862,kitchen,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75863,resulted,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75864,in,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75865,a,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75866,lifestyle,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75867,that,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75868,included,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75869,regular,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75870,physical,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75871,activity,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75872,and,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75873,was,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75874,associated,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75875,with,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75876,low,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75877,rates,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75878,of,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75879,obesity,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
75880,.,O,2638.0,Work in the field or kitchen resulted in a lifestyle that included regular physical activity and was associated with low rates of obesity .
76289,Nonlinear,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76290,mixed,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76291,-,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76292,effects,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76293,modeling,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76294,(,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76295,NLME,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76296,),O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76297,has,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76298,been,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76299,advocated,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76300,as,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76301,a,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76302,suitable,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76303,pharmaco,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76304,-,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76305,statistical,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76306,method,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76307,for,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76308,the,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76309,study,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76310,of,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76311,drug,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76312,residues,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76313,in,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76314,milk,B,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76315,.,O,2649.0,Nonlinear mixed - effects modeling ( NLME ) has been advocated as a suitable pharmaco - statistical method for the study of drug residues in milk .
76343,The,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76344,PBPK,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76345,model,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76346,was,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76347,applied,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76348,to,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76349,NLME,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76350,analysis,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76351,of,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76352,a,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76353,data,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76354,set,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76355,consisting,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76356,of,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76357,milk,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76358,drug,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76359,concentrations,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76360,from,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76361,78,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76362,healthy,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76363,cows,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76364,and,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76365,117,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76366,with,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76367,clinical,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76368,mastitis,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76369,.,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76477,More,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76478,pirlimycin,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76479,was,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76480,systemically,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76481,absorbed,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76482,in,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76483,the,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76484,gram,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76485,-,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76486,positive,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76487,infected,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76488,compared,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76489,with,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76490,the,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76491,gram,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76492,-,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76493,negative,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76494,infected,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76495,or,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76496,healthy,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76497,cows,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76498,",",O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76499,suggesting,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76500,a,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76501,greater,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76502,risk,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76503,of,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76504,violative,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76505,meat,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76506,residues,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76507,in,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76508,gram,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76509,-,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76510,positive,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76511,infected,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76512,cows,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
76513,.,O,2657.0,"More pirlimycin was systemically absorbed in the gram - positive infected compared with the gram - negative infected or healthy cows , suggesting a greater risk of violative meat residues in gram - positive infected cows ."
77512,Mortality,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77513,rates,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77514,for,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77515,these,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77516,diseases,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77517,subsequently,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77518,decreased,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77519,significantly,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77520,while,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77521,the,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77522,already,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77523,low,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77524,rates,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77525,for,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77526,ischemic,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77527,heart,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77528,disease,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77529,and,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77530,cancer,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77531,also,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77532,decreased,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77533,",",O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77534,resulting,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77535,in,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77536,Japanese,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77537,life,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77538,expectancy,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77539,becoming,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77540,the,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77541,longest,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77542,.,O,2691.0,"Mortality rates for these diseases subsequently decreased significantly while the already low rates for ischemic heart disease and cancer also decreased , resulting in Japanese life expectancy becoming the longest ."
77790,During,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77791,a,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77792,mean,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77793,follow,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77794,-,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77795,up,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77796,of,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77797,11.1,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77798,years,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77799,",",O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77800,339,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77801,participants,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77802,developed,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77803,EC,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77804,",",O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77805,of,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77806,which,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77807,142,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77808,were,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77809,esophageal,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77810,adenocarcinoma,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77811,(,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77812,EAC,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77813,),O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77814,and,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77815,174,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77816,were,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77817,esophageal,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77818,squamous,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77819,cell,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77820,carcinoma,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77821,(,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77822,ESCC,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77823,),O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77824,.,O,2700.0,"During a mean follow - up of 11.1 years , 339 participants developed EC , of which 142 were esophageal adenocarcinoma ( EAC ) and 174 were esophageal squamous cell carcinoma ( ESCC ) ."
77894,In,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77895,current,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77896,smokers,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77897,",",O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77898,a,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77899,significant,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77900,and,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77901,inverse,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77902,association,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77903,was,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77904,observed,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77905,between,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77906,ESCC,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77907,risk,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77908,and,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77909,tea,B,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77910,(,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77911,HR,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77912,0.46,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77913,",",O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77914,95,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77915,%,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77916,CI,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77917,0.23,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77918,-,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77919,0.93,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77920,;,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77921,p,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77922,-,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77923,trend=0.053,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77924,),O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77925,and,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77926,coffee,B,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77927,consumption,I,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77928,(,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77929,HR,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77930,0.37,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77931,",",O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77932,95,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77933,%,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77934,CI,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77935,0.19,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77936,-,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77937,0.73,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77938,;,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77939,p,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77940,-,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77941,trend=0.011,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77942,),O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
77943,.,O,2703.0,"In current smokers , a significant and inverse association was observed between ESCC risk and tea ( HR 0.46 , 95 % CI 0.23 - 0.93 ; p - trend=0.053 ) and coffee consumption ( HR 0.37 , 95 % CI 0.19 - 0.73 ; p - trend=0.011 ) ."
78040,This,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78041,article,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78042,reviews,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78043,the,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78044,epidemiologic,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78045,literature,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78046,on,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78047,the,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78048,relationship,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78049,between,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78050,consumption,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78051,of,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78052,major,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78053,food,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78054,groups,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78055,and,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78056,the,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78057,risk,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78058,of,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78059,epithelial,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78060,ovarian,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78061,cancer,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78062,(,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78063,EOC,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78064,),O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78065,.,O,2707.0,This article reviews the epidemiologic literature on the relationship between consumption of major food groups and the risk of epithelial ovarian cancer ( EOC ) .
78333,The,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78334,present,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78335,study,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78336,investigated,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78337,the,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78338,hypothesis,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78339,that,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78340,a,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78341,healthy,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78342,dietary,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78343,pattern,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78344,was,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78345,negatively,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78346,associated,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78347,with,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78348,risk,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78349,of,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78350,TNBC,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78351,in,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78352,women,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78353,with,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78354,dense,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78355,breasts,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78356,(,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78357,density,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78358,types,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78359,3,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78360,and,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78361,4,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78362,),O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78363,.,O,2717.0,The present study investigated the hypothesis that a healthy dietary pattern was negatively associated with risk of TNBC in women with dense breasts ( density types 3 and 4 ) .
78364,After,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78365,total,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78366,mastectomy,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78367,or,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78368,breast,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78369,conserving,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78370,surgery,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78371,",",O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78372,patients,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78373,with,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78374,TNBC,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78375,(,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78376,n,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78377,=,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78378,38,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78379,),O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78380,and,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78381,non,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78382,-,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78383,TNBC,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78384,(,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78385,n,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78386,=,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78387,178,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78388,),O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78389,were,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78390,recruited,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78391,.,O,2718.0,"After total mastectomy or breast conserving surgery , patients with TNBC ( n = 38 ) and non - TNBC ( n = 178 ) were recruited ."
78480,The,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78481,present,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78482,study,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78483,is,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78484,the,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78485,first,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78486,to,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78487,show,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78488,a,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78489,negative,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78490,association,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78491,between,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78492,risk,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78493,of,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78494,TNBC,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78495,and,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78496,a,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78497,healthy,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78498,dietary,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78499,pattern,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78500,in,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78501,women,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78502,with,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78503,dense,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78504,breasts,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78505,and,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78506,suggests,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78507,the,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78508,importance,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78509,of,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78510,diet,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78511,in,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78512,the,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78513,prevention,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78514,of,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78515,TNBC,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78516,.,O,2722.0,The present study is the first to show a negative association between risk of TNBC and a healthy dietary pattern in women with dense breasts and suggests the importance of diet in the prevention of TNBC .
78812,The,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78813,protective,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78814,effect,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78815,may,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78816,exist,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78817,aside,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78818,from,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78819,the,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78820,influence,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78821,of,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78822,caffeine,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78823,intake,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
78824,.,O,2733.0,The protective effect may exist aside from the influence of caffeine intake .
79016,Thus,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79017,the,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79018,present,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79019,study,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79020,gives,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79021,support,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79022,for,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79023,a,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79024,protective,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79025,effect,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79026,associated,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79027,with,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79028,a,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79029,fiber,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79030,-,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79031,rich,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79032,or,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79033,vegetable,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79034,-,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79035,rich,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79036,diet,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79037,",",O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79038,while,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79039,it,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79040,indicates,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79041,that,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79042,frequent,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79043,consumption,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79044,of,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79045,refined,B,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79046,starchy,I,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79047,foods,I,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79048,",",O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79049,eggs,B,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79050,and,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79051,fat,B,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79052,-,I,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79053,rich,I,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79054,foods,I,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79055,such,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79056,as,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79057,cheese,B,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79058,and,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79059,red,B,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79060,meat,I,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79061,is,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79062,a,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79063,risk,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79064,factor,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79065,for,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79066,colo,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79067,-,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79068,rectal,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79069,cancer,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79070,.,O,2737.0,"Thus the present study gives support for a protective effect associated with a fiber - rich or vegetable - rich diet , while it indicates that frequent consumption of refined starchy foods , eggs and fat - rich foods such as cheese and red meat is a risk factor for colo - rectal cancer ."
79097,Despite,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79098,a,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79099,60,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79100,%,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79101,sugar,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79102,content,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79103,",",O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79104,several,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79105,studies,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79106,have,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79107,reported,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79108,health,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79109,-,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79110,promoting,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79111,properties,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79112,for,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79113,raisins,B,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79114,and,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79115,this,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79116,review,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79117,compiles,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79118,the,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79119,intervention,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79120,studies,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79121,",",O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79122,as,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79123,well,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79124,as,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79125,the,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79126,cell,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79127,line,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79128,and,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79129,animal,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79130,model,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79131,studies,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79132,carried,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79133,out,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79134,to,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79135,date,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79136,.,O,2740.0,"Despite a 60 % sugar content , several studies have reported health - promoting properties for raisins and this review compiles the intervention studies , as well as the cell line and animal model studies carried out to date ."
79345,We,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79346,conducted,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79347,a,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79348,study,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79349,to,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79350,investigate,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79351,whether,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79352,milk,B,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79353,and,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79354,fermented,B,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79355,milk,I,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79356,intakes,I,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79357,are,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79358,associated,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79359,with,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79360,incident,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79361,PD,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
79362,.,O,2750.0,We conducted a study to investigate whether milk and fermented milk intakes are associated with incident PD .
80029,Orange,B,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80030,-,I,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80031,yellow,I,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80032,foods,I,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80033,",",O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80034,including,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80035,oranges,B,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80036,",",O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80037,tangerines,B,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80038,and,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80039,lemons,B,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80040,contain,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80041,citrus,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80042,flavonoids,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80043,.,O,2772.0,"Orange - yellow foods , including oranges , tangerines and lemons contain citrus flavonoids ."
80227,Given,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80228,this,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80229,background,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80230,",",O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80231,the,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80232,aim,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80233,of,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80234,this,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80235,review,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80236,is,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80237,to,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80238,evaluate,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80239,the,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80240,evidence,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80241,to,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80242,date,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80243,regarding,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80244,the,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80245,ideal,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80246,dietary,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80247,approach,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80248,for,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80249,management,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80250,of,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80251,RA,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80252,in,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80253,order,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80254,to,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80255,reduce,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80256,the,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80257,counteracting,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80258,inflammation,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80259,",",O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80260,and,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80261,to,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80262,construct,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80263,a,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80264,food,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80265,pyramid,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80266,for,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80267,patients,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80268,with,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80269,RA,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80270,.,O,2780.0,"Given this background , the aim of this review is to evaluate the evidence to date regarding the ideal dietary approach for management of RA in order to reduce the counteracting inflammation , and to construct a food pyramid for patients with RA ."
80792,The,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80793,prevailing,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80794,view,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80795,holds,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80796,that,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80797,the,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80798,integrity,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80799,of,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80800,plant,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80801,cell,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80802,wall,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80803,structure,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80804,is,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80805,the,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80806,primary,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80807,determinant,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80808,of,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80809,energy,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80810,and,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80811,nutrient,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80812,extraction,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80813,from,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80814,plant,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80815,cells,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80816,as,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80817,they,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80818,pass,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80819,through,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80820,the,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80821,gastrointestinal,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80822,(,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80823,GI,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80824,),O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80825,tract,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
80826,.,O,2797.0,The prevailing view holds that the integrity of plant cell wall structure is the primary determinant of energy and nutrient extraction from plant cells as they pass through the gastrointestinal ( GI ) tract .
81083,However,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81084,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81085,mechanisms,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81086,including,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81087,low,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81088,-,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81089,density,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81090,lipoproteins,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81091,oxidation,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81092,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81093,inhibition,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81094,of,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81095,platelet,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81096,aggregation,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81097,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81098,modification,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81099,of,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81100,eicosanoid,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81101,metabolism,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81102,",",O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81103,and,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81104,endothelium,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81105,-,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81106,dependent,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81107,relaxation,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81108,of,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81109,blood,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81110,vessels,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81111,are,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81112,recognized,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81113,as,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81114,contributory,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81115,.,O,2810.0,"However , mechanisms including low - density lipoproteins oxidation , inhibition of platelet aggregation , modification of eicosanoid metabolism , and endothelium - dependent relaxation of blood vessels are recognized as contributory ."
81116,In,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81117,this,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81118,study,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81119,",",O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81120,a,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81121,new,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81122,approach,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81123,has,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81124,been,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81125,examined,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81126,",",O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81127,based,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81128,on,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81129,previous,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81130,reports,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81131,that,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81132,platelet,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81133,-,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81134,activating,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81135,factor,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81136,(,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81137,PAF,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81138,),O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81139,is,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81140,involved,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81141,in,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81142,atherogenesis,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81143,.,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81797,In,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81798,conclusion,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81799,",",O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81800,specific,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81801,IgE,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81802,measurements,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81803,with,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81804,egg,B,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81805,white,I,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81806,and,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81807,milk,B,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81808,were,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81809,useful,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81810,for,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81811,exclusion,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81812,of,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81813,symptomatic,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81814,hypersensitivity,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81815,to,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81816,egg,B,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81817,and,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81818,milk,B,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81819,in,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81820,patients,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81821,with,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81822,a,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81823,positive,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81824,history,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81825,",",O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81826,whereas,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81827,DBPCFC,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81828,is,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81829,still,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81830,mandatory,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81831,in,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81832,patients,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81833,with,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81834,positive,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81835,history,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81836,and,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81837,positive,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81838,test,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81839,.,O,2835.0,"In conclusion , specific IgE measurements with egg white and milk were useful for exclusion of symptomatic hypersensitivity to egg and milk in patients with a positive history , whereas DBPCFC is still mandatory in patients with positive history and positive test ."
81966,A,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81967,vegetarian,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81968,diet,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81969,is,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81970,defined,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81971,as,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81972,one,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81973,that,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81974,does,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81975,not,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81976,include,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81977,meat,B,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81978,(,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81979,including,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81980,fowl,B,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81981,),O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81982,or,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81983,seafood,B,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81984,",",O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81985,or,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81986,products,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81987,containing,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81988,those,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81989,foods,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81990,.,O,2840.0,"A vegetarian diet is defined as one that does not include meat ( including fowl ) or seafood , or products containing those foods ."
81991,This,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81992,article,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81993,reviews,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81994,the,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81995,current,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81996,data,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81997,related,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81998,to,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
81999,key,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82000,nutrients,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82001,for,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82002,vegetarians,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82003,including,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82004,protein,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82005,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82006,n-3,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82007,fatty,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82008,acids,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82009,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82010,iron,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82011,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82012,zinc,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82013,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82014,iodine,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82015,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82016,calcium,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82017,",",O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82018,and,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82019,vitamins,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82020,D,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82021,and,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82022,B-12,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82023,.,O,2841.0,"This article reviews the current data related to key nutrients for vegetarians including protein , n-3 fatty acids , iron , zinc , iodine , calcium , and vitamins D and B-12 ."
82037,In,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82038,some,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82039,cases,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82040,",",O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82041,supplements,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82042,or,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82043,fortified,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82044,foods,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82045,can,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82046,provide,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82047,useful,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82048,amounts,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82049,of,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82050,important,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82051,nutrients,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82052,.,O,2843.0,"In some cases , supplements or fortified foods can provide useful amounts of important nutrients ."
82103,Vegetarians,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82104,also,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82105,appear,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82106,to,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82107,have,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82108,lower,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82109,low,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82110,-,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82111,density,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82112,lipoprotein,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82113,cholesterol,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82114,levels,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82115,",",O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82116,lower,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82117,blood,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82118,pressure,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82119,",",O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82120,and,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82121,lower,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82122,rates,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82123,of,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82124,hypertension,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82125,and,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82126,type,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82127,2,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82128,diabetes,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82129,than,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82130,nonvegetarians,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82131,.,O,2846.0,"Vegetarians also appear to have lower low - density lipoprotein cholesterol levels , lower blood pressure , and lower rates of hypertension and type 2 diabetes than nonvegetarians ."
82205,In,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82206,addition,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82207,to,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82208,assessing,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82209,dietary,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82210,adequacy,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82211,",",O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82212,food,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82213,and,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82214,nutrition,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82215,professionals,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82216,can,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82217,also,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82218,play,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82219,key,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82220,roles,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82221,in,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82222,educating,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82223,vegetarians,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82224,about,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82225,sources,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82226,of,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82227,specific,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82228,nutrients,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82229,",",O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82230,food,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82231,purchase,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82232,and,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82233,preparation,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82234,",",O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82235,and,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82236,dietary,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82237,modifications,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82238,to,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82239,meet,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82240,their,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82241,needs,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82242,.,O,2850.0,"In addition to assessing dietary adequacy , food and nutrition professionals can also play key roles in educating vegetarians about sources of specific nutrients , food purchase and preparation , and dietary modifications to meet their needs ."
82707,Legumes,B,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82708,are,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82709,low,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82710,-,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82711,GI,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82712,foods,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82713,(,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82714,<,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82715,55,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82716,),O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82717,",",O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82718,ranging,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82719,from,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82720,6,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82721,(,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82722,chickpeas,B,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82723,),O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82724,to,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82725,13,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82726,(,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82727,mung,B,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82728,beans,I,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82729,),O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82730,.,O,2865.0,"Legumes are low - GI foods ( < 55 ) , ranging from 6 ( chickpeas ) to 13 ( mung beans ) ."
82969,Nonheme,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82970,iron,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82971,was,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82972,better,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82973,absorbed,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82974,than,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82975,heme,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82976,iron,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82977,regardless,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82978,of,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82979,other,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82980,dietary,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82981,factors,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
82982,.,O,2873.0,Nonheme iron was better absorbed than heme iron regardless of other dietary factors .
83046,Rats,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83047,fed,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83048,nonheme,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83049,iron,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83050,had,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83051,higher,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83052,liver,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83053,Fe,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83054,",",O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83055,but,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83056,not,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83057,Hb,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83058,or,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83059,delta,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83060,Hb,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83061,",",O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83062,when,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83063,fed,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83064,high,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83065,rather,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83066,than,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83067,low,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83068,dietary,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83069,fat,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83070,.,O,2877.0,"Rats fed nonheme iron had higher liver Fe , but not Hb or delta Hb , when fed high rather than low dietary fat ."
83168,Moreover,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83169,",",O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83170,in,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83171,the,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83172,industrial,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83173,area,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83174,of,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83175,Taranto,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83176,",",O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83177,high,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83178,levels,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83179,of,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83180,barium,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83181,",",O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83182,cadmium,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83183,",",O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83184,lead,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83185,",",O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83186,mercury,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83187,",",O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83188,nickel,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83189,",",O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83190,and,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83191,silver,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83192,were,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83193,observed,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83194,in,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83195,comparison,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83196,with,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83197,other,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83198,Apulia,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83199,areas,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83200,.,O,2882.0,"Moreover , in the industrial area of Taranto , high levels of barium , cadmium , lead , mercury , nickel , and silver were observed in comparison with other Apulia areas ."
83201,The,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83202,risk,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83203,odds,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83204,ratios,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83205,(,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83206,ORs,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83207,),O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83208,for,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83209,observing,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83210,values,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83211,above,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83212,the,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83213,50th,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83214,percentile,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83215,were,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83216,elevated,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83217,for,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83218,mercury,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83219,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83220,fish,B,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83221,consumption,I,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83222,",",O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83223,uranium,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83224,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83225,milk,B,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83226,consumption,I,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83227,",",O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83228,lead,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83229,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83230,female,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83231,sex,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83232,",",O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83233,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83234,aluminum,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83235,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83236,mineral,B,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83237,water,I,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83238,consumption,I,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83239,.,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83396,Ginger,B,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83397,(,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83398,Zingiber,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83399,officinale,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83400,Roscoe,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83401,),O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83402,continues,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83403,to,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83404,be,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83405,used,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83406,as,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83407,an,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83408,important,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83409,cooking,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83410,spice,B,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83411,and,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83412,herbal,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83413,medicine,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83414,around,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83415,the,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83416,world,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83417,.,O,2890.0,Ginger ( Zingiber officinale Roscoe ) continues to be used as an important cooking spice and herbal medicine around the world .
83442,In,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83443,the,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83444,current,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83445,study,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83446,",",O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83447,ginger,B,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83448,sequentially,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83449,extracted,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83450,with,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83451,different,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83452,solvents,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83453,-,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83454,namely,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83455,",",O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83456,hexane,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83457,",",O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83458,ethyl,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83459,acetate,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83460,",",O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83461,methanol,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83462,",",O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83463,70,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83464,%,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83465,methanol,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83466,-,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83467,water,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83468,and,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83469,water,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83470,-,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83471,were,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83472,screened,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83473,to,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83474,determine,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83475,the,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83476,variations,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83477,in,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83478,phenolic,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83479,-,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83480,linked,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83481,active,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83482,constituents,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83483,.,O,2892.0,"In the current study , ginger sequentially extracted with different solvents - namely , hexane , ethyl acetate , methanol , 70 % methanol - water and water - were screened to determine the variations in phenolic - linked active constituents ."
83693,Addition,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83694,levels,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83695,of,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83696,brown,B,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83697,rice,I,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83698,flour,I,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83699,(,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83700,0,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83701,%,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83702,to,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83703,100,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83704,%,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83705,),O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83706,and,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83707,sugar,B,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83708,(,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83709,5,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83710,%,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83711,to,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83712,20,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83713,%,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83714,),O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83715,not,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83716,only,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83717,enriched,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83718,flavor,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83719,",",O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83720,but,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83721,also,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83722,lessened,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83723,chewiness,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83724,of,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83725,Seolgitteok,B,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83726,",",O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83727,thereby,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83728,increasing,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83729,an,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83730,overall,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83731,hedonic,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83732,impression,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83733,.,O,2902.0,"Addition levels of brown rice flour ( 0 % to 100 % ) and sugar ( 5 % to 20 % ) not only enriched flavor , but also lessened chewiness of Seolgitteok , thereby increasing an overall hedonic impression ."
83934,Microparticulated,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83935,whey,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83936,protein,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83937,did,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83938,not,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83939,affect,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83940,flowability,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83941,but,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83942,caused,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83943,an,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83944,increase,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83945,in,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83946,the,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83947,storage,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83948,and,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83949,loss,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83950,moduli,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83951,as,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83952,well,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83953,as,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83954,the,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83955,temperature,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83956,at,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83957,gel,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83958,-,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83959,sol,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83960,transition,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83961,.,O,2910.0,Microparticulated whey protein did not affect flowability but caused an increase in the storage and loss moduli as well as the temperature at gel - sol transition .
83986,Corn,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83987,dextrin,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83988,had,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83989,no,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83990,effect,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83991,on,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83992,the,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83993,storage,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83994,and,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83995,loss,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83996,moduli,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83997,",",O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83998,but,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
83999,affected,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84000,the,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84001,gel,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84002,-,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84003,sol,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84004,transition,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84005,temperature,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84006,.,O,2912.0,"Corn dextrin had no effect on the storage and loss moduli , but affected the gel - sol transition temperature ."
84261,Two,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84262,thirds,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84263,of,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84264,the,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84265,consumed,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84266,beverages,B,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84267,",",O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84268,however,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84269,",",O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84270,contained,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84271,sugar,B,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84272,and,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84273,contributed,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84274,substantially,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84275,to,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84276,energy,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84277,intake,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84278,.,O,2922.0,"Two thirds of the consumed beverages , however , contained sugar and contributed substantially to energy intake ."
84523,These,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84524,effects,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84525,were,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84526,not,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84527,markedly,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84528,changed,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84529,by,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84530,carrot,B,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84531,and,I,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84532,tomato,I,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84533,juice,I,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84534,consumption,I,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84535,.,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84564,Faecal,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84565,water,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84566,pH,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84567,decreased,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84568,only,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84569,after,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
84570,carrot,B,2934.0,Faecal water pH decreased only after carrot juice consumption .
84571,juice,I,2934.0,Faecal water pH decreased only after carrot juice consumption .
84572,consumption,I,2934.0,Faecal water pH decreased only after carrot juice consumption .
84573,.,O,2934.0,Faecal water pH decreased only after carrot juice consumption .
85053,The,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85054,latter,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85055,data,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85056,were,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85057,gathered,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85058,from,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85059,six,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85060,government,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85061,household,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85062,surveys,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85063,from,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85064,1963,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85065,-,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85066,64,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85067,to,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85068,1994,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85069,-,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85070,95,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85071,.,O,2947.0,The latter data were gathered from six government household surveys from 1963 - 64 to 1994 - 95 .
85322,Finally,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85323,",",O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85324,children,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85325,and,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85326,parents,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85327,should,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85328,be,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85329,taught,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85330,how,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85331,to,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85332,count,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85333,carbohydrates,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85334,",",O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85335,which,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85336,would,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85337,help,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85338,them,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85339,manage,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85340,exceptions,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85341,in,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85342,their,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85343,daily,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85344,meal,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85345,plan,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85346,.,O,2957.0,"Finally , children and parents should be taught how to count carbohydrates , which would help them manage exceptions in their daily meal plan ."
85397,There,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85398,are,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85399,two,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85400,at,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85401,-,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85402,risk,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85403,periods,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85404,in,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85405,the,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85406,lives,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85407,of,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85408,children,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85409,when,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85410,nutritional,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85411,education,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85412,procedures,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85413,as,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85414,well,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85415,as,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85416,diabetes,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85417,care,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85418,in,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85419,general,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85420,are,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85421,less,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85422,likely,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85423,to,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85424,be,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85425,effective,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85426,:,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85427,early,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85428,years,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85429,of,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85430,life,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85431,and,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85432,adolescence,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85433,.,O,2959.0,There are two at - risk periods in the lives of children when nutritional education procedures as well as diabetes care in general are less likely to be effective : early years of life and adolescence .
85481,In,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85482,adolescents,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85483,",",O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85484,eating,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85485,disorders,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85486,and,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85487,insulin,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85488,misuse,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85489,for,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85490,weight,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85491,control,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85492,purposes,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85493,are,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85494,concrete,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85495,and,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85496,difficult,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85497,problems,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85498,to,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85499,deal,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85500,with,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85501,.,O,2961.0,"In adolescents , eating disorders and insulin misuse for weight control purposes are concrete and difficult problems to deal with ."
85590,The,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85591,word,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85592,cacao,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85593,is,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85594,derived,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85595,from,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85596,Olmec,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85597,and,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85598,the,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85599,subsequent,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85600,Mayan,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85601,languages,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85602,(,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85603,kakaw,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85604,),O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85605,;,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85606,the,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85607,chocolate,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85608,-,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85609,related,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85610,term,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85611,cacahuatl,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85612,is,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85613,Nahuatl,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85614,(,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85615,Aztec,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85616,language,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85617,),O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85618,",",O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85619,derived,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85620,from,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85621,Olmec,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85622,/,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85623,Mayan,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85624,etymology,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85625,.,O,2966.0,"The word cacao is derived from Olmec and the subsequent Mayan languages ( kakaw ) ; the chocolate - related term cacahuatl is Nahuatl ( Aztec language ) , derived from Olmec / Mayan etymology ."
85693,Subsequent,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85694,16th,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85695,to,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85696,early,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85697,20th,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85698,century,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85699,manuscripts,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85700,produced,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85701,in,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85702,Europe,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85703,and,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85704,New,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85705,Spain,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85706,revealed,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85707,>,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85708,100,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85709,medicinal,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85710,uses,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85711,for,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85712,cacao,B,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85713,/,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85714,chocolate,I,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85715,.,O,2969.0,Subsequent 16th to early 20th century manuscripts produced in Europe and New Spain revealed > 100 medicinal uses for cacao / chocolate .
85894,The,O,2975.0,The proceedings are synthesized in this article .
85895,proceedings,O,2975.0,The proceedings are synthesized in this article .
85896,are,O,2975.0,The proceedings are synthesized in this article .
85897,synthesized,O,2975.0,The proceedings are synthesized in this article .
85898,in,O,2975.0,The proceedings are synthesized in this article .
85899,this,O,2975.0,The proceedings are synthesized in this article .
85900,article,O,2975.0,The proceedings are synthesized in this article .
85901,.,O,2975.0,The proceedings are synthesized in this article .
86316,Following,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86317,ingestion,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86318,of,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86319,the,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86320,meals,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86321,containing,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86322,protein,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86323,",",O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86324,the,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86325,plasma,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86326,insulin,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86327,concentration,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86328,was,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86329,increased,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86330,further,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86331,and,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86332,remained,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86333,elevated,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86334,longer,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86335,compared,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86336,with,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86337,the,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86338,meal,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86339,containing,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86340,glucose,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86341,alone,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86342,.,O,2990.0,"Following ingestion of the meals containing protein , the plasma insulin concentration was increased further and remained elevated longer compared with the meal containing glucose alone ."
86427,The,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86428,alpha,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86429,amino,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86430,nitrogen,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86431,concentration,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86432,varied,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86433,considerably,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86434,.,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86601,A,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86602,significant,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86603,trend,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86604,of,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86605,increasing,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86606,GC,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86607,risk,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86608,was,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86609,found,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86610,with,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86611,increasing,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86612,consumption,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86613,of,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86614,traditional,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86615,soups,B,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86616,",",O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86617,meat,B,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86618,",",O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86619,salted,B,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86620,/,B,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86621,dried,B,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86622,fish,I,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86623,and,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86624,a,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86625,combination,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86626,of,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86627,cold,B,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86628,cuts,I,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86629,and,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86630,seasoned,B,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86631,cheeses,I,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86632,.,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86633,The,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86634,habit,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86635,of,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86636,adding,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86637,salt,B,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86638,and,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86639,the,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86640,preference,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86641,for,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86642,salty,B,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86643,foods,I,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86644,were,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86645,associated,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86646,with,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86647,elevated,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86648,GC,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86649,risk,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86650,",",O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86651,while,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86652,more,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86653,frequently,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86654,storing,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86655,foods,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86656,in,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86657,the,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86658,refrigerator,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86659,",",O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86660,the,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86661,availability,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86662,of,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86663,a,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86664,freezer,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86665,and,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86666,use,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86667,of,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86668,frozen,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86669,foods,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86670,lowered,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86671,risk,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
86672,.,O,3001.0,"The habit of adding salt and the preference for salty foods were associated with elevated GC risk , while more frequently storing foods in the refrigerator , the availability of a freezer and use of frozen foods lowered risk ."
87601,At,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87602,all,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87603,study,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87604,time,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87605,points,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87606,",",O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87607,patients,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87608,categorized,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87609,as,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87610,high,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87611,ONS,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87612,consumers,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87613,(,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87614,>,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87615,15,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87616,%,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87617,of,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87618,total,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87619,daily,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87620,calories,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87621,from,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87622,ONS,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87623,),O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87624,had,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87625,higher,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87626,intakes,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87627,of,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87628,micronutrients,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87629,(,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87630,P,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87631,<,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87632,0.003,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87633,),O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87634,.,O,3032.0,"At all study time points , patients categorized as high ONS consumers ( > 15 % of total daily calories from ONS ) had higher intakes of micronutrients ( P < 0.003 ) ."
87781,The,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87782,subjects,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87783,had,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87784,participated,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87785,in,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87786,a,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87787,previous,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87788,study,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87789,",",O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87790,were,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87791,never,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87792,diagnosed,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87793,with,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87794,breast,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87795,cancer,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87796,",",O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87797,provided,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87798,a,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87799,screening,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87800,mammogram,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87801,and,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87802,a,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87803,blood,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87804,sample,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87805,",",O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87806,and,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87807,completed,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87808,validated,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87809,food,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87810,-,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87811,frequency,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87812,questionnaires,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
87813,.,O,3039.0,"The subjects had participated in a previous study , were never diagnosed with breast cancer , provided a screening mammogram and a blood sample , and completed validated food - frequency questionnaires ."
88040,Clinical,O,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88041,and,O,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88042,epidemiological,O,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88043,studies,O,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88044,suggest,O,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88045,that,O,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88046,cocoa,B,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88047,-,B,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88048,rich,B,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88049,products,I,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88050,reduce,O,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88051,the,O,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88052,risk,O,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88053,of,O,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88054,cardiovascular,O,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88055,disease,O,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88056,.,O,3048.0,Clinical and epidemiological studies suggest that cocoa - rich products reduce the risk of cardiovascular disease .
88057,According,O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88058,to,O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88059,this,O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88060,",",O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88061,cocoa,B,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88062,has,O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88063,a,O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88064,high,O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88065,content,O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88066,in,O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88067,polyphenols,O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88068,",",O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88069,especially,O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88070,flavanols,O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88071,.,O,3049.0,"According to this , cocoa has a high content in polyphenols , especially flavanols ."
88109,Cocoa,B,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88110,may,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88111,also,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88112,have,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88113,a,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88114,beneficial,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88115,effect,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88116,by,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88117,protecting,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88118,against,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88119,oxidative,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88120,stress,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88121,alterations,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88122,and,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88123,via,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88124,decreased,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88125,platelet,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88126,aggregation,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88127,",",O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88128,decreased,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88129,lipid,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88130,oxidation,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88131,",",O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88132,and,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88133,insulin,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88134,resistance,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88135,.,O,3051.0,"Cocoa may also have a beneficial effect by protecting against oxidative stress alterations and via decreased platelet aggregation , decreased lipid oxidation , and insulin resistance ."
88420,Meat,B,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88421,and,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88422,grains,B,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88423,contained,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88424,the,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88425,greatest,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88426,quantities,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88427,of,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88428,minerals,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88429,",",O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88430,but,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88431,milk,B,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88432,provided,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88433,a,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88434,relatively,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88435,good,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88436,proportion,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88437,of,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88438,potassium,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88439,",",O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88440,calcium,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88441,",",O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88442,magnesium,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88443,",",O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88444,and,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88445,phosphorus,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88446,.,O,3064.0,"Meat and grains contained the greatest quantities of minerals , but milk provided a relatively good proportion of potassium , calcium , magnesium , and phosphorus ."
88644,Treatments,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88645,were,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88646,acetate,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88647,(,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88648,A,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88649,),O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88650,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88651,glucose,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88652,(,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88653,G,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88654,),O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88655,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88656,each,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88657,at,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88658,5,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88659,%,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88660,of,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88661,ad,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88662,libitum,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88663,ME,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88664,intake,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88665,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88666,casein,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88667,(,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88668,C,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88669,),O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88670,at,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88671,15,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88672,%,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88673,of,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88674,ad,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88675,libitum,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88676,MP,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88677,intake,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88678,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88679,A,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88680,+,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88681,C,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88682,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88683,G,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88684,+,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88685,C,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88686,",",O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88687,or,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88688,a,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88689,saline,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88690,solution,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88691,(,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88692,negative,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88693,control,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88694,),O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88695,.,O,3072.0,"Treatments were acetate ( A ) , glucose ( G ) , each at 5 % of ad libitum ME intake , casein ( C ) at 15 % of ad libitum MP intake , A + C , G + C , or a saline solution ( negative control ) ."
88717,Glucose,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88718,infused,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88719,alone,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88720,increased,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88721,milk,B,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88722,and,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88723,milk,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88724,protein,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88725,yield,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88726,and,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88727,promoted,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88728,the,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88729,highest,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88730,efficiency,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88731,of,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88732,nitrogen,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88733,utilization,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88734,(,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88735,37,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88736,%,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88737,),O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88738,",",O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88739,with,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88740,an,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88741,efficiency,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88742,of,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88743,MP,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88744,use,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88745,for,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88746,milk,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88747,protein,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88748,of,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88749,58,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88750,%,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88751,.,O,3074.0,"Glucose infused alone increased milk and milk protein yield and promoted the highest efficiency of nitrogen utilization ( 37 % ) , with an efficiency of MP use for milk protein of 58 % ."
88897,The,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88898,objective,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88899,of,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88900,this,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88901,experiment,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88902,was,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88903,to,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88904,study,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88905,the,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88906,effects,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88907,of,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88908,incorporating,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88909,lemon,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88910,leaves,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88911,and,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88912,rice,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88913,straw,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88914,into,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88915,the,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88916,compound,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88917,feed,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88918,of,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88919,diets,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88920,for,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88921,dairy,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88922,goats,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
88923,.,O,3080.0,The objective of this experiment was to study the effects of incorporating lemon leaves and rice straw into the compound feed of diets for dairy goats .
89583,Besides,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89584,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89585,these,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89586,are,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89587,reported,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89588,in,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89589,plant,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89590,foods,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89591,such,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89592,as,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89593,apples,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89594,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89595,pears,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89596,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89597,carrot,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89598,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89599,tomato,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89600,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89601,sweet,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89602,potato,I,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89603,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89604,Phyllostachys,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89605,edulis,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89606,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89607,oilseeds,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89608,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89609,Prunus,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89610,domestica,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89611,L,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89612,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89613,cherries,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89614,",",O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89615,and,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89616,eggplant,B,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89617,.,O,3103.0,"Besides , these are reported in plant foods such as apples , pears , carrot , tomato , sweet potato , Phyllostachys edulis , oilseeds , Prunus domestica L , cherries , and eggplant ."
89711,The,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89712,consumption,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89713,of,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89714,coffee,B,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89715,correlated,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89716,to,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89717,several,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89718,health,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89719,benefits,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89720,such,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89721,as,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89722,reducing,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89723,the,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89724,risk,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89725,of,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89726,human,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89727,chronic,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89728,diseases,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89729,such,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89730,as,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89731,inflammation,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89732,",",O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89733,diabetes,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89734,",",O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89735,and,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89736,cardiovascular,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89737,disease,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89738,owing,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89739,to,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89740,its,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89741,antioxidant,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89742,potential,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89743,.,O,3108.0,"The consumption of coffee correlated to several health benefits such as reducing the risk of human chronic diseases such as inflammation , diabetes , and cardiovascular disease owing to its antioxidant potential ."
89899,Nutritional,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89900,quality,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89901,is,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89902,an,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89903,important,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89904,asset,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89905,when,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89906,developing,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89907,gluten,B,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89908,-,I,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89909,free,I,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89910,breads,I,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89911,",",O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89912,and,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89913,different,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89914,strategies,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89915,for,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89916,improving,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89917,it,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89918,are,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89919,reviewed,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89920,.,O,3115.0,"Nutritional quality is an important asset when developing gluten - free breads , and different strategies for improving it are reviewed ."
89921,Gluten,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89922,-,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89923,free,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89924,bread,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89925,quality,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89926,is,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89927,dependent,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89928,on,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89929,ingredients,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89930,and,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89931,additives,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89932,combination,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89933,",",O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89934,but,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89935,also,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89936,processing,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89937,can,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89938,provide,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89939,a,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89940,way,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89941,to,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89942,improve,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89943,bread,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89944,quality,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89945,.,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
90263,This,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90264,work,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90265,demonstrates,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90266,the,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90267,successful,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90268,application,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90269,of,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90270,the,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90271,rejection,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90272,threshold,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90273,method,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90274,to,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90275,a,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90276,complex,B,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90277,dairy,I,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90278,food,I,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90279,.,B,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90341,The,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90342,purpose,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90343,of,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90344,this,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90345,review,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90346,is,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90347,to,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90348,examine,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90349,recent,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90350,literature,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90351,on,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90352,the,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90353,relationship,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90354,between,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90355,dairy,B,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90356,consumption,I,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90357,and,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90358,risk,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90359,of,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90360,cardiovascular,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90361,disease,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90362,incidence,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90363,and,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90364,mortality,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90365,.,O,3130.0,The purpose of this review is to examine recent literature on the relationship between dairy consumption and risk of cardiovascular disease incidence and mortality .
90654,The,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90655,breaking,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90656,stress,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90657,of,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90658,the,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90659,films,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90660,blended,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90661,with,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90662,sugar,B,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90663,and,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90664,oil,B,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90665,was,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90666,less,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90667,than,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90668,that,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90669,of,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90670,control,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90671,.,O,3141.0,The breaking stress of the films blended with sugar and oil was less than that of control .
90874,A,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90875,total,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90876,of,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90877,"31,641",O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90878,(,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90879,86,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90880,%,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90881,),O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90882,participants,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90883,completed,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90884,follow,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90885,-,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90886,up,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90887,",",O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90888,and,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90889,365,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90890,cases,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90891,were,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90892,identified,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90893,.,O,3149.0,"A total of 31,641 ( 86 % ) participants completed follow - up , and 365 cases were identified ."
90920,Variables,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90921,with,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90922,factor,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90923,loadings,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90924,having,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90925,absolute,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90926,values,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90927,of,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90928,0.3,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90929,or,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90930,greater,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90931,were,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90932,used,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90933,in,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90934,interpreting,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90935,the,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90936,factors,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
90937,.,O,3151.0,Variables with factor loadings having absolute values of 0.3 or greater were used in interpreting the factors .
91014,Factor,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91015,2,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91016,",",O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91017,characterized,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91018,by,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91019,salad,B,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91020,and,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91021,cooked,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91022,vegetables,B,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91023,",",O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91024,was,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91025,inversely,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91026,associated,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91027,with,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91028,diabetes,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91029,.,O,3154.0,"Factor 2 , characterized by salad and cooked vegetables , was inversely associated with diabetes ."
91200,In,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91201,the,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91202,fourteen,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91203,-,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91204,week,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91205,study,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91206,",",O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91207,an,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91208,adjustment,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91209,period,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91210,of,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91211,three,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91212,weeks,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91213,was,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91214,followed,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91215,by,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91216,two,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91217,consecutive,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91218,experimental,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91219,periods,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91220,of,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91221,four,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91222,weeks,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91223,each,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91224,",",O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91225,then,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91226,by,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91227,a,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91228,three,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91229,-,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91230,week,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91231,follow,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91232,-,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91233,up,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91234,period,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91235,.,O,3162.0,"In the fourteen - week study , an adjustment period of three weeks was followed by two consecutive experimental periods of four weeks each , then by a three - week follow - up period ."
91520,One,O,3173.0,One hundred nine subjects also completed a weighed food record .
91521,hundred,O,3173.0,One hundred nine subjects also completed a weighed food record .
91522,nine,O,3173.0,One hundred nine subjects also completed a weighed food record .
91523,subjects,O,3173.0,One hundred nine subjects also completed a weighed food record .
91524,also,O,3173.0,One hundred nine subjects also completed a weighed food record .
91525,completed,O,3173.0,One hundred nine subjects also completed a weighed food record .
91526,a,O,3173.0,One hundred nine subjects also completed a weighed food record .
91527,weighed,O,3173.0,One hundred nine subjects also completed a weighed food record .
91528,food,O,3173.0,One hundred nine subjects also completed a weighed food record .
91529,record,O,3173.0,One hundred nine subjects also completed a weighed food record .
91530,.,O,3173.0,One hundred nine subjects also completed a weighed food record .
91621,Intakes,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91622,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91623,vitamin,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91624,C,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91625,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91626,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91627,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91628,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91629,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91630,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91631,folate,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91632,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91633,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91634,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91635,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91636,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91637,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91638,riboflavin,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91639,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91640,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91641,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91642,0.03,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91643,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91644,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91645,thiamine,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91646,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91647,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91648,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91649,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91650,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91651,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91652,and,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91653,magnesium,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91654,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91655,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91656,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91657,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91658,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91659,per,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91660,megajoule,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91661,increased,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91662,as,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91663,quartile,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91664,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91665,total,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91666,fat,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91667,intake,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91668,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91669,as,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91670,a,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91671,%,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91672,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91673,total,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91674,energy,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91675,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91676,decreased,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91677,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91678,reflecting,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91679,increased,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91680,intakes,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91681,of,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91682,cereals,B,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91683,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91684,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91685,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91686,0.002,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91687,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91688,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91689,pasta,B,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91690,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91691,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91692,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91693,0.01,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91694,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91695,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91696,fruit,B,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91697,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91698,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91699,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91700,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91701,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91702,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91703,pure,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91704,meat,B,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91705,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91706,not,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91707,minced,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91708,or,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91709,meat,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91710,products,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91711,;,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91712,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91713,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91714,0.047,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91715,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91716,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91717,skim,B,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91718,milk,I,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91719,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91720,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91721,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91722,0.0001,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91723,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91724,",",O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91725,and,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91726,skim,B,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91727,cheese,I,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91728,(,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91729,P,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91730,=,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91731,0.005,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91732,),O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91733,.,O,3178.0,"Intakes of vitamin C ( P = 0.0001 ) , folate ( P = 0.0001 ) , riboflavin ( P = 0.03 ) , thiamine ( P = 0.0001 ) , and magnesium ( P = 0.0001 ) per megajoule increased as quartile of total fat intake ( as a % of total energy ) decreased , reflecting increased intakes of cereals ( P = 0.002 ) , pasta ( P = 0.01 ) , fruit ( P = 0.0001 ) , pure meat ( not minced or meat products ; P = 0.047 ) , skim milk ( P = 0.0001 ) , and skim cheese ( P = 0.005 ) ."
91950,Further,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91951,indicators,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91952,of,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91953,inflammation,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91954,were,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91955,recently,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91956,investigated,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91957,either,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91958,to,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91959,satisfy,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91960,the,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91961,high,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91962,specificity,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91963,necessary,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91964,for,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91965,automatic,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91966,separation,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91967,of,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91968,milk,B,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91969,or,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91970,to,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91971,create,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91972,reliable,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91973,alarm,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91974,lists,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
91975,.,O,3187.0,Further indicators of inflammation were recently investigated either to satisfy the high specificity necessary for automatic separation of milk or to create reliable alarm lists .
92461,Obesity,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92462,is,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92463,associated,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92464,with,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92465,increased,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92466,risk,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92467,for,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92468,chronic,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92469,diseases,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92470,",",O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92471,and,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92472,affects,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92473,both,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92474,developed,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92475,and,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92476,developing,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92477,nations,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92478,.,O,3206.0,"Obesity is associated with increased risk for chronic diseases , and affects both developed and developing nations ."
92479,Yogurt,B,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92480,is,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92481,a,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92482,nutrient,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92483,-,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92484,dense,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92485,food,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92486,that,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92487,may,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92488,benefit,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92489,individuals,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92490,with,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92491,lactose,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92492,intolerance,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92493,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92494,constipation,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92495,and,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92496,diarrheal,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92497,diseases,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92498,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92499,hypertension,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92500,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92501,cardiovascular,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92502,diseases,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92503,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92504,diabetes,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92505,",",O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92506,and,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92507,certain,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92508,types,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92509,of,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92510,cancer,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
92511,.,O,3207.0,"Yogurt is a nutrient - dense food that may benefit individuals with lactose intolerance , constipation and diarrheal diseases , hypertension , cardiovascular diseases , diabetes , and certain types of cancer ."
93074,In,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93075,addition,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93076,",",O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93077,some,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93078,of,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93079,these,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93080,plants,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93081,carry,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93082,free,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93083,radical,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93084,scavenging,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93085,and,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93086,anti,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93087,-,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93088,inflammatory,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93089,activities,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93090,that,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93091,are,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93092,helpful,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93093,against,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93094,cancer,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93095,insurgence,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
93096,.,O,3230.0,"In addition , some of these plants carry free radical scavenging and anti - inflammatory activities that are helpful against cancer insurgence ."
94047,The,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94048,discussion,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94049,is,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94050,emphasized,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94051,on,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94052,the,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94053,clinical,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94054,aspect,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94055,of,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94056,these,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94057,botanicals,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94058,.,O,3265.0,The discussion is emphasized on the clinical aspect of these botanicals .
94059,Due,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94060,to,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94061,the,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94062,lack,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94063,of,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94064,sufficient,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94065,evidence,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94066,from,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94067,clinical,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94068,studies,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94069,for,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94070,any,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94071,of,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94072,the,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94073,botanicals,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94074,reviewed,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94075,",",O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94076,it,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94077,is,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94078,premature,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94079,to,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94080,actively,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94081,recommend,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94082,use,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94083,of,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94084,any,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94085,particular,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94086,herb,B,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94087,to,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94088,treat,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94089,either,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94090,glucose,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94091,or,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94092,other,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94093,risk,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94094,factors,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94095,.,O,3266.0,"Due to the lack of sufficient evidence from clinical studies for any of the botanicals reviewed , it is premature to actively recommend use of any particular herb to treat either glucose or other risk factors ."
94154,In,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94155,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94156,first,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94157,study,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94158,",",O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94159,hamsters,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94160,fed,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94161,on,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94162,coconut,B,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94163,oil,I,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94164,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94165,150,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94166,g,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94167,/,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94168,kg,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94169,diet,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94170,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94171,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94172,cholesterol,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94173,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94174,30,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94175,g,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94176,/,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94177,kg,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94178,diet,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94179,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94180,developed,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94181,lipid,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94182,-,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94183,rich,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94184,lesions,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94185,in,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94186,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94187,ascending,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94188,aorta,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94189,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94190,0.28,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94191,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94192,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94193,0.14,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94194,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94195,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94196,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94197,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94198,aortic,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94199,arch,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94200,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94201,0.01,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94202,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94203,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94204,0.01,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94205,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94206,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94207,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94208,after,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94209,4,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94210,weeks,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94211,that,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94212,continued,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94213,to,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94214,progress,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94215,over,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94216,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94217,next,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94218,8,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94219,weeks,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94220,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94221,0.75,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94222,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94223,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94224,0.41,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94225,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94226,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94227,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94228,0.12,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94229,(,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94230,SD,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94231,0.11,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94232,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94233,mm2,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94234,for,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94235,the,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94236,ascending,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94237,aorta,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94238,and,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94239,aortic,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94240,arch,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94241,respectively,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94242,),O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
94243,.,O,3270.0,"In the first study , hamsters fed on coconut oil ( 150 g / kg diet ) and cholesterol ( 30 g / kg diet ) developed lipid - rich lesions in the ascending aorta ( 0.28 ( SD 0.14 ) mm2 ) and aortic arch ( 0.01 ( SD 0.01 ) mm2 ) after 4 weeks that continued to progress over the next 8 weeks ( 0.75 ( SD 0.41 ) mm2 and 0.12 ( SD 0.11 ) mm2 for the ascending aorta and aortic arch respectively ) ."
95085,Public,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95086,awareness,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95087,and,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95088,misunderstandings,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95089,of,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95090,lactose,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95091,intolerance,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95092,are,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95093,at,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95094,an,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95095,all,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95096,-,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95097,time,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95098,high,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95099,.,O,3295.0,Public awareness and misunderstandings of lactose intolerance are at an all - time high .
95868,Since,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95869,avoidance,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95870,of,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95871,dietary,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95872,gluten,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95873,is,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95874,the,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95875,only,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95876,option,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95877,for,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95878,celiac,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95879,patients,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95880,",",O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95881,a,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95882,sensitive,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95883,gluten,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95884,detection,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95885,and,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95886,quantitation,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95887,method,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95888,is,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95889,warranted,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
95890,.,O,3323.0,"Since avoidance of dietary gluten is the only option for celiac patients , a sensitive gluten detection and quantitation method is warranted ."
96073,These,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96074,results,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96075,suggest,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96076,that,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96077,the,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96078,suitability,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96079,of,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96080,ELISA,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96081,for,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96082,accurate,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96083,gluten,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96084,quantitation,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96085,is,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96086,dependent,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96087,upon,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96088,various,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96089,factors,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96090,",",O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96091,such,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96092,as,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96093,grain,B,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96094,source,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96095,",",O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96096,antibody,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96097,specificity,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96098,",",O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96099,gluten,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96100,proteins,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96101,and,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96102,the,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96103,level,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96104,of,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96105,their,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96106,hydrolysis,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96107,in,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96108,foods,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96109,.,O,3333.0,"These results suggest that the suitability of ELISA for accurate gluten quantitation is dependent upon various factors , such as grain source , antibody specificity , gluten proteins and the level of their hydrolysis in foods ."
96488,Intervention,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96489,studies,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96490,provide,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96491,evidence,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96492,that,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96493,dairy,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96494,proteins,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96495,have,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96496,more,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96497,potent,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96498,effects,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96499,on,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96500,insulin,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96501,and,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96502,incretin,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96503,secretion,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96504,compared,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96505,to,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96506,other,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96507,commonly,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96508,consumed,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96509,animal,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96510,proteins,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
96511,.,O,3343.0,Intervention studies provide evidence that dairy proteins have more potent effects on insulin and incretin secretion compared to other commonly consumed animal proteins .
97038,There,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97039,is,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97040,a,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97041,lack,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97042,of,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97043,sufficient,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97044,evidence,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97045,of,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97046,a,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97047,protective,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97048,relationship,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97049,between,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97050,FD,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97051,or,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97052,cheese,B,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97053,consumption,I,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97054,and,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97055,metabolic,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97056,syndrome,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97057,.,O,3361.0,There is a lack of sufficient evidence of a protective relationship between FD or cheese consumption and metabolic syndrome .
97252,Ingestion,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97253,of,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97254,lectins,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97255,also,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97256,sequesters,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97257,the,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97258,available,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97259,body,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97260,pool,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97261,of,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97262,polyamines,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97263,",",O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97264,thereby,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97265,thwarting,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97266,cancer,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97267,cell,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97268,growth,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97269,.,O,3369.0,"Ingestion of lectins also sequesters the available body pool of polyamines , thereby thwarting cancer cell growth ."
97771,The,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97772,benefits,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97773,of,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97774,fruit,B,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97775,products,I,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97776,are,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97777,thought,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97778,to,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97779,be,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97780,a,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97781,result,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97782,of,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97783,its,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97784,polyphenol,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97785,content,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
97786,.,O,3389.0,The benefits of fruit products are thought to be a result of its polyphenol content .
98185,Women,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98186,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98187,both,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98188,ethnic,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98189,groups,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98190,were,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98191,found,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98192,to,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98193,avoid,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98194,saturated,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98195,fat,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98196,and,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98197,cholesterol,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98198,to,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98199,a,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98200,greater,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98201,degree,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98202,than,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98203,men,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98204,",",O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98205,scoring,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98206,higher,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98207,on,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98208,five,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98209,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98210,the,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98211,six,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98212,components,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98213,of,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98214,the,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98215,scale,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98216,.,O,3402.0,"Women of both ethnic groups were found to avoid saturated fat and cholesterol to a greater degree than men , scoring higher on five of the six components of the scale ."
98325,The,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98326,impact,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98327,of,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98328,coffee,B,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98329,and,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98330,green,B,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98331,tea,I,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98332,consumption,I,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98333,on,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98334,upper,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98335,aerodigestive,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98336,tract,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98337,(,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98338,UADT,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98339,),O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98340,cancer,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98341,risk,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98342,has,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98343,not,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98344,been,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98345,established,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98346,.,O,3407.0,The impact of coffee and green tea consumption on upper aerodigestive tract ( UADT ) cancer risk has not been established .
98442,Consumption,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98443,of,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98444,three,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98445,or,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98446,more,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98447,cups,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98448,of,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98449,coffee,B,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98450,per,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98451,day,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98452,had,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98453,a,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98454,significant,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98455,inverse,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98456,association,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98457,with,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98458,UADT,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98459,cancer,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98460,[,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98461,odds,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98462,ratio,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98463,(,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98464,OR,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98465,),O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98466,0.73,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98467,",",O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98468,95,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98469,%,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98470,confidence,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98471,interval,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98472,(,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98473,CI,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98474,),O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98475,0.55,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98476,-,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98477,0.96,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98478,],O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98479,.,O,3412.0,"Consumption of three or more cups of coffee per day had a significant inverse association with UADT cancer [ odds ratio ( OR ) 0.73 , 95 % confidence interval ( CI ) 0.55 - 0.96 ] ."
98581,These,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98582,findings,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98583,suggest,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98584,that,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98585,consumption,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98586,of,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98587,coffee,B,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98588,might,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98589,be,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98590,associated,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98591,with,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98592,a,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98593,decreased,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98594,risk,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98595,of,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98596,UADT,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98597,cancer,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98598,",",O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98599,whereas,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98600,that,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98601,of,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98602,green,B,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98603,tea,I,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98604,might,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98605,be,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98606,associated,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98607,with,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98608,an,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98609,increased,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98610,risk,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
98611,.,O,3418.0,"These findings suggest that consumption of coffee might be associated with a decreased risk of UADT cancer , whereas that of green tea might be associated with an increased risk ."
99547,Supplementation,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99548,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99549,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99550,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99551,increased,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99552,plasma,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99553,concentrations,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99554,of,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99555,vitamin,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99556,C,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99557,at,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99558,calving,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99559,",",O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99560,but,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99561,no,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99562,differences,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99563,were,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99564,observed,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99565,in,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99566,samples,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99567,taken,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99568,24,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99569,h,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99570,postinfusion,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
99571,.,O,3449.0,"Supplementation of vitamin C increased plasma concentrations of vitamin C at calving , but no differences were observed in samples taken 24 h postinfusion ."
100878,Whole,B,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100879,-,I,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100880,fat,I,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100881,yogurt,I,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100882,as,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100883,a,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100884,substitution,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100885,for,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100886,any,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100887,other,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100888,subgroup,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100889,was,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100890,associated,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100891,with,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100892,a,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100893,lower,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100894,rate,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100895,of,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100896,ischaemic,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100897,stroke,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100898,(,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100899,HR,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100900,between,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100901,0·33,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100902,and,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100903,0·36,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100904,/,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100905,serving,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100906,per,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100907,d,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100908,),O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100909,.,O,3499.0,Whole - fat yogurt as a substitution for any other subgroup was associated with a lower rate of ischaemic stroke ( HR between 0·33 and 0·36 / serving per d ) .
100959,The,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100960,incidence,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100961,and,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100962,severity,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100963,of,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100964,hypertension,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100965,are,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100966,affected,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100967,by,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100968,nutritional,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100969,status,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100970,and,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100971,intake,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100972,of,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100973,many,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100974,nutrients,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100975,.,O,3502.0,The incidence and severity of hypertension are affected by nutritional status and intake of many nutrients .
100987,Obesity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100988,is,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100989,associated,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100990,with,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100991,increased,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100992,activity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100993,of,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100994,the,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100995,renin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100996,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100997,angiotensin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100998,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
100999,aldosterone,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101000,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101001,sympathetic,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101002,nervous,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101003,systems,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101004,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101005,possibly,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101006,other,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101007,mineralcorticoid,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101008,activity,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101009,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101010,insulin,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101011,resistance,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101012,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101013,salt,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101014,-,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101015,sensitive,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101016,hypertension,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101017,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101018,excess,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101019,salt,B,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101020,intake,I,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101021,",",O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101022,and,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101023,reduced,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101024,kidney,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101025,function,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101026,.,O,3504.0,"Obesity is associated with increased activity of the renin - angiotensin - aldosterone and sympathetic nervous systems , possibly other mineralcorticoid activity , insulin resistance , salt - sensitive hypertension and excess salt intake , and reduced kidney function ."
101834,The,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101835,PEQ,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101836,consists,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101837,of,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101838,questions,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101839,taken,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101840,from,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101841,the,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101842,Morphine,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101843,-,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101844,Benzedrine,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101845,Group,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101846,(,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101847,MBG,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101848,),O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101849,",",O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101850,Morphine,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101851,(,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101852,M,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101853,",",O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101854,),O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101855,and,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101856,Excitement,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101857,(,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101858,E,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101859,),O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101860,subscales,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101861,of,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101862,the,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101863,Addiction,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101864,Research,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101865,Center,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101866,Inventory,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
101867,.,O,3534.0,"The PEQ consists of questions taken from the Morphine - Benzedrine Group ( MBG ) , Morphine ( M , ) and Excitement ( E ) subscales of the Addiction Research Center Inventory ."
102106,Among,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102107,the,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102108,phytochemicals,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102109,present,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102110,in,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102111,consumed,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102112,cocoa,B,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102113,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102114,theobromine,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102115,is,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102116,most,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102117,available,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102118,in,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102119,human,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102120,plasma,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102121,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102122,followed,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102123,by,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102124,caffeine,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102125,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102126,(,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102127,-)-epicatechin,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102128,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102129,catechin,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102130,",",O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102131,and,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102132,procyanidins,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102133,.,O,3544.0,"Among the phytochemicals present in consumed cocoa , theobromine is most available in human plasma , followed by caffeine , ( -)-epicatechin , catechin , and procyanidins ."
102175,This,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102176,review,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102177,summarizes,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102178,comprehensive,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102179,recent,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102180,findings,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102181,on,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102182,the,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102183,beneficial,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102184,actions,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102185,of,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102186,cocoa,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102187,-,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102188,driven,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102189,phytochemicals,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102190,in,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102191,molecular,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102192,mechanisms,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102193,of,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102194,human,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102195,health,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102196,.,O,3546.0,This review summarizes comprehensive recent findings on the beneficial actions of cocoa - driven phytochemicals in molecular mechanisms of human health .
102854,These,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102855,findings,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102856,support,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102857,the,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102858,need,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102859,for,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102860,education,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102861,campaigns,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102862,to,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102863,reduce,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102864,salt,B,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102865,added,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102866,during,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102867,cooking,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102868,and,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102869,for,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102870,strategies,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102871,to,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102872,reduce,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102873,salt,B,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102874,content,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102875,in,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102876,selected,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102877,manufactured,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102878,foods,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102879,in,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102880,the,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102881,region,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102882,.,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
103221,For,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103222,thiamine,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103223,",",O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103224,heterogeneity,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103225,by,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103226,subtype,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103227,(,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103228,cardia,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103229,and,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103230,non,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103231,-,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103232,cardia,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103233,),O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103234,was,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103235,found,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103236,(,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103237,P,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103238,The,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103239,reported,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103240,milk,B,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103241,consumption,I,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103242,habits,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103243,of,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103244,"3,334",O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103245,cancer,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103246,patients,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103247,and,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103248,"1,300",O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103249,comparable,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103250,control,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103251,subjects,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103252,seen,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103253,at,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103254,Roswell,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103255,Park,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103256,Memorial,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103257,Institute,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103258,were,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103259,studied,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103260,.,O,3583.0,"For thiamine , heterogeneity by subtype ( cardia and non - cardia ) was found ( P The reported milk consumption habits of 3,334 cancer patients and 1,300 comparable control subjects seen at Roswell Park Memorial Institute were studied ."
103553,Flavonoids,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103554,represent,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103555,a,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103556,large,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103557,class,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103558,of,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103559,phenolic,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103560,compounds,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103561,found,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103562,in,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103563,fruits,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103564,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103565,vegetables,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103566,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103567,nuts,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103568,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103569,grains,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103570,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103571,cocoa,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103572,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103573,tea,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103574,",",O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103575,and,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103576,other,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103577,beverages,B,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103578,.,O,3594.0,"Flavonoids represent a large class of phenolic compounds found in fruits , vegetables , nuts , grains , cocoa , tea , and other beverages ."
103655,Laboratory,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103656,and,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103657,human,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103658,studies,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103659,on,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103660,the,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103661,activities,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103662,of,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103663,major,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103664,flavonoids,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103665,(,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103666,flavones,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103667,",",O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103668,isoflavones,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103669,",",O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103670,flavonols,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103671,",",O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103672,etc,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103673,.,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103797,Formation,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103798,of,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103799,antioxidant,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103800,",",O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103801,bioactive,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103802,",",O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103803,anti,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103804,-,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103805,hypertensive,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103806,",",O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103807,anti,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103808,-,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103809,diabetic,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103810,",",O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103811,and,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103812,FODMAP,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103813,-,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103814,reducing,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103815,components,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103816,in,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103817,fermented,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103818,foods,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103819,are,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103820,mainly,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103821,presented,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103822,and,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103823,discussed,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103824,.,O,3603.0,"Formation of antioxidant , bioactive , anti - hypertensive , anti - diabetic , and FODMAP - reducing components in fermented foods are mainly presented and discussed ."
103845,Anti,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103846,-,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103847,hypertensive,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103848,peptides,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103849,are,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103850,detected,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103851,in,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103852,fermented,B,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103853,milk,I,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103854,and,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103855,cereals,B,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103856,.,O,3605.0,Anti - hypertensive peptides are detected in fermented milk and cereals .
103882,Other,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103883,effects,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103884,such,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103885,as,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103886,anti,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103887,-,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103888,diabetic,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103889,properties,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103890,",",O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103891,FODMAP,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103892,reduction,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103893,",",O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103894,and,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103895,changes,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103896,in,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103897,fatty,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103898,acid,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103899,profile,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103900,are,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103901,peculiar,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103902,of,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103903,specific,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103904,food,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103905,categories,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103906,.,O,3608.0,"Other effects such as anti - diabetic properties , FODMAP reduction , and changes in fatty acid profile are peculiar of specific food categories ."
103986,Treatment,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103987,of,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103988,linoleic,B,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103989,acid,I,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103990,-,I,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103991,rich,I,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103992,oils,I,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103993,such,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103994,as,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103995,safflower,B,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103996,oil,I,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103997,",",O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103998,soybean,B,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103999,oil,I,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104000,",",O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104001,or,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104002,maize,B,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104003,oil,I,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104004,with,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104005,base,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104006,and,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104007,heat,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104008,will,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104009,result,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104010,in,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104011,the,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104012,formation,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104013,of,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104014,CLA,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104015,.,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104072,CLA,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104073,has,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104074,also,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104075,been,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104076,shown,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104077,to,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104078,inhibit,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104079,cholesterol,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104080,-,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104081,induced,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104082,atherosclerosis,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104083,in,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104084,rabbits,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104085,.,O,3617.0,CLA has also been shown to inhibit cholesterol - induced atherosclerosis in rabbits .
104086,When,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104087,young,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104088,animals,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104089,(,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104090,mice,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104091,",",O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104092,pigs,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104093,),O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104094,are,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104095,placed,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104096,on,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104097,CLA,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104098,-,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104099,containing,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104100,diets,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104101,after,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104102,weaning,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104103,they,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104104,accumulate,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104105,more,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104106,body,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104107,protein,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104108,and,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104109,less,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104110,fat,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104111,.,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104616,We,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104617,report,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104618,17,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104619,patients,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104620,with,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104621,immediate,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104622,hypersensitivity,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104623,to,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104624,avocado,B,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104625,.,O,3639.0,We report 17 patients with immediate hypersensitivity to avocado .
104728,Avocado,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104729,-,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104730,sensitized,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104731,patients,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104732,with,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104733,latex,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104734,allergy,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104735,were,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104736,typically,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104737,middle,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104738,-,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104739,aged,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104740,women,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104741,",",O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104742,professionally,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104743,exposed,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104744,to,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104745,latex,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104746,",",O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104747,who,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104748,also,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104749,exhibited,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104750,frequent,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104751,associated,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104752,sensitizations,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104753,to,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104754,chestnut,B,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104755,",",O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104756,banana,B,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104757,",",O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104758,and,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104759,other,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104760,fruits,B,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
104761,.,O,3643.0,"Avocado - sensitized patients with latex allergy were typically middle - aged women , professionally exposed to latex , who also exhibited frequent associated sensitizations to chestnut , banana , and other fruits ."
105215,Studies,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105216,on,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105217,dietary,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105218,patterns,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105219,in,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105220,association,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105221,with,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105222,potassium,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105223,intake,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105224,will,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105225,be,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105226,useful,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105227,to,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105228,provide,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105229,dietary,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105230,advice,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105231,to,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105232,increase,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105233,potassium,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105234,intake,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105235,.,O,3661.0,Studies on dietary patterns in association with potassium intake will be useful to provide dietary advice to increase potassium intake .
105522,The,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105523,adipose,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105524,tissue,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105525,becomes,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105526,hypertrophic,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105527,and,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105528,undergoes,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105529,hyperplasia,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105530,",",O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105531,resulting,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105532,in,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105533,a,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105534,hypoxic,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105535,environment,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105536,",",O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105537,oxidative,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105538,stress,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105539,and,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105540,production,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105541,of,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105542,pro,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105543,-,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105544,inflammatory,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105545,mediators,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105546,that,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105547,can,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105548,be,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105549,responsible,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105550,for,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105551,other,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105552,disorders,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105553,",",O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105554,such,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105555,as,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105556,metabolic,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105557,syndrome,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105558,and,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105559,neurodegeneration,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105560,.,O,3670.0,"The adipose tissue becomes hypertrophic and undergoes hyperplasia , resulting in a hypoxic environment , oxidative stress and production of pro - inflammatory mediators that can be responsible for other disorders , such as metabolic syndrome and neurodegeneration ."
105856,The,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105857,requirement,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105858,of,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105859,quantity,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105860,and,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105861,quality,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105862,for,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105863,gluten,B,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105864,-,I,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105865,free,I,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105866,packaged,I,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105867,foods,I,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105868,is,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105869,increasing,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105870,consistently,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105871,at,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105872,a,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105873,faster,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105874,rate,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105875,than,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105876,lactose,B,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105877,-,I,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105878,free,I,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105879,and,I,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105880,diabetic,I,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105881,-,I,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105882,friendly,I,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105883,foods,I,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
105884,.,O,3681.0,The requirement of quantity and quality for gluten - free packaged foods is increasing consistently at a faster rate than lactose - free and diabetic - friendly foods .
106090,(,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106091,1,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106092,),O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106093,Background,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106094,:,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106095,Aspects,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106096,of,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106097,the,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106098,Mongolian,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106099,food,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106100,supply,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106101,",",O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106102,including,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106103,high,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106104,availability,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106105,of,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106106,animal,B,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106107,-,I,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106108,source,I,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106109,foods,I,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106110,and,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106111,few,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106112,plant,B,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106113,foods,I,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106114,",",O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106115,are,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106116,plausibly,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106117,associated,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106118,with,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106119,disease,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106120,in,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106121,the,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106122,population,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106123,.,O,3689.0,"( 1 ) Background : Aspects of the Mongolian food supply , including high availability of animal - source foods and few plant foods , are plausibly associated with disease in the population ."
106138,The,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106139,purpose,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106140,of,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106141,this,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106142,study,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106143,was,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106144,to,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106145,provide,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106146,a,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106147,multifaceted,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106148,nutritional,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106149,analysis,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106150,of,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106151,the,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106152,modern,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106153,Mongolian,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106154,diet,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106155,.,O,3691.0,The purpose of this study was to provide a multifaceted nutritional analysis of the modern Mongolian diet .
106252,Exploratory,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106253,dietary,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106254,patterns,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106255,were,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106256,derived,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106257,and,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106258,analyzed,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106259,for,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106260,associations,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106261,with,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106262,diet,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106263,and,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106264,nutrition,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106265,measurements,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106266,.,O,3695.0,Exploratory dietary patterns were derived and analyzed for associations with diet and nutrition measurements .
106975,There,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106976,is,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106977,also,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106978,evidence,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106979,that,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106980,a,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106981,low,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106982,serum,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106983,albumin,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106984,may,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106985,be,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106986,causally,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106987,linked,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106988,to,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106989,stroke,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106990,risk,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106991,and,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106992,outcome,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106993,and,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106994,that,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106995,a,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106996,significant,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106997,number,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106998,of,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
106999,stroke,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107000,patients,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107001,are,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107002,undernourished,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107003,on,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107004,admission,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107005,and,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107006,their,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107007,nutritional,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107008,status,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107009,deteriorates,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107010,further,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107011,whilst,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107012,in,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107013,hospital,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107014,.,O,3719.0,There is also evidence that a low serum albumin may be causally linked to stroke risk and outcome and that a significant number of stroke patients are undernourished on admission and their nutritional status deteriorates further whilst in hospital .
107224,Metabolic,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107225,B12,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107226,deficiency,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107227,is,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107228,common,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107229,and,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107230,usually,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107231,missed,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107232,.,O,3728.0,Metabolic B12 deficiency is common and usually missed .
107514,The,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107515,approach,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107516,by,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107517,which,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107518,the,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107519,insulinemia,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107520,was,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107521,kept,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107522,constant,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107523,by,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107524,the,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107525,artificial,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107526,pancreas,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107527,seems,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107528,to,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107529,be,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107530,a,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107531,valuable,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107532,tool,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107533,for,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107534,studying,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107535,glycemic,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107536,responses,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107537,to,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107538,different,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107539,meals,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107540,in,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107541,IDDM,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107542,patients,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107543,who,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107544,otherwise,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107545,show,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107546,great,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107547,variations,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107548,in,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107549,circulating,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107550,insulin,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107551,and,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107552,glucose,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107553,levels,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107554,when,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107555,treated,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107556,by,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107557,subcutaneously,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107558,administered,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107559,insulin,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107560,.,O,3738.0,The approach by which the insulinemia was kept constant by the artificial pancreas seems to be a valuable tool for studying glycemic responses to different meals in IDDM patients who otherwise show great variations in circulating insulin and glucose levels when treated by subcutaneously administered insulin .
107756,Dietary,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107757,patterns,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107758,analysis,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107759,is,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107760,a,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107761,powerful,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107762,technique,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107763,to,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107764,study,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107765,the,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107766,relations,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107767,between,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107768,diet,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107769,and,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107770,cancer,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107771,.,O,3745.0,Dietary patterns analysis is a powerful technique to study the relations between diet and cancer .
107863,Three,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107864,dietary,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107865,patterns,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107866,were,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107867,identified,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107868,",",O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107869,with,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107870,the,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107871,following,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107872,main,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107873,characteristics,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107874,:,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107875,(,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107876,I,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107877,),O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107878,high,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107879,consumption,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107880,of,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107881,fruits,B,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107882,and,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107883,dairy,B,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107884,products,I,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107885,",",O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107886,and,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107887,low,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107888,consumption,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107889,of,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107890,alcoholic,B,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107891,beverages,I,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107892,;,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107893,(,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107894,II,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107895,),O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107896,low,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107897,consumption,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107898,of,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107899,fruit,B,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107900,",",O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107901,salads,B,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107902,",",O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107903,vegetables,B,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107904,",",O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107905,dairy,B,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107906,products,I,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107907,",",O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107908,fish,B,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107909,and,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107910,meat,B,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107911,;,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107912,(,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107913,III,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107914,),O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107915,high,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107916,consumptions,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107917,of,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107918,most,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107919,food,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107920,groups,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107921,and,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107922,low,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107923,vegetable,B,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107924,soup,I,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107925,intake,I,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
107926,.,O,3752.0,"Three dietary patterns were identified , with the following main characteristics : ( I ) high consumption of fruits and dairy products , and low consumption of alcoholic beverages ; ( II ) low consumption of fruit , salads , vegetables , dairy products , fish and meat ; ( III ) high consumptions of most food groups and low vegetable soup intake ."
108315,Saturated,B,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108316,vegetable,I,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108317,oils,I,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108318,(,O,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108319,coconut,B,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108320,",",B,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108321,palm,I,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108322,",",B,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108323,and,I,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108324,palm,I,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108325,kernel,I,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108326,oil,I,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108327,),O,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108328,and,O,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108329,fats,B,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108330,(,O,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108331,butter,B,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108332,and,O,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108333,lard,B,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108334,),O,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108335,are,O,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108336,hypercholesterolemic,O,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108337,relative,O,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108338,to,O,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108339,monounsaturated,B,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108340,and,I,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108341,polyunsaturated,I,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108342,vegetable,I,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108343,oils,I,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
108344,.,O,3765.0,"Saturated vegetable oils ( coconut , palm , and palm kernel oil ) and fats ( butter and lard ) are hypercholesterolemic relative to monounsaturated and polyunsaturated vegetable oils ."
109021,It,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109022,was,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109023,found,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109024,that,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109025,cranberries,B,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109026,positively,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109027,affect,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109028,atherosclerotic,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109029,cholesterol,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109030,profiles,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109031,and,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109032,that,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109033,they,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109034,reduced,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109035,several,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109036,cardiometabolic,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109037,risk,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109038,factors,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109039,.,O,3794.0,It was found that cranberries positively affect atherosclerotic cholesterol profiles and that they reduced several cardiometabolic risk factors .
109870,Moreover,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109871,",",O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109872,the,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109873,water,B,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109874,intake,I,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109875,should,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109876,be,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109877,increased,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109878,and,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109879,the,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109880,actual,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109881,need,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109882,to,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109883,consume,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109884,iodized,B,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109885,salt,I,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109886,should,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109887,be,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109888,verified,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109889,for,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109890,each,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109891,subject,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109892,/,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109893,area,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
109894,.,O,3825.0,"Moreover , the water intake should be increased and the actual need to consume iodized salt should be verified for each subject / area ."
110084,The,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110085,allergen,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110086,-,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110087,MLPA,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110088,method,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110089,is,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110090,modular,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110091,and,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110092,can,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110093,be,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110094,adapted,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110095,by,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110096,adding,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110097,probe,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110098,pairs,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110099,for,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110100,other,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110101,allergens,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110102,.,O,3834.0,The allergen - MLPA method is modular and can be adapted by adding probe pairs for other allergens .
110103,The,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110104,DNA,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110105,-,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110106,based,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110107,allergen,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110108,-,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110109,MLPA,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110110,method,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110111,will,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110112,constitute,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110113,a,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110114,complementary,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110115,method,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110116,to,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110117,the,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110118,traditional,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110119,protein,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110120,-,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110121,based,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110122,methods,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110123,.,O,3835.0,The DNA - based allergen - MLPA method will constitute a complementary method to the traditional protein - based methods .
110259,A,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110260,brief,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110261,overview,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110262,of,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110263,the,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110264,antioxidant,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110265,potential,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110266,",",O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110267,and,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110268,current,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110269,research,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110270,on,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110271,the,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110272,health,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110273,effects,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110274,of,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110275,cereal,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110276,-,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110277,based,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110278,anthocyanins,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110279,will,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110280,be,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110281,provided,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110282,.,O,3842.0,"A brief overview of the antioxidant potential , and current research on the health effects of cereal - based anthocyanins will be provided ."
110526,Borderline,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110527,statistically,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110528,significant,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110529,lower,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110530,bladder,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110531,cancer,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110532,risks,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110533,were,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110534,found,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110535,among,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110536,never,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110537,smokers,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110538,with,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110539,increased,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110540,consumption,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110541,of,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110542,fruit,B,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110543,and,I,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110544,vegetables,I,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110545,combined,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110546,(,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110547,HR,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110548,=,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110549,0.94,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110550,95%CI,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110551,:,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110552,0.87,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110553,-,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110554,1.00,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110555,with,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110556,increments,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110557,of,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110558,100,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110559,g,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110560,/,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110561,day,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110562,;,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110563,calibrated,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110564,HR,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110565,=,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110566,0.92,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110567,95%CI,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110568,0.79,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110569,-,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110570,1.06,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110571,),O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110572,and,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110573,increased,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110574,consumption,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110575,of,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110576,apples,B,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110577,and,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110578,pears,B,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110579,(,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110580,hard,B,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110581,fruit,I,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110582,;,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110583,calibrated,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110584,HR,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110585,=,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110586,0.90,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110587,95%CI,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110588,:,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110589,0.82,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110590,-,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110591,0.98,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110592,with,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110593,increments,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110594,of,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110595,25,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110596,g,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110597,/,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110598,day,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110599,),O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110600,.,O,3852.0,Borderline statistically significant lower bladder cancer risks were found among never smokers with increased consumption of fruit and vegetables combined ( HR = 0.94 95%CI : 0.87 - 1.00 with increments of 100 g / day ; calibrated HR = 0.92 95%CI 0.79 - 1.06 ) and increased consumption of apples and pears ( hard fruit ; calibrated HR = 0.90 95%CI : 0.82 - 0.98 with increments of 25 g / day ) .
110638,In,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110639,recent,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110640,history,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110641,",",O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110642,some,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110643,dietary,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110644,recommendations,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110645,have,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110646,treated,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110647,dairy,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110648,fat,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110649,as,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110650,an,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110651,unnecessary,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110652,source,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110653,of,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110654,calories,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110655,and,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110656,saturated,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110657,fat,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110658,in,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110659,the,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110660,human,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110661,diet,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110662,.,O,3855.0,"In recent history , some dietary recommendations have treated dairy fat as an unnecessary source of calories and saturated fat in the human diet ."
110663,These,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110664,assumptions,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110665,",",O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110666,however,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110667,",",O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110668,have,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110669,recently,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110670,been,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110671,brought,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110672,into,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110673,question,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110674,by,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110675,current,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110676,research,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110677,on,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110678,regular,B,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110679,fat,I,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110680,dairy,I,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110681,products,I,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110682,and,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110683,human,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110684,health,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110685,.,O,3856.0,"These assumptions , however , have recently been brought into question by current research on regular fat dairy products and human health ."
110968,Here,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110969,",",O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110970,studies,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110971,are,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110972,summarized,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110973,pointing,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110974,to,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110975,a,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110976,species,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110977,-,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110978,specific,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110979,risk,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110980,for,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110981,colon,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110982,cancer,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110983,after,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110984,consumption,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110985,of,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110986,beef,B,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110987,originating,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110988,from,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110989,dairy,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110990,cattle,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110991,.,O,3866.0,"Here , studies are summarized pointing to a species - specific risk for colon cancer after consumption of beef originating from dairy cattle ."
110992,Uptake,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110993,of,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110994,dairy,B,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110995,products,I,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110996,of,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110997,Bos,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110998,taurus,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
110999,-,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111000,derived,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111001,milk,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111002,cattle,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111003,",",O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111004,particularly,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111005,consumed,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111006,at,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111007,early,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111008,age,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111009,",",O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111010,is,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111011,suggested,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111012,to,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111013,represent,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111014,one,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111015,of,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111016,the,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111017,main,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111018,risk,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111019,factors,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111020,for,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111021,the,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111022,development,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111023,of,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111024,breast,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111025,cancer,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111026,.,O,3867.0,"Uptake of dairy products of Bos taurus - derived milk cattle , particularly consumed at early age , is suggested to represent one of the main risk factors for the development of breast cancer ."
111623,An,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111624,inverse,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111625,association,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111626,was,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111627,also,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111628,observed,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111629,for,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111630,vitamin,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111631,A,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111632,",",O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111633,carotene,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111634,",",O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111635,vitamin,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111636,C,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111637,",",O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111638,vitamin,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111639,E,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111640,",",O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111641,and,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111642,fiber,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111643,intake,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111644,.,O,3893.0,"An inverse association was also observed for vitamin A , carotene , vitamin C , vitamin E , and fiber intake ."
111778,injection,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111779,of,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111780,cadmium,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111781,chloride,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111782,(,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111783,1.2,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111784, ,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111785,mg,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111786,/,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111787,kg,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111788,body,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111789,weight,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111790,),O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111791,diluted,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111792,in,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111793,water,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
111794,.,O,3901.0,injection of cadmium chloride ( 1.2   mg / kg body weight ) diluted in water .
112472,Therefore,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112473,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112474,we,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112475,aimed,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112476,to,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112477,evaluate,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112478,the,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112479,association,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112480,of,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112481,FPS,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112482,with,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112483,excess,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112484,body,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112485,weight,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112486,(,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112487,EBW,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112488,),O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112489,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112490,and,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112491,to,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112492,monitor,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112493,differences,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112494,in,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112495,the,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112496,population,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112497,from,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112498,São,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112499,Paulo,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112500,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112501,Brazil,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112502,",",O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112503,from,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112504,2003,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112505,to,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112506,2015,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112507,.,O,3925.0,"Therefore , we aimed to evaluate the association of FPS with excess body weight ( EBW ) , and to monitor differences in the population from São Paulo , Brazil , from 2003 to 2015 ."
112533,Dietary,O,3927.0,Dietary data were obtained from 24 - h recalls .
112534,data,O,3927.0,Dietary data were obtained from 24 - h recalls .
112535,were,O,3927.0,Dietary data were obtained from 24 - h recalls .
112536,obtained,O,3927.0,Dietary data were obtained from 24 - h recalls .
112537,from,O,3927.0,Dietary data were obtained from 24 - h recalls .
112538,24,O,3927.0,Dietary data were obtained from 24 - h recalls .
112539,-,O,3927.0,Dietary data were obtained from 24 - h recalls .
112540,h,O,3927.0,Dietary data were obtained from 24 - h recalls .
112541,recalls,O,3927.0,Dietary data were obtained from 24 - h recalls .
112542,.,O,3927.0,Dietary data were obtained from 24 - h recalls .
112641,In,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112642,this,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112643,population,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112644,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112645,EBW,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112646,was,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112647,associated,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112648,with,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112649,larger,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112650,FPS,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112651,of,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112652,11,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112653,of,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112654,the,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112655,30,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112656,food,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112657,groupings,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112658,investigated,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112659,(,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112660,cold,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112661,cuts,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112662,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112663,fried,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112664,snacks,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112665,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112666,fruit,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112667,and,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112668,commercial,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112669,juices,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112670,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112671,pizza,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112672,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112673,red,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112674,meat,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112675,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112676,rice,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112677,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112678,salted,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112679,snacks,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112680,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112681,soft,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112682,drinks,I,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112683,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112684,soups,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112685,",",O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112686,sugar,B,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112687,),O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112688,.,O,3931.0,"In this population , EBW was associated with larger FPS of 11 of the 30 food groupings investigated ( cold cuts , fried snacks , fruit and commercial juices , pizza , red meat , rice , salted snacks , soft drinks , soups , sugar ) ."
112689,These,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112690,findings,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112691,could,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112692,support,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112693,future,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112694,interventions,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112695,and,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112696,policies,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112697,for,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112698,optimal,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112699,food,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112700,intake,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112701,in,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112702,Brazil,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
112703,.,O,3932.0,These findings could support future interventions and policies for optimal food intake in Brazil .
113171,Increasing,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113172,intake,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113173,of,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113174,any,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113175,combination,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113176,of,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113177,HFCS,B,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113178,-,I,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113179,sweetened,I,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113180,soda,I,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113181,",",O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113182,fruit,B,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113183,drinks,I,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113184,and,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113185,apple,B,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113186,juice,I,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113187,was,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113188,significantly,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113189,associated,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113190,with,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113191,progressively,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113192,higher,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113193,asthma,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113194,risk,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113195,",",O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113196,plateauing,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113197,at,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113198,5,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113199,-,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113200,7,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113201,times,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113202,/,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113203,week,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113204,v.,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113205,never,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113206,/,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113207,seldom,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113208,",",O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113209,independent,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113210,of,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113211,potential,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113212,confounders,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113213,(,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113214,hazard,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113215,ratio,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113216,1·91,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113217,",",O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113218,P<0·001,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113219,),O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113220,.,O,3945.0,"Increasing intake of any combination of HFCS - sweetened soda , fruit drinks and apple juice was significantly associated with progressively higher asthma risk , plateauing at 5 - 7 times / week v. never / seldom , independent of potential confounders ( hazard ratio 1·91 , P<0·001 ) ."
113606,These,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113607,health,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113608,effects,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113609,may,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113610,be,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113611,attributed,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113612,to,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113613,the,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113614,synergistic,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113615,effects,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113616,of,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113617,nutrients,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113618,and,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113619,phytochemicals,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113620,in,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113621,strawberries,B,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
113622,.,O,3957.0,These health effects may be attributed to the synergistic effects of nutrients and phytochemicals in strawberries .
114093,The,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114094,discrepancy,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114095,in,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114096,the,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114097,use,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114098,of,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114099,foods,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114100,rendered,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114101,gluten,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114102,free,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114103,exists,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114104,because,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114105,the,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114106,amount,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114107,of,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114108,toxic,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114109,prolamins,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114110,that,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114111,individuals,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114112,with,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114113,celiac,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114114,disease,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114115,may,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114116,consume,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114117,without,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114118,damaging,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114119,the,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114120,mucosa,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114121,of,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114122,the,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114123,small,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114124,intestine,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114125,is,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114126,unknown,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114127,.,O,3974.0,The discrepancy in the use of foods rendered gluten free exists because the amount of toxic prolamins that individuals with celiac disease may consume without damaging the mucosa of the small intestine is unknown .
114633,Dietary,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114634,patterns,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114635,were,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114636,:,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114637,low,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114638,Med,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114639,-,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114640,style,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114641,diet,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114642,32·0,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114643,%,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114644,",",O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114645,moderate,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114646,Med,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114647,-,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114648,style,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114649,diet,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114650,42·1,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114651,%,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114652,and,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114653,high,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114654,Med,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114655,-,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114656,style,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114657,diet,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114658,26·0,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114659,%,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
114660,.,O,3993.0,"Dietary patterns were : low Med - style diet 32·0 % , moderate Med - style diet 42·1 % and high Med - style diet 26·0 % ."
115095,Olive,B,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115096,oil,I,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115097,is,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115098,a,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115099,source,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115100,of,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115101,at,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115102,least,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115103,30,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115104,phenolic,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115105,compounds,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115106,.,O,4008.0,Olive oil is a source of at least 30 phenolic compounds .
115476,Some,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115477,vegetarian,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115478,immigrants,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115479,from,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115480,underprivileged,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115481,households,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115482,may,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115483,be,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115484,predisposed,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115485,to,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115486,iron,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115487,and,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115488,zinc,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115489,deficiency,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115490,because,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115491,of,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115492,nondietary,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115493,factors,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115494,such,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115495,as,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115496,chronic,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115497,inflammation,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115498,",",O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115499,parasitic,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115500,infections,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115501,",",O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115502,overweight,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115503,",",O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115504,and,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115505,genetic,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115506,hemoglobin,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115507,disorders,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
115508,.,O,4024.0,"Some vegetarian immigrants from underprivileged households may be predisposed to iron and zinc deficiency because of nondietary factors such as chronic inflammation , parasitic infections , overweight , and genetic hemoglobin disorders ."
116250,Preventive,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116251,and,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116252,therapeutic,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116253,trials,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116254,of,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116255,garlic,B,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116256,are,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116257,still,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116258,in,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116259,early,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116260,stages,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116261,.,O,4052.0,Preventive and therapeutic trials of garlic are still in early stages .
116656,The,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116657,intake,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116658,of,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116659,several,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116660,minerals,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116661,found,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116662,in,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116663,milk,B,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116664,has,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116665,been,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116666,demonstrated,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116667,to,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116668,have,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116669,an,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116670,inverse,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116671,relationship,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116672,with,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116673,blood,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116674,pressure,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116675,.,O,4069.0,The intake of several minerals found in milk has been demonstrated to have an inverse relationship with blood pressure .
116676,Peptides,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116677,formed,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116678,during,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116679,the,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116680,digestion,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116681,of,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116682,milk,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116683,proteins,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116684,have,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116685,also,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116686,been,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116687,demonstrated,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116688,to,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116689,have,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116690,a,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116691,blood,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116692,pressure,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116693,lowering,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116694,effect,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
116695,.,O,4070.0,Peptides formed during the digestion of milk proteins have also been demonstrated to have a blood pressure lowering effect .
117043,Blood,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117044,pressure,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117045,",",O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117046,visceral,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117047,adiposity,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117048,and,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117049,the,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117050,metabolic,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117051,syndrome,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117052,also,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117053,appear,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117054,to,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117055,be,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117056,positively,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117057,influenced,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117058,by,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117059,nut,B,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117060,consumption,I,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117061,.,O,4084.0,"Blood pressure , visceral adiposity and the metabolic syndrome also appear to be positively influenced by nut consumption ."
117106,Safety,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117107,concerns,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117108,are,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117109,limited,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117110,to,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117111,the,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117112,infrequent,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117113,occurrence,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117114,of,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117115,nut,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117116,allergy,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117117,in,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117118,children,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117119,.,O,4087.0,Safety concerns are limited to the infrequent occurrence of nut allergy in children .
117146,Dietary,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117147,factors,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117148,in,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117149,the,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117150,aetiology,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117151,of,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117152,stomach,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117153,cancer,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117154,were,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117155,investigated,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117156,using,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117157,data,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117158,from,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117159,a,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117160,case,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117161,-,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117162,control,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117163,study,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117164,conducted,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117165,in,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117166,Northern,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117167,Italy,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117168,on,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117169,206,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117170,histologically,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117171,confirmed,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117172,carcinomas,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117173,and,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117174,474,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117175,control,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117176,subjects,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117177,in,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117178,hospital,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117179,for,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117180,acute,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117181,",",O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117182,non,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117183,-,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117184,digestive,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117185,conditions,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117186,",",O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117187,unrelated,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117188,to,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117189,any,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117190,of,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117191,the,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117192,potential,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117193,risk,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117194,factors,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117195,for,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117196,gastric,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117197,cancer,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117198,.,O,4089.0,"Dietary factors in the aetiology of stomach cancer were investigated using data from a case - control study conducted in Northern Italy on 206 histologically confirmed carcinomas and 474 control subjects in hospital for acute , non - digestive conditions , unrelated to any of the potential risk factors for gastric cancer ."
117249,Pasta,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117250,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117251,rice,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117252,(,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117253,the,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117254,major,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117255,sources,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117256,of,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117257,starch,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117258,),O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117259,",",O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117260,polenta,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117261,(,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117262,a,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117263,porridge,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117264,made,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117265,of,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117266,maize,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117267,),O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117268,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117269,ham,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117270,were,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117271,positively,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117272,related,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117273,with,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117274,gastric,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117275,cancer,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117276,risk,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117277,",",O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117278,whereas,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117279,green,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117280,vegetables,I,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117281,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117282,fresh,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117283,fruit,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117284,as,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117285,a,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117286,whole,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117287,(,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117288,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117289,specifically,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117290,citrus,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117291,fruit,I,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117292,),O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117293,and,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117294,selected,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117295,fibre,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117296,-,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117297,rich,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117298,aliments,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117299,(,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117300,such,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117301,as,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117302,whole,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117303,-,I,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117304,grain,I,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117305,bread,I,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117306,or,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117307,pasta,B,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117308,),O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117309,showed,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117310,protective,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117311,effects,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117312,on,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117313,gastric,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117314,cancer,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117315,risk,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
117316,.,O,4091.0,"Pasta and rice ( the major sources of starch ) , polenta ( a porridge made of maize ) and ham were positively related with gastric cancer risk , whereas green vegetables and fresh fruit as a whole ( and specifically citrus fruit ) and selected fibre - rich aliments ( such as whole - grain bread or pasta ) showed protective effects on gastric cancer risk ."
118009,A,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118010,considerable,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118011,amount,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118012,of,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118013,Cd,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118014,was,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118015,mobilized,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118016,from,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118017,raw,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118018,vegetables,B,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118019,during,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118020,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118021,digestion,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118022,process,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118023,(,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118024,on,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118025,average,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118026,85,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118027,%,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118028,in,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118029,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118030,gastric,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118031,phase,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118032,and,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118033,69,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118034,%,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118035,in,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118036,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118037,gastrointestinal,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118038,phase,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118039,),O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118040,",",O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118041,which,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118042,could,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118043,be,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118044,attributed,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118045,to,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118046,a,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118047,high,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118048,uptake,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118049,of,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118050,Cd,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118051,during,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118052,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118053,growth,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118054,of,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118055,the,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118056,vegetables,B,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118057,.,O,4117.0,"A considerable amount of Cd was mobilized from raw vegetables during the digestion process ( on average 85 % in the gastric phase and 69 % in the gastrointestinal phase ) , which could be attributed to a high uptake of Cd during the growth of the vegetables ."
118110,For,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118111,potato,B,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118112,",",O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118113,few,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118114,or,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118115,no,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118116,significant,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118117,differences,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118118,of,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118119,Cd,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118120,bioaccessibility,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118121,were,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118122,observed,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118123,after,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118124,the,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118125,steaming,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118126,process,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118127,",",O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118128,while,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118129,the,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118130,frying,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118131,process,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118132,strongly,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118133,decreased,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118134,bioaccessibility,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118135,in,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118136,both,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118137,phases,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118138,.,O,4120.0,"For potato , few or no significant differences of Cd bioaccessibility were observed after the steaming process , while the frying process strongly decreased bioaccessibility in both phases ."
118265,There,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118266,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118267,it,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118268,suppresses,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118269,the,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118270,proinflammatory,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118271,transcription,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118272,factors,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118273,nuclear,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118274,factor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118275,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118276,kappa,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118277,B,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118278,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118279,signal,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118280,transducer,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118281,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118282,activators,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118283,of,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118284,transcription-3,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118285,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118286,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118287,Wnt,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118288,/,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118289,beta,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118290,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118291,catenin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118292,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118293,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118294,it,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118295,activates,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118296,peroxisome,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118297,proliferator,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118298,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118299,activated,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118300,receptor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118301,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118302,gamma,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118303,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118304,Nrf2,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118305,cell,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118306,-,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118307,signaling,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118308,pathways,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118309,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118310,thus,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118311,leading,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118312,to,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118313,the,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118314,downregulation,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118315,of,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118316,adipokines,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118317,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118318,including,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118319,tumor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118320,necrosis,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118321,factor,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118322,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118323,interleukin-6,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118324,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118325,resistin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118326,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118327,leptin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118328,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118329,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118330,monocyte,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118331,chemotactic,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118332,protein-1,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118333,",",O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118334,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118335,the,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118336,upregulation,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118337,of,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118338,adiponectin,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118339,and,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118340,other,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118341,gene,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118342,products,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118343,.,O,4126.0,"There , it suppresses the proinflammatory transcription factors nuclear factor - kappa B , signal transducer and activators of transcription-3 , and Wnt / beta - catenin , and it activates peroxisome proliferator - activated receptor - gamma and Nrf2 cell - signaling pathways , thus leading to the downregulation of adipokines , including tumor necrosis factor , interleukin-6 , resistin , leptin , and monocyte chemotactic protein-1 , and the upregulation of adiponectin and other gene products ."
118393,Shellfish,B,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118394,",",O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118395,including,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118396,various,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118397,species,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118398,of,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118399,mollusks,B,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118400,(,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118401,e.g.,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118402,",",O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118403,clams,B,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118404,",",O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118405,oysters,B,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118406,",",O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118407,and,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118408,mussels,B,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118409,),O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118410,and,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118411,crustaceans,B,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118412,(,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118413,e.g.,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118414,",",O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118415,shrimp,B,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118416,and,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118417,crab,B,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118418,),O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118419,",",O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118420,have,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118421,been,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118422,a,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118423,cornerstone,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118424,of,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118425,healthy,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118426,dietary,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118427,recommendations,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118428,.,O,4129.0,"Shellfish , including various species of mollusks ( e.g. , clams , oysters , and mussels ) and crustaceans ( e.g. , shrimp and crab ) , have been a cornerstone of healthy dietary recommendations ."
118947,Thus,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118948,",",O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118949,the,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118950,aim,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118951,of,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118952,this,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118953,study,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118954,was,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118955,to,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118956,summarize,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118957,the,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118958,findings,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118959,on,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118960,the,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118961,acute,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118962,and,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118963,chronic,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118964,effects,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118965,of,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118966,cocoa,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118967,administration,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118968,on,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118969,cognitive,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118970,functions,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118971,and,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118972,brain,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118973,health,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118974,in,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118975,young,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118976,adults,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
118977,.,O,4147.0,"Thus , the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults ."
119740,In,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119741,the,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119742,comparison,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119743,with,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119744,olive,B,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119745,oil,I,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119746,",",O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119747,no,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119748,differences,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119749,in,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119750,effects,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119751,on,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119752,aortic,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119753,cholesterol,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119754,content,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119755,were,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119756,detected,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119757,between,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119758,butter,B,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119759,",",O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119760,lard,B,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119761,and,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119762,coconut,B,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119763,oil,I,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119764,.,O,4172.0,"In the comparison with olive oil , no differences in effects on aortic cholesterol content were detected between butter , lard and coconut oil ."
119765,These,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119766,findings,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119767,do,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119768,not,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119769,support,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119770,the,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119771,view,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119772,that,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119773,replacement,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119774,of,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119775,dietary,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119776,saturated,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119777,fat,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119778,with,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119779,olive,B,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119780,oil,I,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119781,has,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119782,a,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119783,major,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119784,impact,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119785,on,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119786,the,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119787,development,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119788,of,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119789,atherosclerosis,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119790,in,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119791,addition,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119792,to,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119793,that,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119794,accounted,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119795,for,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119796,by,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119797,changes,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119798,in,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119799,plasma,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119800,cholesterol,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119801,levels,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119802,.,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
120261,In,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120262,summary,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120263,",",O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120264,the,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120265,positive,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120266,effects,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120267,of,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120268,specific,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120269,plant,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120270,extracts,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120271,on,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120272,insulin,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120273,activity,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120274,suggest,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120275,a,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120276,possible,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120277,role,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120278,of,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120279,these,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120280,plants,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120281,in,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120282,improving,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120283,glucose,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120284,and,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120285,insulin,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120286,metabolism,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120287,.,O,4189.0,"In summary , the positive effects of specific plant extracts on insulin activity suggest a possible role of these plants in improving glucose and insulin metabolism ."
120340,It,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120341,is,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120342,known,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120343,that,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120344,bioactive,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120345,metabolites,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120346,and,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120347,live,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120348,enzymes,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120349,that,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120350,occur,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120351,by,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120352,fermentation,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120353,and,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120354,digestion,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120355,",",O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120356,affect,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120357,the,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120358,health,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120359,positively,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120360,by,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120361,improving,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120362,gut,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120363,microbiota,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120364,.,O,4192.0,"It is known that bioactive metabolites and live enzymes that occur by fermentation and digestion , affect the health positively by improving gut microbiota ."
120384,As,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120385,with,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120386,other,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120387,noninfectious,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120388,diseases,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120389,",",O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120390,the,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120391,diet,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120392,has,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120393,an,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120394,important,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120395,effect,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120396,on,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120397,the,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120398,prevention,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120399,and,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120400,treatment,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120401,of,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120402,metabolic,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120403,syndrome,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120404,.,O,4194.0,"As with other noninfectious diseases , the diet has an important effect on the prevention and treatment of metabolic syndrome ."
120551,There,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120552,are,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120553,seen,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120554,very,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120555,few,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120556,randomized,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120557,controlled,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120558,studies,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120559,that,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120560,are,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120561,focused,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120562,on,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120563,the,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120564,relationship,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120565,between,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120566,yogurt,B,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120567,and,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120568,metabolic,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120569,syndrome,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120570,",",O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120571,and,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120572,these,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120573,are,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120574,based,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120575,on,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120576,contradictory,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120577,results,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
120578,.,O,4201.0,"There are seen very few randomized controlled studies that are focused on the relationship between yogurt and metabolic syndrome , and these are based on contradictory results ."
121618,Further,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121619,observational,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121620,prospective,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121621,research,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121622,and,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121623,well,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121624,-,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121625,designed,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121626,randomised,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121627,-,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121628,controlled,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121629,studies,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121630,are,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121631,needed,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121632,to,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121633,confirm,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121634,this,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121635,cross,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121636,-,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121637,sectional,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121638,relationship,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121639,and,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121640,to,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121641,comprehend,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121642,the,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121643,role,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121644,and,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121645,mechanisms,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121646,that,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121647,different,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121648,types,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121649,of,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121650,chocolate,B,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121651,may,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121652,play,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121653,in,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121654,insulin,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121655,resistance,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121656,and,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121657,cardiometabolic,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121658,disorders,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121659,.,O,4237.0,Further observational prospective research and well - designed randomised - controlled studies are needed to confirm this cross - sectional relationship and to comprehend the role and mechanisms that different types of chocolate may play in insulin resistance and cardiometabolic disorders .
121878,Acute,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121879,and,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121880,sub,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121881,-,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121882,chronic,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121883,studies,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121884,were,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121885,considered,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121886,for,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121887,inclusion,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
121888,.,O,4244.0,Acute and sub - chronic studies were considered for inclusion .
122186,Aortic,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122187,fatty,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122188,streak,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122189,area,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122190,(,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122191,AFSA,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122192,),O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122193,was,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122194,significantly,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122195,reduced,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122196,in,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122197,the,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122198,groups,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122199,receiving,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122200,PE,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122201,in,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122202,ethanol,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122203,(,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122204,-32,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122205,%,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122206,),O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122207,or,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122208,PE,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122209,in,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122210,water,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122211,(,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122212,-29,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122213,%,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122214,),O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122215,in,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122216,comparison,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122217,with,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122218,their,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122219,respective,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122220,controls,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122221,.,O,4257.0,Aortic fatty streak area ( AFSA ) was significantly reduced in the groups receiving PE in ethanol ( -32 % ) or PE in water ( -29 % ) in comparison with their respective controls .
122449,A,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122450,linear,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122451,trend,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122452,for,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122453,a,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122454,dose,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122455,-,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122456,response,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122457,protective,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122458,effect,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122459,was,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122460,observed,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122461,for,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122462,milk,B,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122463,",",O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122464,while,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122465,coffee,B,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122466,increased,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122467,risk,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122468,only,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122469,when,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122470,40,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122471,or,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122472,more,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122473,cups,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122474,were,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122475,consumed,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122476,per,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122477,week,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122478,.,O,4266.0,"A linear trend for a dose - response protective effect was observed for milk , while coffee increased risk only when 40 or more cups were consumed per week ."
122572,Reduced,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122573,rank,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122574,regression,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122575,(,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122576,RRR,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122577,),O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122578,is,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122579,an,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122580,innovative,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122581,technique,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122582,to,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122583,establish,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122584,dietary,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122585,patterns,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122586,related,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122587,to,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122588,biochemical,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122589,risk,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122590,factors,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122591,for,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122592,type,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122593,2,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122594,diabetes,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122595,",",O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122596,but,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122597,has,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122598,not,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122599,been,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122600,applied,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122601,in,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122602,sub,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122603,-,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122604,Saharan,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122605,Africa,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122606,.,O,4271.0,"Reduced rank regression ( RRR ) is an innovative technique to establish dietary patterns related to biochemical risk factors for type 2 diabetes , but has not been applied in sub - Saharan Africa ."
122607,In,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122608,a,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122609,hospital,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122610,-,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122611,based,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122612,case,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122613,-,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122614,control,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122615,study,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122616,for,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122617,type,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122618,2,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122619,diabetes,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122620,in,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122621,Kumasi,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122622,(,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122623,diabetes,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122624,cases,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122625,",",O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122626,538,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122627,;,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122628,controls,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122629,",",O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122630,668,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122631,),O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122632,dietary,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122633,intake,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122634,was,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122635,assessed,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122636,by,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122637,a,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122638,specific,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122639,food,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122640,frequency,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122641,questionnaire,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
122642,.,O,4272.0,"In a hospital - based case - control study for type 2 diabetes in Kumasi ( diabetes cases , 538 ; controls , 668 ) dietary intake was assessed by a specific food frequency questionnaire ."
123516,When,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123517,the,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123518,pH,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123519,of,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123520,the,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123521,salad,B,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123522,dressing,I,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123523,was,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123524,adjusted,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123525,to,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123526,pH,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123527,7,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123528,prior,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123529,to,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123530,spiking,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123531,with,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123532,mustard,B,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123533,",",O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123534,recovery,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123535,improved,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123536,to,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123537,94.1%+/-,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123538,7.6,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123539,%,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
123540,.,O,4307.0,"When the pH of the salad dressing was adjusted to pH 7 prior to spiking with mustard , recovery improved to 94.1%+/- 7.6 % ."
124424,This,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124425,preliminary,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124426,study,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124427,was,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124428,performed,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124429,on,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124430,blood,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124431,samples,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124432,of,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124433,women,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124434,with,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124435,FM,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124436,who,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124437,consumed,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124438,50,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124439,mL,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124440,of,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124441,organic,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124442,olive,B,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124443,oil,I,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124444,daily,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124445,for,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124446,3,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124447,weeks,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124448,.,O,4340.0,This preliminary study was performed on blood samples of women with FM who consumed 50 mL of organic olive oil daily for 3 weeks .
124736,The,O,4350.0,The liver plays an outsized role in oncology .
124737,liver,O,4350.0,The liver plays an outsized role in oncology .
124738,plays,O,4350.0,The liver plays an outsized role in oncology .
124739,an,O,4350.0,The liver plays an outsized role in oncology .
124740,outsized,O,4350.0,The liver plays an outsized role in oncology .
124741,role,O,4350.0,The liver plays an outsized role in oncology .
124742,in,O,4350.0,The liver plays an outsized role in oncology .
124743,oncology,O,4350.0,The liver plays an outsized role in oncology .
124744,.,O,4350.0,The liver plays an outsized role in oncology .
125012,Here,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125013,we,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125014,review,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125015,how,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125016,Westernized,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125017,high,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125018,-,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125019,fat,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125020,diets,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125021,and,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125022,excessive,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125023,alcohol,B,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125024,intake,I,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125025,can,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125026,influence,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125027,inflammation,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125028,within,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125029,the,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125030,liver,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125031,microenvironment,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125032,",",O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125033,stimulating,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125034,both,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125035,primary,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125036,and,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125037,metastatic,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125038,liver,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125039,tumorigenesis,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125040,.,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125126,Diet,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125127,was,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125128,assessed,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125129,by,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125130,a,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125131,validated,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125132,192,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125133,-,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125134,item,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125135,FFQ,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125136,at,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125137,baseline,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125138,.,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125935,Little,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125936,information,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125937,is,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125938,available,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125939,about,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125940,how,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125941,fluid,B,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125942,intake,I,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125943,from,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125944,beverages,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125945,and,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125946,sources,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125947,of,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125948,fluid,B,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125949,intake,I,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125950,influence,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125951,risk,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125952,of,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125953,rectal,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125954,cancer,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
125955,.,O,4392.0,Little information is available about how fluid intake from beverages and sources of fluid intake influence risk of rectal cancer .
126366,Dietary,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126367,habits,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126368,during,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126369,the,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126370,year,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126371,before,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126372,sigmoidoscopy,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126373,and,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126374,when,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126375,subjects,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126376,were,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126377,30,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126378,yr,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126379,old,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126380,were,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126381,collected,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126382,using,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126383,a,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126384,food,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126385,-,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126386,frequency,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126387,questionnaire,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126388,.,O,4403.0,Dietary habits during the year before sigmoidoscopy and when subjects were 30 yr old were collected using a food - frequency questionnaire .
126931,This,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126932,suggests,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126933,that,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126934,eating,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126935,low,B,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126936,-,I,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126937,density,I,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126938,foods,I,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126939,in,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126940,the,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126941,morning,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126942,and,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126943,avoiding,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126944,high,B,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126945,-,I,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126946,density,I,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126947,foods,I,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126948,at,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126949,night,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126950,might,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126951,aid,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126952,in,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126953,reducing,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126954,overall,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126955,intake,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126956,and,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126957,may,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126958,be,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126959,useful,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126960,in,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126961,dietary,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126962,interventions,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126963,for,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126964,overweight,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126965,and,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126966,obesity,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126967,.,O,4418.0,This suggests that eating low - density foods in the morning and avoiding high - density foods at night might aid in reducing overall intake and may be useful in dietary interventions for overweight and obesity .
126968,The,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126969,increasing,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126970,prevalence,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126971,of,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126972,childhood,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126973,obesity,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126974,is,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126975,a,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126976,serious,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126977,public,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126978,health,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126979,problem,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126980,associated,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126981,with,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126982,co,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126983,-,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126984,morbidities,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126985,in,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126986,adulthood,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126987,",",O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126988,as,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126989,well,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126990,as,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126991,childhood,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
126992,.,O,4419.0,"The increasing prevalence of childhood obesity is a serious public health problem associated with co - morbidities in adulthood , as well as childhood ."
127075,Dietary,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127076,intake,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127077,data,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127078,were,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127079,collected,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127080,via,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127081,three,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127082,-,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127083,day,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127084,24,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127085,-,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127086,h,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127087,food,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127088,records,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127089,",",O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127090,and,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127091,sugar,B,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127092,intake,I,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127093,was,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127094,calculated,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127095,for,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127096,the,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127097,total,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127098,sugar,B,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127099,content,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127100,of,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127101,foods,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127102,using,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127103,our,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127104,database,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127105,compiled,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127106,from,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127107,various,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127108,sources,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127109,.,O,4422.0,"Dietary intake data were collected via three - day 24 - h food records , and sugar intake was calculated for the total sugar content of foods using our database compiled from various sources ."
127554,The,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127555,colons,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127556,of,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127557,rats,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127558,of,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127559,groups,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127560,3,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127561,(,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127562,fed,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127563,5,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127564,%,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127565,soy,B,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127566,flour,I,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127567,fortified,I,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127568,Baladi,I,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127569,bread,I,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127570,),O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127571,and,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127572,5,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127573,(,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127574,fed,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127575,Baladi,B,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127576,bread,I,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127577,fortified,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127578,with,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127579,5,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127580,%,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127581,soy,B,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127582,flour+8,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127583,mg,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127584,folic,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127585,acid,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127586,/,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127587,kg,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127588,wheat,B,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127589,flour,I,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127590,),O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127591,were,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127592,the,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127593,mostly,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127594,affected,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127595,by,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127596,DMH,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127597,injection,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127598,as,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127599,premalignant,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127600,changes,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127601,were,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127602,observed,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127603,.,O,4441.0,The colons of rats of groups 3 ( fed 5 % soy flour fortified Baladi bread ) and 5 ( fed Baladi bread fortified with 5 % soy flour+8 mg folic acid / kg wheat flour ) were the mostly affected by DMH injection as premalignant changes were observed .
127960,Administration,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127961,of,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127962,either,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127963,PG,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127964,or,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127965,fat,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127966,increased,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127967,plasma,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127968,glucose,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127969,and,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127970,liver,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127971,glycogen,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127972,concentrations,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127973,compared,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127974,to,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127975,the,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127976,control,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127977,or,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127978,PG,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127979,plus,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127980,fat,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127981,treatments,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127982,.,O,4453.0,Administration of either PG or fat increased plasma glucose and liver glycogen concentrations compared to the control or PG plus fat treatments .
127994,Administration,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
127995,of,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
127996,PG,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
127997,did,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
127998,not,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
127999,affect,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128000,dry,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128001,matter,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128002,intake,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128003,or,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128004,milk,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128005,yield,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128006,and,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128007,composition,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128008,during,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128009,the,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128010,first,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128011,3,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128012,wk,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128013,postpartum,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128014,;,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128015,however,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128016,",",O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128017,cows,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128018,drenched,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128019,with,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128020,fat,B,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128021,tended,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128022,to,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128023,have,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128024,lower,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128025,dry,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128026,matter,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128027,intake,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128028,and,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128029,milk,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128030,yield,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128031,during,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128032,the,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128033,first,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128034,3,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128035,wk,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128036,of,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128037,lactation,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128038,.,O,4455.0,"Administration of PG did not affect dry matter intake or milk yield and composition during the first 3 wk postpartum ; however , cows drenched with fat tended to have lower dry matter intake and milk yield during the first 3 wk of lactation ."
128832,This,O,4481.0,This is also demonstrated in an in vivo human study .
128833,is,O,4481.0,This is also demonstrated in an in vivo human study .
128834,also,O,4481.0,This is also demonstrated in an in vivo human study .
128835,demonstrated,O,4481.0,This is also demonstrated in an in vivo human study .
128836,in,O,4481.0,This is also demonstrated in an in vivo human study .
128837,an,O,4481.0,This is also demonstrated in an in vivo human study .
128838,in,O,4481.0,This is also demonstrated in an in vivo human study .
128839,vivo,O,4481.0,This is also demonstrated in an in vivo human study .
128840,human,O,4481.0,This is also demonstrated in an in vivo human study .
128841,study,O,4481.0,This is also demonstrated in an in vivo human study .
128842,.,O,4481.0,This is also demonstrated in an in vivo human study .
129254,About,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129255,50,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129256,%,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129257,of,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129258,those,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129259,studied,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129260,ate,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129261,meat,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129262,products,I,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129263,<,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129264,1,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129265,time,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129266,/,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129267,wk,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129268,or,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129269,not,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129270,at,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129271,all,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129272,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129273,and,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129274,vegetarians,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129275,consumed,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129276,more,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129277,tomatoes,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129278,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129279,legumes,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129280,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129281,nuts,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129282,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129283,and,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129284,fruit,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129285,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129286,but,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129287,less,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129288,coffee,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129289,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129290,doughnuts,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129291,",",O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129292,and,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129293,eggs,B,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129294,than,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129295,did,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129296,nonvegetarians,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129297,.,O,4497.0,"About 50 % of those studied ate meat products < 1 time / wk or not at all , and vegetarians consumed more tomatoes , legumes , nuts , and fruit , but less coffee , doughnuts , and eggs than did nonvegetarians ."
129479,Higher,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129480,consumption,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129481,of,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129482,all,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129483,fruit,B,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129484,or,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129485,dried,B,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129486,fruit,I,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129487,was,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129488,associated,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129489,with,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129490,lower,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129491,risks,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129492,of,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129493,lung,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129494,",",O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129495,prostate,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129496,",",O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129497,and,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129498,pancreatic,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129499,cancers,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
129500,.,O,4502.0,"Higher consumption of all fruit or dried fruit was associated with lower risks of lung , prostate , and pancreatic cancers ."
130069,A,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130070,panel,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130071,of,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130072,148,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130073,extracts,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130074,from,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130075,37,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130076,food,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130077,products,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130078,was,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130079,prepared,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130080,using,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130081,organic,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130082,and,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130083,aqueous,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130084,solvents,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130085,and,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130086,both,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130087,neutral,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130088,and,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130089,acidic,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130090,conditions,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130091,.,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130206,Aqueous,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130207,extracts,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130208,of,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130209,banana,B,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130210,",",O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130211,apple,B,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130212,and,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130213,orange,B,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130214,all,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130215,enhanced,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130216,the,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130217,growth,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130218,of,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130219,the,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130220,three,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130221,probiotic,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130222,strains,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130223,significantly,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130224,",",O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130225,and,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130226,inhibited,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130227,the,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130228,pathogens,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130229,to,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130230,approximately,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130231,80,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130232,%,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130233,of,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130234,the,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130235,controls,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130236,(,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130237,not,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130238,significant,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130239,),O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130240,.,O,4528.0,"Aqueous extracts of banana , apple and orange all enhanced the growth of the three probiotic strains significantly , and inhibited the pathogens to approximately 80 % of the controls ( not significant ) ."
130546,Both,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130547,oral,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130548,and,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130549,external,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130550,oil,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130551,dosing,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130552,studies,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130553,identified,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130554,oil,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130555,-,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130556,related,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130557,toxicity,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130558,endpoints,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130559,associated,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130560,with,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130561,oxidative,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130562,stress,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130563,such,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130564,as,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130565,hemolytic,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130566,anemia,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130567,",",O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130568,liver,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130569,and,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130570,kidney,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130571,damage,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130572,",",O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130573,and,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130574,immuno,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130575,-,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130576,modulation,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130577,or,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130578,compromise,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130579,.,O,4541.0,"Both oral and external oil dosing studies identified oil - related toxicity endpoints associated with oxidative stress such as hemolytic anemia , liver and kidney damage , and immuno - modulation or compromise ."
130924,Critical,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130925,knowledge,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130926,on,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130927,these,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130928,compounds,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130929,and,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130930,their,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130931,signaling,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130932,pathways,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130933,may,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130934,help,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130935,in,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130936,formulation,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130937,of,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130938,effective,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130939,anticancer,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130940,drugs,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130941,.,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
131333,Histone,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131334,deacetylase,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131335,inhibitors,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131336,(,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131337,HDACi,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131338,),O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131339,regulate,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131340,the,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131341,activity,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131342,of,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131343,HDACs,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131344,and,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131345,are,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131346,being,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131347,used,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131348,in,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131349,cancer,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131350,treatment,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131351,either,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131352,alone,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131353,or,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131354,in,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131355,combination,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131356,with,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131357,other,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131358,chemotherapeutic,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131359,drugs,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131360,/,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131361,radiotherapy,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131362,.,O,4566.0,Histone deacetylase inhibitors ( HDACi ) regulate the activity of HDACs and are being used in cancer treatment either alone or in combination with other chemotherapeutic drugs / radiotherapy .
131363,The,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131364,Food,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131365,and,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131366,Drug,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131367,Administration,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131368,(,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131369,FDA,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131370,),O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131371,has,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131372,already,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131373,approved,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131374,four,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131375,compounds,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131376,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131377,namely,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131378,vorinostat,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131379,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131380,romidepsin,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131381,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131382,belinostat,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131383,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131384,and,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131385,panobinostat,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131386,",",O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131387,as,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131388,HDACi,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131389,for,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131390,the,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131391,treatment,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131392,of,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131393,cancer,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131394,.,O,4567.0,"The Food and Drug Administration ( FDA ) has already approved four compounds , namely vorinostat , romidepsin , belinostat , and panobinostat , as HDACi for the treatment of cancer ."
131515,HDACi,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131516,exhibit,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131517,their,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131518,antitumor,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131519,effect,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131520,by,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131521,the,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131522,activation,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131523,of,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131524,cell,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131525,cycle,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131526,arrest,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131527,",",O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131528,induction,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131529,of,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131530,apoptosis,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131531,and,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131532,autophagy,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131533,",",O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131534,angiogenesis,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131535,inhibition,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131536,",",O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131537,increased,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131538,reactive,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131539,oxygen,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131540,species,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131541,generation,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131542,causing,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131543,oxidative,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131544,stress,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131545,",",O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131546,and,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131547,mitotic,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131548,cell,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131549,death,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131550,in,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131551,cancer,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131552,cells,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131553,.,O,4571.0,"HDACi exhibit their antitumor effect by the activation of cell cycle arrest , induction of apoptosis and autophagy , angiogenesis inhibition , increased reactive oxygen species generation causing oxidative stress , and mitotic cell death in cancer cells ."
131774,Bread,B,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131775,prepared,I,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131776,with,I,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131777,buckwheat,I,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131778,flour,I,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131779,had,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131780,improved,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131781,quality,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131782,:,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131783,an,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131784,increased,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131785,specific,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131786,volume,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131787,",",O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131788,a,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131789,softer,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131790,texture,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131791,",",O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131792,color,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131793,characteristics,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131794,",",O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131795,and,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131796,gas,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131797,-,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131798,cell,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131799,size,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131800,distribution,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131801,similar,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131802,to,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131803,French,B,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131804,bread,I,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131805,.,O,4581.0,"Bread prepared with buckwheat flour had improved quality : an increased specific volume , a softer texture , color characteristics , and gas - cell size distribution similar to French bread ."
131806,Bread,B,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131807,with,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131808,1.9,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131809,%,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131810,guar,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131811,gum,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131812,(,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131813,w,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131814,/,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131815,w,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131816,",",O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131817,total,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131818,flour,B,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131819,basis,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131820,),O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131821,and,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131822,5,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131823,%,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131824,buckwheat,B,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131825,flour,I,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131826,(,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131827,of,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131828,all,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131829,flours,B,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131830,and,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131831,substitutes,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131832,),O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131833,mimicked,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131834,French,B,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131835,bread,I,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131836,quality,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131837,attributes,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
131838,.,O,4582.0,"Bread with 1.9 % guar gum ( w / w , total flour basis ) and 5 % buckwheat flour ( of all flours and substitutes ) mimicked French bread quality attributes ."
132191,This,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132192,indicates,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132193,that,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132194,the,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132195,transfer,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132196,of,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132197,fat,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132198,from,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132199,diet,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132200,to,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132201,milk,B,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132202,might,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132203,facilitate,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132204,transfer,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132205,of,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132206,Zn,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132207,from,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132208,diet,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132209,to,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132210,milk,B,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
132211,.,O,4595.0,This indicates that the transfer of fat from diet to milk might facilitate transfer of Zn from diet to milk .
